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ABSTRACT
The exact composition of focal adhesions and the role of single components in 
their assembly and regulation during dynamic adhesive processes are poorly understood. 
I have characterised and used a "cell-free" system consisting of ventral plasma 
membranes (VPMs) prepared from adherent fibroblasts, and found that this subcellular 
fraction preserves intact focal adhesion components and the connected actin cytoskeleton. 
Moreover, VPMs show an accumulation of several tyrosine phosphorylated proteins, 
including tyrosine phosphorylated focal adhesion kinase and paxillin. In particular, a 
pool of higly phosphorylated paxillin is found in focal adhesions, suggesting an 
important role pf the phosphorylated polypeptide in the mechanism of integrin-mediated 
adhesion.
With the aim of obtaining new important tools for my studies, I have produced 
and characterised monoclonal antibodies (mAbs) raised against VPM preparations.
The use of VPM preparations as a "cell-free" system has shown that changes in 
[Ca2+] can affect integrin behaviour within VPMs. I observed a correlation between 
integrin localisation and the functional state of the receptors, which can be reversibly 
modulated either by changes in free [Ca^+J, or by function modulating anti-integrin p i 
mAbs. [Ca2+]-induced integrin redistribution is dependent on the presence of the p i 
cytoplasmic domain, whereas it is independent from the presence of filamentous actin (F- 
actin) and focal adhesion components in this experimental system, thus implicating the 
uncoupling of events relevants for focal adhesion assembly under "cell-free" conditions. 
Moreover, reconstitution experiments show that a-actinin colocalises and redistributes 
with p i receptors on VPMs depleted of actin, implicating binding of a-actinin to the 
receptors. Finally, I found that recruitment of exogenous actin is specifically restricted to 
focal adhesions under conditions in which new actin polymerisation is inhibited. These 
data attest the value of the system for further analysis of the molecular mechanisms 
regulating integrin function and focal adhesions.
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Chapter 1 -
INTRODUCTION
In multicellular organisms the interactions between cells and the extracellular 
environment are fundamental both during embryonic development and during adulthood. 
In fact, the processes of controlled morphogenesis and appropriate tissue growth and 
repair require cells to continuously sense their relationship to the extracellular matrix 
(ECM) and to each other. These interactions are mediated by different families of 
receptors present on the surface of the cell, including growth factors receptors, cadherins, 
immunoglubulin superfamily receptors (NCAM, ICAM, etc...), selectins and integrins.
Integrins are the most important family of cell surface receptors that mediate 
attachment to and signalling from the ECM. Specific classes of integrins mediate also 
important cell-cell adhesive interactions. Integrin-mediated adhesive interactions are 
intimately involved in the regulation of many cellular functions (Fig. 1.1). During 
embryonic development they mediate cell migration towards the correct targets, and 
control the organisation of individual cells into tissues. In the adult animal, they are 
involved in co-stimulation and migration of lymphocytes, as well as in wound repair, 
bone resorption, clot retraction, and the response of cells to mechanical stress. Integrins 
cooperate with growth factors to promote cell proliferation, a mechanism explained, in 
part, by the anchorage-dependence of the Gl-to-S phase transition during cell cycle 
progression. Adhesion is necessary also for cells to exit from the cell cycle and to 
differentiate. In addition, when adherent cells are released from their surrounding ECM, 
they forfeit survival signals and undergo apoptosis. The great effort in the last years in 
the understanding of the molecular basis of adhesion regulation and integrin-mediated 
signalling is justified also by the involvement of these receptors in several pathological 
situations, including tumour cell growth and metastasis, thrombosis and inflammation.
Integrin signalling leading to these different functions is initiated by the interaction 
of the receptors with the extracellular ligand, a mechanism that will be discussed in 1.1. 
Integrin affinity for the ligand is often regulated by cells, through a mechanism called 
"inside-out signalling", that allows cells to modify the strength of adhesion during several 
important processes, such as migration: the molecular basis of this phenomenon will be 
discussed in 1.2. Signal transduction initiated by integrins involves the interaction and
1
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Figure 1.1. Integrin-based adhesion and its function in the biological 
processes.
Upon activation of integrins by the interaction with the ECM, focal adhesions are 
organised and connected to the actin cytoskeleton. Integrins are known to initiate signals 
for the reorganisation of the cytoskeleton, required for cell shape modification and for 
several important biological functions. Integrin affinity for the ligand can be regulated by 
an "inside-out" mechanism. The numbers in the boxes indicate the paragraphs were the 
various aspects of cell adhesion will be treated.
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reorganisation of the actin cytoskeleton, to allow cells to change their morphology in 
different situations. For several cells in culture on ECM components, this interaction 
leads to the organisation of sites of tight adhesion, called focal adhesions. These 
structures are considered to be a valuable model to study the mutual interactions occurring 
between the ECM and the cytoskeleton. The molecular organisation of focal adhesions 
and their function will be analysed in 1.3. Focal adhesions are also known to contain 
signalling molecules for the reorganisation of the actin cytoskeleton. The molecular basis 
of actin cytoskeleton organisation and dynamics will be discussed in 1.4.
1.1 THE INTEGRIN RECEPTORS FOR THE ECM
1.1.1 Variety of integrins and ligands
The ECM is a composed of a variety of versatile glycoproteins and proteoglycans 
that are secreted locally and assembled into an organised meshwork in close association 
with the surface of the cell. It represents a dynamic and information-rich environment
Vwô
controlling several aspects of cell behaviour; in fact itjSC M jrophic and support
functions, and it plays an active and complex role in regulating cell development,
migration, proliferation, shape and function. The ECM has a complex molecular
ory
composition which vary both^d the types of macromolecules and on the way they are 
organised. This gives rise to an amazing diversity of forms, each adapted to the 
functional requirements of the particular tissue. ECM molecules can be secreted by 
different types of cells, in particular by fibroblasts and other cells of the connective 
tissues. Some of the best known components of the ECM are collagens, laminins, 
fibronectin, vitronectin, thrombospondin and proteoglycans. Fibronectin is one of the 
most abundant ECM proteins secreted by chicken embryo fibroblasts (CEFs), the cell 
system utilised in this study. It is a large glycoprotein composed of two subunits joint by 
a pair of disulphide bonds, each of which contains 15 typical type III fibronectin repeats. 
Fibronectin assembles on the surface of cells as highly insoluble fibrils, composed by 
fibronectin dimers cross-linked to one-another by additional disulphide bonds.
The family of integrin receptors for the ECM is made by heterodimers composed 
of a  and p transmembrane subunits, interacting by non covalent bonds. The association 
between the two subunits determines the specificity of the receptor for various molecules
INTEGRIN LIGAND
a l Laminin, Collagen
a2 Laminin, Collagen, a3pi
a3* Laminin, Collagen, Fibronectin, Entactin, 
Vitronectin, a2pl, a3pi
p i* a4 Fibronectina, VCAM-1, MadCAM-1
a5 Fibronectin
a6* Laminin
a7* Laminin
a8 Fibronectin, Vitronectin, Tenascin .
aV Fibronectin, Vitronectin
a9 Osteopontin, Tenascin
aL ICAM-1, ICAM-2, ICAM-3
P2 aD ICAM-3
aM iC3b, Fibrinogen, Factor X, ICAM-1
aX iC3b, Fibrinogen
allb Fibrinogen, Fibronectin, vWFactor, Vitronectin,
p3* Thrombospondin
aV Fibrinogen, Fibronettina, vWFactor, Vitronettina, 
Thrombospondin
64* a6* Laminin
P5 aV Vitronectin
P6 aV Fibronectin
P7 a4 Fibronectin, VCAM-1, MadCAM-1
aE E-cadherin
P8 aV ? ■
Table 1.1 The family of integrin receptors in vertebrates.
Asterisks indicate the subunits for which alternative splicing variants have been 
described. aE=ct subunit specifically expressed in intraepithélial lymphocytes; 
iC3b=inactive component of the complement C3b; MadCAM-1=Mucosal Addressin Cell 
Adhesion Molecule.
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of the extracellular matrix. Currently, the family of integrin receptors comprises 22 a/p  
heterodimers, obtained by several combinations of 8 different p and 16 different a  
subunits (Table 1.1). The existence for some a  and p subunits of alternative splicing 
variants for both cytoplasmic and extracellular domains, further increases the complexity 
of the integrin family (see 1.1.2). As shown in Table 1.1, an integrin can often bind 
more than one ligand, and a single ligand can be recognised by more than one integrin. 
Most of the ligands in Table 1.1 are ECM molecules that mediate cell-substrate adhesion, 
but some, like fibrinogen, also mediate cell-cell interactions. Moreover, some integrins 
bind to integral transmembrane proteins of the immunoglobulin superfamily (ICAM, 
VCAM or MadCAM), mediating cell-cell interactions directly. The p i subunit, by 
combining with 10 different a  chains, constitutes the largest subfamily of integrin 
receptors, p i integrins are the most important family of receptors for the ECM in CEFs 
(Bossy and Reichardt, 1990).
1.1.2 Integrin structure
Both a  and p subunits of integrins are transmembrane glycoproteins composed 
by a large extracellular, N-terminal domain, a single transmembrane segment, and an 
usually short cytoplasmic, C-terminal domain (Fig. 1.2). Both the intracellular and the 
large extracellular domain (more than 75 KD for p and more than 100 KD for a  subunits) 
are known to be involved in a  and p interaction, which is believed to occur in a pre- 
Golgi compartment (Hynes et a l, 1989). The N-terminal portion of integrin a  subunits 
comprises seven homologous, tandemly repeated domains of about 50 aminoacids 
(Fig. 1.2 B). Repeats 4-7 (or in some integrins 5-7) contain cation-binding sequences, 
similar to the EF-hand motif found in Ca^-binding proteins, such as calmodulin, a  
subunits can be divided in two groups, on the basis of biochemical analysis and sequence 
comparison. The first group includes aV, a3, a6, and ctllb, and comprises a  subunits 
processed by a post-translational proteolitic cut that separates them in a large extracellular 
portion covalently associated by a disulphide bond to a shorter portion (25-30 KD) 
including the transmembrane domain. Members of the second group of a  subunits, 
including a l ,  «2, aE, ctL, ctX, aM , and aD , are not proteolitically processed and 
contain a domain (the A-, or I-domain) of around 200 aminoacids inserted between the 
second and the third N-terminal repeats. This domain is homologous in sequence to the 
A-domains of von Willebrand factor, and has been shown to contain a single cation
5
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Figure 1.2. Structural features of integrin receptors.
Panel A: Overall shape of integrin receptors,, as deduced from electron microscopy. The 
putative, location of the cysteine rich repeats of the p subunit (crosshatched), and the 
metal-binding.sites in the a  subunit (M++), are indicated. The shaded area represents the 
ligand-binding region. (From Hynes, 1992).
Panel B: Schematic diagram of integrin structure (from Mould, 1996). See text for 
further details.
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binding site (Lee et al., 1995; Qu and Leahy, 1995). The extracellular portion of the p 
subunit contains some cystein-rich regions in the "stalk" region, with homology to EGF 
modules, probably involved in the formation of intramolecular disulphide bonds. Near 
the N-terminus, the |3 subunit contains a region of about 240 amino acids that is highly 
conserved between different p subunits. By comparison of consensus hydropathy plots 
or secondary structure prediction, this structure appears to contain an A-domain-like 
structure with a cation-binding site. This structure includes multiple conserved 
oxygenated residues critical for ligand binding, and non-conserved residues critical for 
ligand specificity (see below).
With the exception of p4 cytoplasmic domain, containing more than 1000 
aminoacids, integrin cytoplasmic domains contain less than 60 aminoacids and they don't 
have any known enzymatic activity. The primary sequence of the p subunits is highly 
conserved during evolution, and in particular three clusters of residues are conserved 
among species (Fig. 1.3). The first cluster, which is unique to p i integrins, is a stretch 
of 11 amino acids adiecient to the transmembrane domain that consists primarily of 
charged amino residues. The second cluster includes an NPXY sequence that has been 
associated with internalisation in the low density lipoprotein receptor (Chen et al., 1990), 
and is conserved between all p subunits (with the exception of p4). The third cluster 
contains an NPXY-related sequence conserved between p i, P2 and p7, and is somewhat 
divergent in the P3, P5 and p6 subunits (Fig. 1.3). A number of isbforms for some of 
the P subunit cytoplasmic domains have been identified which arise from alternative 
Ificing. In particular, 4 different alternative splicing variants have been described for the 
cytoplasmic tail of the p i subunit: p i A, B, C, and D; only p i A (which is ubiquitous) 
and D (muscle specific) localise to focal adhesions. plB is found in skin and liver, while 
p iC  is found in non-proliferative cells and it has been suggested to have an inhibitory 
effect on cell cycle progression (see Fomaro and Languino, 1997, for a review).
Like the p subunit cytoplasmic domains, the a  subunit cytoplasmic domains are 
highly conserved among different species. However, in contrast to the p subunits, the 
different a  subunit cytoplasmic domains show little homology among one another, 
suggesting distinct roles. The most striking conserved motif is the sequence GFFKR, 
which is adjacent to the transmembrane domain and is conserved among all a  subunits. 
At the C-terminus, the sequence TSDA is conserved among the a5, a6, aV  and a 8 
subunits and is partially conserved in the a3 subunit, but its exact function is not clear 
yet. Like the p subunits, some a  subunit cytoplasmic domains present variants obtained
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a-actinin talin
pi Ac KLLMI IHDB^FMFMEKMNAKWDTGENPXYKSAVTTWNPKYRGK ( 757-803 )
pi Ah KLLMIIHDSREr^KfE^E^D^ftKWDTGENPXYKSAVTTWNPKYRGK (752-798)
p2 KALIHLSDLREYRRFEKEKLKSQWNND-NPLFKSATTTVMNPKFAKS (724-769)
P3A KLLITIHDRKEFAKFEEERARAKWDTANNPLYKEATSTFTNITYRGT (742-788)
P5 KLLVTIHDRREFAKFQSERSRARYEMASNPLYRKPISTHTVDFTFMKFNKSYNGTVn (743-799)
p6 KLLVSFHDRKEVAKFEAERSKAKWQTGTJSELXRGSTSTFIQJYÏXKHREKQKVDLSTDC (731-788)
RLSVEIYDRRE YSRFEKEQQQLNWKQDSIffiLXKSAITTTINPRFOEADSPTT ■ (747-798)P7
Figure 1.3 Aligment of the cytoplasmic domains of p integrins.
Sequence alignment of the integrin (3 subunit cytoplasmic domains from the membrane 
proximal lysme. piA is one of four cytoplasmic domain splice variants; piAu represents 
the chicken cytoplasmic domain sequence, and piAh is the equivalent human sequence. 
All other sequences are from human. The residues numbers are in parentheses. The 
three major conserved clusters are underlined. The major binding site for a-actinin 
(FAKFEKEKMN) and talin (WDTGENPIYK) in the chicken pi integrin cytoplasmic 
domain, as determined using in vitro binding assays, are indicated.
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from alternative splicing. The splicing variants are often expressed in a tissue-specific 
manner, but their exact biological function is not completely clear.
1.1.3 The structural basis of integrin-ligand interactions
Integrin ligand-binding sites within integrin ap  heterodimers have been identified 
by a combination of approaches, including chemical cross-linking of ligand peptides, 
synthesis of recombinant integrin fragments and peptides, functional mAb epitope- 
mapping, and analysis of natural and engineered integrin mutants (Humphries et al, 1994; 
Loftus et al, 1994). These studies have implicated three regions in ligand binding: first, 
sequences close to, or at EF-hand-like motifs in the N-terminal part of the a  subunit; 
second, the A-domain that is found in a subset of a  subunits; and third, the A-domain- 
like structure present near the N-terminus of the (3 subunit (see previous paragraph). The 
ligand-binding pocket appears therefore to involve both subunits and the interaction is 
likely to be complex in nature. The seven sequence repeats present in the N-terminal 
region of the a  subunits have been proposed to arrange in a p-propeller model, in which 
seven four-stranded p-sheets are organised in a torus around a pseudo-symmetry axis 
(Springer, 1997). Several predicted loops critical for ligand binding have been identified 
in the upper face of the proposed P-propeller model, in the face opposite to the cation- 
binding site (Fig. 1.4). If an A-domain was present in the a  subunit, it would be 
inserted between the second and the third of the propeller blades. The structure of the A- 
domain from several a  subunits have now been solved (Lee et al., 1995; Qu and Leahy, 
1995; Qu and Leahy, 1996). It adopts a Rossmann, or dinucleotide-binding fold, with a 
central sheet of p-strands decorated peripherally by six a-helices. At one end of the 
module, a series of loops coordinate a divalent cation. The A-domain-like structure 
present in the N-terminal domain of the p subunits, has also been implicated in ligand 
recognition (Fig. 1.4). Although the overall structure of integrin domains can not be 
predicted, their arrangement relative to each other and to the ligand, together with a 
transition from inactivity to activity, has been hypothesized for a5 p i integrin binding to 
fibronectin (Humphries and Newham, 1998), and it is described in Fig. 1.4.
All integrin-ligand interactions are divalent cation dependent and, consistent with 
this finding, all three of the regions above that are implicated in ligand binding have been 
shown to contain sequences that interact with divalent cations. As large integrin ligands 
frequently employ a short acidic peptide as a key binding determinant (e.g. RGD, present 
in several ECM molecules), it has been suggested that a receptor-bound cation might
Inactive integrin
• 01 subunit
putative
A-domain
ctS subunit 
propeiler
Ugand-occupied integrin .
Fibronectin
‘Synergy'
sequence
Figure 1.4. A speculative model for the s tru c tu re  o f a 5 p i  in teg rin  
w » Jigandrbinding site, based on homology to heterotrim eric G-proteins.
Panel A'vjn\the inactive form of the integrin, the a2  helix of the pi subunit putative A- 
; i bu rdpm^in interacts with loops projecting from the top surface of the <x5 subunit p-propeller. 
!)ir; ci i Panel Efej jcpnformational changes in the a2  helix, induced by cation-binding or addition 
r:. , , ;. of stjmulatqry; mAbs that recognise this region, elicit a major repositioning of the integrin 
v i* IS&buâiitSj i #  opening of the integrin dimer and a concomitant exposure of ligand-binding 
v* i . site.s in (the^oS, subunit. The RGD motif in type in  repeat 10 of fibronectin then engages 
v the bound; cation in the pA-domain, and the synergy sequence (PHSRN) present in type 
in  repeat 9 engages a site in the ci5 subunit p-propeller (from Humphries and Newham, 
1998).
10
function as an integrin-ligand bridge (Humphries et al., 1994). The cation dependence of 
ligand binding has been investigated for a number of integrins, and a similar, though not 
exclusive, specificity has been observed: Mn^+ and Mg2+ usually promote ligand 
binding, while Ca^+ has usually an inhibitory effect (Tuckwell et al., 1992). Integrins 
are believed to exist in an equilibrium between at least two different conformations: one 
with a low affinity for the ligand (inactive) and one with a high affinity for the ligand 
(active). Some cations, like Ca2+, have been suggested to displace the conformational 
equilibrium in favour of a conformation that is unable to bind ligand, whereas others, like 
Mg2+ or Mn2+} displace the equilibrium in the opposite direction and increase the 
proportion of integrin that is competent to bind ligand (Mould, 1996). A large number of 
anti-integrin mAbs have been reported which either perturb or enhance ligand binding. In 
this scenario, stimulatory mAbs may act by increasing the proportion of the integrin 
population that is in a ligand-competent state, either by displacing the conformational 
equilibrium or by directly inducing changes in integrin shape. On the contrary, inhibitory 
mAbs stabilise an integrin conformation that has a low affinity for the ligand, or directly 
induce the formation of such a conformation (Humphries, 1996).
1.2 INSIDE-OUT REGULATION OF INTEGRIN AFFINITY
1.2.1 The biological importance of integrin affinity regulation
Cells have the ability to rapidly modulate binding affinity of the integrins for their 
ligands, a process known as "affinity regulation". This process allows the cell to 
modulate the strength of adhesion and adds extraordinary flexibility to integrins. Ligand- 
binding regulation can be achieved by cells by using both integrin affinity modulation and 
integrin clustering (avidity modulation). Integrin clustering can be regulated by 
intracellular signalling events that remodel cytoskeletal linkages, such as the ones 
occurring at focal adhesion sites (see 1.3), or alter receptor diffusion rates within the cell 
membrane. Changes in both integrin affinity and avidity are not mutually exclusive, but 
the relative contributions of each to ligand binding vary with integrin type and the cellular 
context (Hato et al., 1998; Stewart and Hogg, 1996; Lub et a l,  1995). Thus far, 
integrins of the p i, p2, P3 and p? families have been shown to modulate their ligand- 
binding affinities in response to cytoplasmic signals (Faull et a l, 1993; Crowe et a l, 
1994; Shattil et a l, 1998). Platelet aggregation is a classical example of a physiological
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process dependent on integrin affinity modulation. The aggregation of platelets relies on 
their crosslinking by fibrinogen, a soluble plasma protein that binds to the integrin 
allbp3. Resting platelets are unable to aggregate because their allb|33 is in a partially 
active conformation that has low affinity for soluble fibrinogen. Following platelet 
activation by specific agonists, cxllb|33 undergoes a conformational change that 
dramatically increases its binding to fibrinogen, resulting in platelets aggregation (Shattil 
et a l,  1998).
Another example of integrin affinity modulation concerns cell migration, which is 
dependent on rapid, controlled changes in integrin-dependent cell adhesion, suggesting 
that coordinated activation and de-activation of integrins play a crucial role in this process 
(Lauffenburger and Horwitz, 1996). Indeed, the importance of integrin affinity 
modulation as a crucial regulator in cell migration is illustrated by the observation that 
locking integrins in a constitutive high affinity state can inhibit cell migration (Kuijpers et 
al, 1993; Huttenlocher et a l, 1996). Significantly, a role for integrin affinity modulation 
in embryonic development is starting to emerge. Martin-Bermudo et al. (1998) have 
recently demonstrated in the Drosophila embryo that normal morphological development 
is disrupted by a constitutively active variant of the aPS2 subunit.
1.2.2 Integrin cytoplasmic domains play a central role in affinity 
modulation
Integrin affinity modulation is proposed to involve the propagation of 
conformational changes from the integrin cytoplasmic domain to the extracellular ligand- 
binding sites, leading to a direct increase in ligand-binding affinity.
The role of integrin cytoplasmic domains in activation has been demonstrated by 
expression and analysis of recombinant integrins. The membrane proximal regions of (3 
and a  subunit cytoplasmic domains share a similar organisation of polar and apolar 
amino acids just after the membrane-cytoplasm interface. The conserved sequences for 
the a  and (3 subunits are GFFKR and LLv-iHDR, respectively, and the deletion of these 
sequences in either the a  or p subunit activates integrins (Crowe et a l, 1994; O'Toole et 
al, 1994). These sequences form a structural constraint, referred to as the membrane- 
proximal "hinge", that locks the integrins in the low affinity conformation. Sequences C- 
terminal to the membrane proximal motifs in the a  and |3 subunit cytoplasmic domains 
also play a crucial role in integrin activation. In fact, the deletion of sequences C-terminal 
to the GFFRK motif in a number of distinct a  cytoplasmic domains inhibit cell adhesion,
12
suggesting that these sequences are required for integrin activation (Williams et al., 
1994). The well-conserved NPXY motif in the |3 cytoplasmic domain appears to be 
essential for integrin activation (O'Toole et a l, 1995). Together these observations lead 
to the idea that the interactions of a  and p cytoplasmic domains with specific regulatory 
factors could modulate integrin affinity. This hypothesis is supported by the observation 
that the transfection of either isolated p i or (33 cytoplasmic domains induces a dose- 
dependent decrease in the ligand-binding affinity of active al3bp3 chimeras (Chen et a l, 
1994), a process referred to as "dominant-suppression". This suggests that isolated 
cytoplasmic domains compete for limiting amounts of intracellular factors required for 
integrin activation.
The presence of highly conserved tyrosine, threonine and serine residues in 
integrin cytoplasmic domains suggests that phosphorylation has the potential to regulate 
integrin activation. Indeed, there is some evidence that suggests that the phosphorylation 
of tyrosine residues in the P3 cytoplasmic domain plays a role in the activation of aVp3 
(Blystone, et al., 1996). However, detailed studies on allbp3, aLp2 and a6A pi have 
thus far failed to demonstrate a potential role for phosphorylation in the activation of these 
integrins (Williams et a l, 1994).
1.2.3 Intracellular signalling pathways involved in affinity 
modulation
At present, the cytoplasmic signalling pathways regulating integrin affinity are 
poorly understood. During platelet aggregation, agonists such as thrombin, activate 
a llb p 3  via heterotrimeric G-protein-coupled receptors, which in turn, stimulate 
phospholipase C, resulting in phosphoinositide hydrolysis and activation of protein 
kinase C (Shattil et a l, 1998). Experiments with inhibitors of various protein tyrosine 
kinases or phosphatases suggest that changes in protein phosphorylation play a key role 
in the activation of integrins in platelets (Shattil et a l, 1992). A number of recent studies 
in cells other than platelets indicate that the Ras family of small GTP-binding proteins and 
their effectors play a crucial role in regulating integrin affinity. Activated H-Ras and its 
kinase effector Raf-1 inhibit integrin activation in Chinese hamster ovary (CHO) cells 
(Huges et a l, 1997). R-Ras, a small GTP-binding protein highly homologous to H-Ras, 
is also a regulator of integrin activation but, unlike H-Ras, activated R-Ras stimulates 
rather than inhibiting integrin ligand-binding affinity (Zhang et a l, 1996). This raises the 
possibility that these small GTP-binding proteins act in concert to modulate integrin
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Figure 1.5. Signalling pathways implicated in integrin affinity 
modulation.
In most cases, it is unclear how the depicted pathways are directly linked to a molecular 
interaction with the integrin. Protein Kinase C (PKC) might act via its substrate Rack 1, 
which binds directly to integrin p tail. Phosphoinositide (PI) 3-kinase might activate 
integrins through members of a novel protein family consisting of a Sec7- and a 
pleckstrin-homology (PH) domain, a member of which is cytohesin-1. After 
phosphatidylinositol (3,4,5)-triphosphate [Ptdlns(3,4,5)Ps]-induced translocation to the 
membrane, these proteins might interact directly with integrin p cytoplasmic domains to 
modulate ligand-binding affinity. Symbols and abbreviations: +, a positive regulator of 
activation; -, a negative regulator of activation; PKC, Rackl, receptor for activated 
protein kinase C; MAPK, mitogen activated protein kinase; Sec7, Sec7-homology 
domain. From Huges and Pfaff, 1998.
affinity (Fig. 1.5). There is also evidence suggesting that the small GTP-binding protein 
Rho plays a role in integrins activation. Inactivation of Rho by C3 exoenzyme blocks 
a4pl-dependent adhesion of chemoattractant-stimulated lymphocytes to VCAM-1 and 
dL|32-dependent adhesion of neutrophils to fibrinogen (Laudanna et al., 1996). Recent 
studies on integrin function in leukocytes have identified a potentially important role for 
PI 3-kinase in regulating the activation of p i and p2 integrins (Shimizu and Hunt, 1996). 
Interestingly, R-Ras can stimulate PI 3-kinase activity, providing a plausible explanation 
for an involvement of R-Ras in integrin activation (Marte and Downward, 1997).
A potential link between PI 3-kinase and the activation of p2 integrins is emerging - 
from the finding that the PI 3-kinase product phosphoinositide (3,4,5)-trisphosphate 
binds to certain pleckstrin-homology (PH) domains, leading to the recruitment of the PH 
domain to the plasma membrane (Lemmon et a l, 1997). Cytohesin-1, which interacts 
with the cytoplasmic domains and subsequently activates aLp2, contains a PH domain 
(Kolanus et a l, 1996). Therefore it is possible to envisage a scenario in which PI 3- 
kinase activation results in the membrane localisation of cytohesin-1 (Fig. 1.5). n
Subsequently, cytohesin-1 could then bind to the p2 subunit cytoplasmic domain and 
induce activation. It remains to be determined whether the cytoplasmic domains of other 
P subunits can bind to other cytohesin-like proteins.
1.2.4 Direct interactions of proteins with integrin cytoplasmic 
domains
Given the importance of integrin cytoplasmic tails in integrin activation, proteins 
that interact directly with integrin cytoplasmic domains are potentially excellent candidates 
for regulators of activation. Consequently, there has been an intense effort in the last few 
years to identify such proteins. This has resulted in a growing list of proteins that can 
bind to integrin cytoplasmic domains, at least in vitro, including both cytoskeletal and 
potential regulatory proteins (Table. 1.2). However, it should be stressed that solid 
evidence for an occurrence of these interactions in vivo and for their implication in 
affinity modulation is mostly lacking. Interactions of integrins with the cytoskeleton via 
talin (Horwitz et a l, 1986) and a-actinin (Otey et a l, 1990) are thought to occur as a 
consequence of integrin-ligand engagement, contributing to the formation of focal 
adhesion complexes (see 1.3). It is unclear whether such interactions also occur 
independently of ligand binding to regulate receptor affinity. However, recent evidence
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suggests that interactions of integrin cytoplasmic domains with the cytoskeleton can lock 
integrins in their inactive state (Stewart et ah, 1998).
Calreticulin has been shown to bind to the highly conserved and functionally 
important GFFKR motif in integrin a  tails (Rojiani et al., 1991). This interaction is 
increased upon integrin stimulation and proposed to be required for the stabilisation of the 
high affinity state of the receptor (Coppolino et a l, 1995). Moreover, a potential role for 
calreticulin in affinity modulation is illustrated by the defects of calreticulin-null 
embryonic stem cells in integrin-mediated cell adhesion and Ca^+ influx (Coppolino et 
al., 1997). Focal adhesion kinase (p!25 FAK) and paxillin also interact directly with 
integrin p cytoplasmic domains peptides in vitro (Schaller et a l, 1995). However, a role 
for these interactions in regulating integrin affinity in vivo has yet to be determined. A 
serine/threonine protein kinase (p59 ILK), which binds to p i, P2 and P3 cytoplasmic 
tails, disrupts cell-substratum adhesion when overexpressed in cells, indicating a possible 
role in integrin affinity modulation (Hannigan et al., 1996). The receptor for activated 
protein kinase C (Rack 1), a Trp-Asp (WD) repeat protein, binds to the conserved 
membrane-proximal region of pi, p2 and p5 subunit cytoplasmic domains (Liliental and 
Chang, 1998). The association of Rack 1 in vivo appears to depend upon prior 
stimulation with phorbol esters, suggesting that Rack 1 could potentially act as link 
between protein kinase C (PKC) and integrins. Recently, several less ubiquitous 
proteins have been identified that interact with specific integrin subunit cytoplasmic 
domains: p3-endonexin, which is specific for p3 integrin tails (Shattil et al., 1995), 
cytohesin-1, a protein binding to the cytoplasmic domain of P2 integrins (Kolanus et a l, 
1996), a Ca2+-and integrin-binding protein (CIB) interacting with the integrin crilb tail in 
platelets (Naik et a l, 1997), and ICAP-1, a novel 200 amino acid protein that interacts 
specifically with the p i integrin cytoplasmic domain (Chang et a l, 1997). The role of 
CIB and ICAP-1 in integrin activation is unknown, but there is evidence for a role for 
P3-endonexin and cytohesin-1 in the regulation of integrin affinity (Kolanus et a l, 1996; 
Kashiwagi et al., 1997).
Finally, lateral associations of integrins with membrane proteins might also 
modulate integrin affinity, not necessarily through interactions with integrin cytoplasmic 
domains. The transmembrane protein CD98, and early T-cell activation antigen that 
associates with "active" p i integrins, was implicated as a regulator of integrin activation 
(Pfaff et a l,  1998). p3 integrins can associate with CD47 or IAP (integrin associated 
protein), and it has been shown recently that binding of LAP to its ligand thrombospondin 
can activate platelet integrin allbp3 (Chung et al, 1997). Members of the tetraspanning
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CIB «m, 2HYB
Calreticulin a PEP, COIP
pplZS*4* 3 PEP
pp59M 3 2HYB
Paxillin 3 . PEP
Cytohesin-1 3 : 2HYB
3 3-Endonexin 3 , 2HYB
ICAP-1 3i 2HYB
Rack! 3 2HYB
Structural cytoskeletal protein 
Structural cytoskeletal protein 
Structural cytoskeletal protein 
Has hom ology  to  calcineurin B; contains tw o EF-hand 
motifs
Expression correlates w ith in tegrin-m ediated  cell 
adhesion
A tyrosine kinase localized to  focal adhesions 
C ontains a serine-threonine kinase dom ain; 
overexpression inhibits ceil adhesion 
An ad ap to r protein contain ing SH2- and  SH3- 
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Overexpressjon activates a ,lbP j 
Ligation of.p1 integrins induces phosphorylation 
of ICAP-1
Interaction w ith integrins in vivo is PMA d ep en d en t
Table 1.2. Proteins interacting directly with integrin cytoplasmic
domains.
Abbreviations: CIB, calcium- and integrin-binding protein; COIP, co-
immunoprecipitation; EQ, equilibrium gel filtration; FAK, focal adhesion kinase; ICAP, 
integrin cytoplasmic domain-associated protein; ILK, integrin-linked kinase; INT, 
binding to purified integrin; PEP, synthetic/recombinant peptide studies; PH, plekstrin- 
homology domain; Sec7, Sec7-homology domain; SH2, Src-homology 2 domain; SH3, 
Src-homology 3 domain; 2HYB, yeast two-hybrid. (Modified from Huges and Pfaff, 
1998).
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class of transmembrane (TM4) proteins, including CD9, CD81, NAG-2 and CD63, have 
been shown to associate with certain integrins, but to date there is no evidence that these 
interactions contribute to the regulation of integrin affinity (Hemler et aL, 1996; Indig et 
a l,  1997).
Currently, it is not clear how "activating" signals acting on integrin cytoplasmic 
tails can mediate changes in integrin ligand-binding affinity. Current experimental data 
suggest that integrins are present on the surface of the cell surface in an default inactive 
state, with the membrane-proximal hinge providing a constraint that locks the receptor in 
a resting conformation. Activation could then be initiated by the interaction of 
cytoplasmic factors with the integrin cytoplasmic tails, thus inducing changes in the 
spatial relationship of the a  and p tails, breaking the membrane proximal hinge. This 
initial conformational change would then cross the lipidic bilayer to the extracellular 
domain of integrin, ultimately changing its affinity for the ligand (see Fig. 1.4).
1.3 INTEGRIN SIGNALLING: THE FOCAL ADHESION  
COMPLEX
1.3.1 Signalling from cell-substrate adhesion complexes
It has been known for many years that, upon interaction with their extracellular 
ligands, integrin receptors are able to transduce signals inside the cell. Protein 
phosphorylation is one of the earliest events detected in response to integrin stimulation 
(Schaller and Parson, 1993), and it will be further discussed in 1.3.4. Integrin 
engagement can induce an increase in the intracellular [Ca^+J, a key regulator of 
intracellular signalling via several integrins (Ingber et a l, 1990; Hendey and Maxfield, 
1993;, Shankar et a l, 1993; Zimolo et a l,  1994; Sjaadtad et a l,  1996; Lawson and 
Maxfield, 1995). Numerous phospholipid metabolites generated in response to integrin 
engagement also function in integrin-mediated signal transduction, in part by activating 
PKC (Divecha and Irvine, 1995), in part by regulating the function of cytoskeletal 
proteins such as profilin, gelsolin, a-actinin, or vinculin (Janmey, 1994). Integrins 
engagement causes elevation of the intracellular pH, as a result of the activation of a 
proton antiporter, and this accompanies cell spreading and appears to be regulated by 
several different integrins (Schwartz and Ingber, 1994).
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Since integrins possess short cytoplasmic tails, and like the T-cell receptor they 
have no intrinsic enzymatic activity, their signalling strategies must be distinct from those 
of growth factor and other receptors with documented kinase or phosphatese activities in 
their cytoplasmic domains. Several evidences support the idea that the mechanism of 
signalling mediated by integrins depends critically on their ability to assemble a 
cytoskeletal framework for the effective interaction of components of the intracellular 
signalling machinery. Therefore, focal adhesions provide a valuable model system for 
studying both integrin-mediated signal transduction and cytoskeletal transmembrane 
linkages. They are present on fibroblasts, and some other cells, which are well spread on. 
ECM substrates, and they are a characteristic of p i and p3 integrins. They are found 
primarily at cell borders where bundles of actin filaments terminate, and contain a very 
large number of different proteins. Whereas focal adhesions are seldom seen in vivo, 
and are only readily apparent under certain conditions, it is assumed that comparable 
molecular structures exist in tissue. In addition to major structural components such as 
a-actinin, talin, and vinculin (discussed in 1.3.3), focal adhesions in spread fibroblasts 
also contain several additional non-enzymatic proteins that are present at low levels, 
suggesting that they may play a regulatory role (Fig. 1.6). These include paxillin (see 
also 1.3 .3), which is a major substrate for tyrosine kinases, and tensin, which has a src 
homology 2 (SH2) domain (Davis et al., 1991; Lo et a l, 1994). As SH2 domains 
recognise phosphorylated tyrosine residues on proteins, they could potentially link 
regulatory and structural proteins at focal adhesion sites. Finally, focal adhesions contain 
enzymatic regulatory molecules that become associated with the cytoskeleton as it is 
reorganised during cell spreading. These include the protein tyrosine kinase pp!25FAK 
(FAK, focal adhesion kinase) (Schaller et a l,  1992), the protein kinase C (Barry and 
Critchley, 1994), pp60src (Clark et a l,  1994; Schlaepfer et a l ,  1994), a Ca2+- 
dependent proteolitic enzyme (calpain II) (Beckerle et a l,  1987), and perhaps 
components of the Rho family of small GTP-binding proteins.
1.3.2 The role of integrin cytoplasmic domains in the association 
with the cytoskeleton
Several lines of evidence point to the integrin p cytoplasmic domain as the 
structure that targets integrins to focal adhesions. Deletion of the p i cytoplasmic domain 
prevents the localisation of the truncated chicken p i integrin to focal adhesions when 
transfected in NIH 3T3 fibroblasts (Hayashi et a l, 1990). The use of chimeric receptors
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Figure 1.6 Model of the m^jor protein-protein interactions in focal 
adhesions.
The model has been obtained from colocalisation studies and from reconstitution of some 
interactions in vitro, altough most associations have not been verified in vivo yet. 
Abbreviations are: ECM, extracellular matrix; PM, plasma membrane; R/E/M, member 
of the radixin/ezrin/moesin family; VASP, vasodilatator-stimulated .phosphoprotein. 
(From Luna and Hitt, 1992).
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containing the cytoplasmic domain of the p i  or p3 integrin subunit fused to the 
transmembrane and extracellular domains of the interleukin-2 receptor has demonstrated 
directly that targeting information is contained in the p cytoplasmic domain (LaFlamme et 
al., 1992; LaFlamme et al., 1994). When overexpressed, these chimeric proteins behave 
as dominant-negative mutants, blocking both the adhesive functions of integrins and the 
signalling induced by ligand binding (LaFlamme et al., 1994; Smilenov, et al., 1994). 
Several complementary studies point to all three conserved clusters in the p i cytoplasmic 
tail (see 1.1.2 and Fig. 1.3) for localisation to focal adhesion^. They include site- 
directed mutagenesis, cytoplasmic domain swaps, homologies among p subunits that 
localise to focal adhesions, and in vitro binding studies with synthetic peptides 
corresponding to cytoplasmic domain sequences (Marcantônio et aL, 1990; Takada et a l, 
1992; Vignoud et al., 1997; Reszka et a l,  1992; Filardo et al., 1995; O'Toole et a l, 
1995). p integrin cytoplasmic domains are known to bind to the different cytoskeletal 
proteins, including a-actinin and talin (Horwitz et aL, 1986; Pfaff et aL, 1998; Otey et 
al., 1990; Schaller et al., 1995), and different lines of evidence support the idea that 
activated integrins do associate with the actin cytoskeleton (Fox et al., 1993; Felsenfeld et 
al., 1996; Choquet et a l, 1997). The use of beads coated with integrin ligands and anti- 
integrin antibodies has revealed à hierarchy of accumulation of molecules at adhesive sites 
(Miyamoto et al, 1995a; Miyamoto et al., 1995b). For example, ppl25FAK and tensin 
accumulate on the cytoplasmic side of the plasma membrane after simple clustering of pi 
integrins, accompanied by a number of signalling molecules, including members of the 
Src family, Rho family GTPases, members of the lipid signalling and mitogen-activated 
protein kinase pathways, in a process that also required protein tyrosine phosphorylation. 
On the other hand, a number of cytoskeletal molecules, including a-actinin, talin and 
vinculin, require both integrin clustering and receptor occupancy by a ligand to 
accumulate in adhesion complexes, suggesting that, to recruit cytoskeletal proteins, the 
integrin must be in the ligand-bound state.
There is current evidence that integrin a-subunits play a negative role in regulating 
integrin association with the actin cytoskeleton. In fact, the cytoplasmic domain of the a- 
subunit is thought to mask the p integrin cytoplasmic domain and to prevent its 
localisation to focal adhesions by default. When the heterodimer is in the ligand-bound 
state, the two cytoplasmic domains move apart to reveal binding sites for cytoplasmic 
proteins (Ylanne eA aL, 1993; O'Toole et aL, 1994; Huges et aL, 1996).
1.3.3 The major structural components of focal adhesions
The best characterised structural proteins mediating the connection between 
integrin receptors and the actin cytoskeleton are talin, a-actinin and vinculin (see Fig. 
1.6). Talin is the first cytoplasmic protein found to interact in vitro with p i integrins 
(Horwitz et a l, 1986), and the interaction requires both NPXY motifs of the chicken p i 
subunit (Reszka et al, 1992). Talin appears to bind as a homodimer, providing a 
potential mechanism by which it might cross-link integrins (Vignoud et aL, 1997). In 
addition to binding to integrins, talin has three binding sites for vinculin (Gilmore et a l,
1993), and at least three binding sites for actin (Bolton et aL, 1997) (Fig.l.7A). 
Interestingly, talin has also been reported to possess actin nucleating activity (Kaufmann 
et a l,  1991). The fact that talin is recruited to newly forming focal adhesions before 
vinculin (DePasquale and Izzard, 1991), suggests that it might play a role in both the 
recruitment of pre-existing actin filaments to the cytoplasmic domain of integrins and de 
novo assembly of actin filaments (see also 1.4). Talin is also known to interact with 
charged lipids and to membranes (Niggli et a l, 1994). The N-terminal domain of talin 
contains regions of identity with the ezrin, radixin, moesin (ERM) family of proteins 
(Vaheri et a l, 1997), which are known to contain cryptic F-actin binding sites, hidden in 
an intramolecular association. These sites are regulated by phosphatidylinositol 4,5- 
bisphosphate (PIP2), as well as by Rho family GTP-binding proteins (Hirao et aL, 1996; 
Mackay et aL, 1997). It is still to be estabilished whether a similar mechanism of 
regulation occurs for talin.
The actin cross-linking protein a-actinin provides another potential link between 
integrins and the actin cytoskeleton. a-actinin is a rod-shaped, anti parallel homodimer, 
with an N-terminal globular head containing the actin-binding site, a central region with 
four spectrin-like repeats which are responsible for the formation of the a-actinin 
homodimer, and a C-terminal region containing two EF-hand-like calcium binding motifs 
(Flood et a l, 1995; Critchley et aL, 1999)(Fig. 1.7B). There are muscle and non-muscle 
isoforms of a-actinin, and only the non-muscle ones are able to bind calcium which 
inhibits their F-actin crosslinking activity (Imamura et aL, 1994). In vitro, a-actinin 
binds to peptides derived from integrin pi cytoplasmic domains via undefined sequences 
within the spectrin-like repeats (Otey et aL, 1990; Otey et aL, 1993) and to vinculin via 
the fourth repeat (McGregor et a l, 1994). Zyxin, another focal adhesion component, 
binds to the N-terminal globular head of a-actinin (Crawford et aL, 1992). Also 
components of signalling pathways bind a-actinin, including the p85a subunit of
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phosphoinositide 3-kinase (Shibasaki et al., 1994) and protein kinase N (Mukai et al., 
1997). In addition, a-actinin can bind the acidic phospholipid PIP2 (Fukami et a l, 1992) 
which can regulate its F-actin binding activity. The importance of a-actinin for focal 
adhesion and stress fibers integrity is suggested by microinjection experiments of 
proteolitic fragments of a-actinin into fibroblast, resulting in disruption of focal 
adhesions and actin stress fibers (Pavalko and Burridge, 1991), and by down-regulation 
experiments of a-actinin levels by antisense mRNA, which resulted in cells with fewer, 
smaller, focal adhesions and stress fibers (Gluck and Ben-Zeiev, 1994).
Vinculin is a well characterised cytoskeletal protein composed of an N-terminal 
globular head and a C-terminal rod-like domain or tail (Fig. 1.7C). In vitro studies have 
identified numerous binding sites within vinculin for other focal adhesion proteins, 
including talin and a-actinin, which bind to regions in the N-terminal head, and paxillin 
and actin, which bind to the C-terminal tail. Vinculin can bind also the vasodilatator- 
stimulating protein (VASP), tensin, and protein kinase C (PKC) (rewieved by Critchley 
et al., 1999). Vinculin shows an intramolecular interaction between residues within the 
C-terminal region and the N-terminal head, which inhibits the binding of vinculin to 
several of its ligands (Johnson and Craig, 1994). Interestingly, this interaction is 
inhibited in vitro by acidic phospholipids, such as PIP2 (Gilmore and Burridge, 1996). 
Both microinjection experiments with anti-vinculin mAbs (Westmeyer et al., 1990), and 
reduction of the level of expression of vinculin (Rodriguez Fernandez et a l,  1993), 
caused a reduction in number of focal adhesions and stress fibers, suggesting that 
vinculin stabilises focal adhesions and their link to actin stress fibers.
1.3.4 The role of phosphorylation in focal adhesion assembly
For many cells in culture, focal adhesions are the sites with the highest 
concentration of phosphotyrosine. The relationship between tyrosine phosphorylation 
and focal adhesion assembly is complex. Tyrosine phosphorylation is known to be an 
early event in integrin-mediated signalling (Schaller and Parson, 1993), and evidence 
exists that this phosphorylation has a role in focal adhesion assembly (Burridge et a l, 
1992). Several tyrosine kinases have been identified in focal adhesions, including 
members of the Src family, C-terminal Src kinase (CSK), and the focal adhesion kinase 
(FAK). The latter appears to be the most abundant and becomes tyrosine-phosphorylated 
and activated in response to integrin-mediated adhesion (Kornberg et al., 1992; 
Haimovich et a l, 1993). FAK is a multifunctional tyrosine kinase, known to interact
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with several proteins in vitro (Fig. 1.8A). Paxillin, another well characterised 
component of focal adhesions, is known to be phosphorylated by FAK in vitro , together 
with tensin (Turner et al.9 1990; Beilis et al., 1995)(Fig. 1.8B). Moreover, tyrosine 
phosphorylation of paxillin parallels the activation of FAK during early embryonic 
development (Turner et al., 1991; Turner et al., 1993), upon integrin-mediated cell 
adhesion or antibody-induced.receptor clustering (Kornberg et al., 1991; Burridge et al., 
1992), and in response to a variety of mitogens (Zachary et al., 1992; Zachary et al., 
1993; Rankin and Rozengurt, 1994). These evidences suggest that the activity of FAK 
and paxillin tyrosine phosphorylation may be closely related, although their exact role in 
focal adhesion assembly and cytoskeletal reorganisation is not clear yet. A possible 
mechanism of action of tyrosine phosphorylation in focal adhesions involves the binding 
of SH2 domains present in many signalling molecules and some cytoskeletal molecules to 
protein tyrosine phosphorylated sites (Pawson, 1995). This provides a mechanism for 
assembling protein complexes which can be readily regulated by a host of protein 
tyrosine kinases and phosphateses. Paxillin is believed to play a role in the assembly of 
focal adhesions, by forming complexes with several components of the adhesive sites, as 
shown by in vitro and in vivo studies (Birge et al, 1993; Hildebrand et al., 1995; Sabe et 
al., 1994; Turner and Miller, 1994; Weng et al., 1993). In vitro studies have shown that 
the SH2 domains of Crk, Csk, Src and Fyn can recognise tyrosine phosphorylated 
paxillin (Schaller and Parson, 1995), but still the role of paxillin tyrosine phosphorylation 
in vivo remains to be estabilished. Moreover, paxillin contains 3 LIM domains at the C- 
tenninus (Fig. 1.8B). These are cysteine and histidine rich sequences that are organised 
in Zn-fingers and appear to be responsible in mediating protein-protein interactions (Gill,
1995), and they represent the principal determinant of paxillin localisation to focal 
adhesions (Brown et al., 1996). Several evidences suggest that tyrosine phosphorylation 
of FAK and paxillin may play a role in focal adhesion assembly, including the finding 
that tyrosine kinase inhibitors block the assemby of both stress fibers and focal 
adhesions, accompanied by a decrease of tyrosine phosphorylation of FAK and paxillin 
(Burridge et al., 1992; Defilippi et al., 1994). However, the fact that FAK-/- cells are 
still able to form focal adhesions (Ilic et al., 1995), make these conclusions controversial, 
and raises the possibility that another tyrosine kinase may play a major role in focal 
adhesion assembly. Interestingly, several FAK isoforms are produced from internal 
promoter within the gene and through alternative splicing. For instance, chicken cells 
express an N-terminally truncated form of FAK, termed FRNK, which probably acts as a 
negative regulator of FAK activity (Richardson and Parson, 1996). Moreover, a FAK-
related protein, called proline-rich tyrosine kinase 2 (Pyk2), is highly expressed in the 
central nervous system and in cells of the haematopoietic lineage (Girault et al., 1999; 
Avraham and Avraham, 1997)
Although tyrosine phosphorylation has been better characterised, other types of 
phosphorylation are also likely to play significant roles in the formation of adhesive 
complexes. For example, protein kinase C has been implicated in the formation of focal 
adhesions (Woods and Couchman, 1992). Serine phosphorylation of paxillin was 
observed after adhesion of macrophages to vitronectin, via the integrin aV|35 in a process 
that was independent of FAK and apparently mediated by protein kinase C (De Nichilo 
and Yamada, 1996), and after adhesion of CHO cells to fibronectin (Brown et al., 1998). 
Whether serine phosphorylation of paxillin may play a role in the assembly or regulation 
focal adhesion is still unclear.
1.4 THE ACTIN CYTOSKELETON
1.4.1 The regulation of actin polymerisation
Actin filaments consist of two double tight helices of uniformly oriented actin 
molecules (globular, G-actin). Polymerisation of pure actin in vitro requires ATP as 
well as divalent cations, usually Mg2 +, and occurs with an initial lag phase, 
corresponding to nucléation of the first three actin monomers, and a rapid elongation 
phase (Fig. 1.9). Actin filaments are polarised, presenting a slow-growing minus end, 
and a fast-growing plus end. Because myosin heads lean to confer an arrowhead 
structure on actin filaments visible in the electron microscope, the minus end is also 
referred to as the "pointed end", and the plus end as the "barbed end". The 
polymerisation rate is different at the two ends of the actin filament: the plus (or barbed) 
end polymerises at up to 10 times the rate of the minus (or pointed) end. The critical 
concentration for actin polymerisation in vitro, that is the free monomer G-actin 
concentration required for actin polymerisation, is 0.2 pM. Shortly after polymerisation, 
the terminal phosphate of the ATP bound to the actin molecule is hydrolysed to ADP, 
Hydrolysis serves to weaken the bounds in the polymer and thereby promote 
depolymerisation.
Actin filaments and monomeric G-actin are maintained in a dynamic steady state. 
As a result of the dissipative nature of the polymerisation reaction, the flux of ATP-G-
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Figure 1.9 Schema of actin polymerisation in vitro.
In vitro actin polymerisation occurs through a slow nucléation phase, and an elongation 
phase. Polymerisation at the plus end (+) is favoured compared to depolymerisation, 
which occur preferentially at the minus (-) end. Shortly after polymerisation, ATP on 
actin is hydrolysed to ADP. ADP-G-actin is reloaded with ATP by nucleotide exchange.
actin association into barbed ends is balanced by the dissociation flux of ADP-G-actin 
subunits from the pointed ends, resulting in what is known as a treadmilling process 
(Fig. 1.9). Although much is known about actin polymerisation in vitro, the situation 
is very different in the cell. In fact, within cells monomeric actin is present at a 
concentration well above the one required for rapid polymerisation in vitro, suggesting 
that the cell has evolved special mechanisms for the control of actin polymerisation. 
Moreover, actin filaments can be organised in a wide range of different structures, 
ranging from well organised and compact stress fibers, where bundles of actin filaments 
are kept together by cross-linking proteins, to more dynamic structures, such as those 
present in lamellipodia or filopodia. More than 200 actin-binding proteins are known in 
vertebrates, potentially involved in the modulation of actin properties and functions, 
indicating that the mechanisms underneath regulation of actin dynamics are very complex.
One way that cells control actin assembly is by sequestering monomeric actin 
through binding to proteins such as tymosin (34, which is the most abundant G-actin 
binding protein in cells, and profilin, which is present in all cells and is thought to play a 
part in controlling actin polymerisation in response to extracellular stimuli. Profilin 
accelerates the exchange of ATP for ADP on actin monomers, thus favouring the 
polymerisation from the barbed end. Cells also contain a variety of barbed ends capping 
proteins. Gelsolin and its relatives (severin, adseverin/scinderin, villin and fragmin) bind 
very tightly to barbed ends and sever filaments in response to certain stimuli, such as the 
increase in the intracellular concentration of PIP2 and calcium (Weber et al., 1991). 
Other "weaker", non-severing capping proteins (which bind actin with a lower affinity) 
have recently received much attention. These are capping protein (32, which is the 
homologous of Cap Z in non-muscle cells, and Cap G (Schafer and Cooper, 1995).
The rate of polymerisation, especially at the pointed end, is controlled 
preferentially by ADF (Actin depolymerizing factor)/cofilin proteins. These are 
ubiquitous, conserved actin binding proteins binding preferentially to the ADP-bound 
forms of G-actin and F-actin. They increase by 25 folds the rate of depolymerisation of 
ADP-F-actin specifically from the pointed ends. (Carrier et al., 1997).
1.4.2 The problem of actin nucléation in the cell
The rate limiting step in actin filament formation involves the generation of an 
assembly-competent actin nucleus, such as an actin trimer. Mechanisms that nucleate 
actin filaments in riving cells have not been elucidated yet, but the fact that adhesion to the
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extracellular matrix can stimulate vectorial cell migration suggests that spatial coincidence 
must exist between sites of substratum recognition by integrins and the actin machinery 
necessary for cell surface extension. Some insights in this mechanism come from the 
movement of intracellular pathogens such as Listeria, and from genetic studies of 
budding yeast. Listeria uses a single protein (ActA) to initiate actin assembly and to 
move inside the host cell (Higley and Way, 1997). The central domain of ActA contains 
a proline-rich repeat which forms the binding site for VASP (vasodilatator-stimulated 
phosphoprotein) (Chakraborty et a l, 1995). VASP belongs to the Enabled/mammalian 
Enabled (Mena)/VASP family of proteins, targeted to proline-rich ligands in focal 
adhesions (possibly to zyxin or vinculin, see below) via their EVH1 (Enabled/VASP 
homology 1) domain, which is also found in WASP (Wiscott-Aldrich syndrome protein). 
VASP/Enabled/WASP proteins act as molecular connectors, recruiting other ligands via 
their prolin-rich sequence. One potential link between VASP and actin polymerisation 
comes from the ability of this protein to multimerise and to dock profilin through the 
prolin-rich sequence (Kang et al., 1997).
Interestingly, a proline repeat similar to those found in ActA is present in the focal 
adhesion protein vinculin and binds to VASP (Brindle et al., 1996); however, the ability 
of vinculin to cooperate with VASP to regulate actin assembly has not been proven yet. 
On the other hand, several approaches including biochemical, immunological, and 
functional studies suggest that one mammalian protein mimicked by ActA is the focal 
adhesion component zyxin (Beckerle, 1997; Golsteyn et al., 1997). The proline region 
of zyxin has three known partners: a-actinin, Vav and VASP. All of these proteins have 
themselves been implicated in actin assembly and organisation, a-actinin could serve to 
cross-link actin filaments and to tether these cytoskeletal elements directly to integrin 
receptors. Vav is a protooncogene product that interacts with zyxin via its C-terminal 
SH3 domain (Robert et al., 1996); it exhibits guanine nucleotide exchange activity for 
Rho family members (see 1.4.3)(01son et al., 1996; Crespo et al., 1997), and thus may 
contribute significantly to zyxin's ability to stimulate changes in the actin cytoskeleton. 
Similarities between actin assembly on the surface of Listeria and at the cytoplasmic face 
of the plasma membrane is shown in Fig 1.10. In searching for cellular factors that 
initiate actin assembly at the surface of Listeria, Welch et al, (1997) isolated a stable 
complex containing the actin-related proteins Arp2-Arp3, which is highly conserved 
among eukaryotes. At least two factors acting sequentially to nucleate actin assembly 
have been isolated in yeast, namely Bee-1, and pca-1 (Lechler and Li, 1997). 
Interestingly, Bee-1 is a yeast homolog of the members of the VASP/Enabled/WASP
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Figure 1.10 Similarities between actin assembly on the Listeria  surface 
and at the cytoplasmic face of the plasma membrane.
The Listeria ActA protein appears to stimulate actin assembly by interacting with the 
Arp2/3 complex and members of the Ena/VASP family (E/V) that recruit profilin (P). In 
an uninfected mammalian cell, one region of zyxin may function like ActA recruiting 
Ena/VASP and ultimately profilin. Zyxin also binds a-actinin, which could facilitate the 
cross-linking of newly assembled actin filaments as well as linking zyxin directly to 
integrin receptors. Vav bound to zyxin may locally reduce actin filaments capping, thus 
enhancing filaments elongation. From Beckerle, 1998.
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family (Li, 1997), suggesting that the mechanism for the nucléation of actin filaments is 
conserved from yeast to mammals.
1.4.3 Role of Rho GTPases in the reorganisation of the actin 
cytoskeleton
The Rho family of small GTP-binding proteins, including Rho, Rac, and Cdc42, 
has attracted much attention in the last years for their role in many cellular functions, 
including the regulation of the actin cytoskeleton and of focal adhesion organisation. Rho 
family proteins act as molecular switches cycling between an active, or GTP-bound state, 
and an inactive, or GDP-bound state (Fig. 1.11 A). In their GTP-bound form they 
associate to the membrane via a post-traslational modification at their C-terminal. In 
general, these proteins have a low intrinsic GTPase activity. Cycling of nucleotides is 
regulated by several different molecules, including guanine nucleotide exchange factors 
(GEFs), GTPase activating proteins (GAPs), and guanine nucleotide dissociation 
inhibitors (GDI)(Fig. 1.11A).
The role of Rho GTPases in the regulation of the actin cytoskeleton is best 
characterised in fibroblasts, where several studies have described distinct types of 
organisation of the actin cytoskeleton following activation of different Rho members. In 
Swiss 3T3 fibroblasts, RhoA induces the organisation of contractile actin-based stress 
fibers; Rac proteins are involved in the formation of dynamic actin structures at the cell 
periphery, such as membrane ruffles and lamellipodia; and Cdc42 has been implicated in 
the extension of actin-rich protrusions, called filopodia (Fig. 1.1 IB); in addition, all three 
proteins are required for focal adhesion assembly (Kozma et al., 1995; Ridley et al., 
1992; Nobles and Hall, 1995). It has been demonstrated that Rac is able to activate Rho 
(Ridley et a l, 1992) and that a cascade of activation occurs in the cell: Cdc42 activates 
Rac, which in turn activates Rho; still each protein maintains a specific and independent 
effect.
Several potential downstream targets for Rho proteins have been identified, 
including protein kinases and adaptor proteins (Van Aelst and D'Souza-Schorey, 1997). 
The assembly of actin stress fibers by Rho is mediated, at least in part, by the activation 
of a serine/threonine kinase (ROKa), which phosphorylates and inhibits the activity of
myosin light chain phosphatase, resulting in an increased levels of myosin light chain 
phosphorylation (Kimura et al., 1996). This favours the formation of an acto-myosin 
complex, and promotes an actin-activated myosin ATPase activity (Burridge et a l.
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Figure 1.11 The cycle of the Rho family GTPase and their function in 
fibroblasts.
Panel A: The Rho family GTPases are known to cycle between an active, or GTP-bound 
state, and an inactive, or GDP-bound state. The cycle is regulated by Guanine nucleotide 
Exchange Factors (GEF), GTPase Activating Proteins (GAP), and Guanine nucleotide 
Dissociation Inhibitors (GDI).
Panel B: The function of the GTPases Rho, Rac and Cdc42 in the reorganisation of the 
actin cytoskeleton in fibroblasts.
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1996). Contraction of acto-myosin is thought to lead to the alignment of actin filaments 
into bundles. Moreover, evidence has been presented that this results in the clustering of 
integrins and of associated cytoskeletal proteins in the plane of the plasma membrane to 
form focal adhesions (Chrzanowska-Wodnicka and Burridge, 1996). Rho is known to 
activate also the phosphatidylinositol (PI)-5-kinase resulting in an elevation of PI?2 
levels (Chong et al., 1994). Several G-actin binding proteins (e.g. profilin, see 1.4.1) 
are induced toiffelease actin upon interaction with PIP2. Similarly, proteins that cap the 
ends of actin filaments, such as gelsolin (see 1.4.1), dissociate from filament ends in 
response to PIP2 - Together, these effects of PIP2 promote actin polymerisation. In 
addition, elevated PIP2 enhances the interaction of a-actinin with actin filaments, and of 
vinculin with talin and actin (as described in 1.3.3), thus promoting both bundling and 
attachment of actin filaments to integrins, and contributing to the assembly of focal 
adhesions.
The role of Rac and Cdc42 in the reorganisation of the actin cytoskeleton is less
well characterised. One downstream target of both Rac and Cdc42 is the serine/threonine
kinase PAK (Manser et a l, 1994). This kinase is implicated in the regulation of actin
organisation and focal adhesion assembly (Sells et al., 1997), but its molecular
mechanism of action is controversial. Rac and Cdc42 are also known to increase the
level of PIP2, resulting in the uncapping of actin filaments barbed ends (Hartwig et al.,
1995). Cdc42 can also bind to WASP (Aspenstrom et a l, 1996)(see 1.4.2). Moreover,
Rac has been recently shown to regulate the phosphorylation of the myosin II heavy
chain inducing the disassembly of acto-myosin complexes (van Leeuwen et al., 1999).
u
This suggests an antagonistic mechanism to Rho function, and adds a new fnction to Rac 
in regulating the actin cytoskeleton.
1.5 AIM OF THE WORK
It is now becoming evident that focal adhesions are not just static anchoring 
structures, but they are rapidly and dynamically regulated during the process of adhesion, 
and during important functions such as migration. Most of the information that we have 
about focal adhesion sites have been obtained from colocalisation studies and from in 
vitro reconstitution of the interactions between purified components. Still the sequence 
of molecular events leading to focal adhesions organisation, the way they are regulated, 
and the exact role of the different focal adhesion components have not been clarified yet.
34
Much attempts have been made in the last years in this direction, but still the 
information that we have is largely fragmentary. This is probably due to the complexity 
of the crosstalk between integrins and other signalling pathways occurring in the cell at 
the same time. The complexity is further increased by peculiarities that may be present in 
the different cell types studied.
We think that a "cell-free" system would make an important contribution in the 
field, allowing the dissection, and possibly the reconstitution, of some of the molecular 
events leading to focal adhesion organisation and regulation, in an environment at least 
partially separated from other signalling pathways occurring in the intact cell. Successful! 
attempts have already been made in this direction. They include studies in which 
receptor-stimulated actin polymerisation has been achieved in permeabilised neutrophils 
(Redmond et a l, 1994) and platelets (Hartwig et a l, 1995). Furthermore, permeabilised 
Swiss 3T3 cells have been utilised to show the involvement of activated RhoA GTP- 
binding protein in the stimulation of phosphorylation of p l25FAK and paxillin (Seckl et 
a l, 1995). Crowley and Horwitz (1995) have used permeabilised chicken fibroblasts to 
show an ATP-dependent destabilisation of focal adhesions during cell detachment. 
McKay et a l (1997) have shown that moesin, ezrin and radixin can reconstitute actin 
polymerisation and focal complex formation in response to activation of Rho and Rac in 
serum starved Swiss 3T3 cells permeabilised with digitonin. More recently, Norman et 
a l . (1998) have demonstrated an Arfl-mediated recruitment of paxillin to focal adhesions 
in permeabilised Swiss 3T3 fibroblasts.
In this work, I will use a modification of the lysis-squirting technique (Avnur and 
Geiger, 1981; Nermut et a l, 1991), for the preparation of detergent-free ventral plasma 
membranes (VPMs) obtained frdm adherent chicken embryo fibroblasts (CEFs). Two 
important advantages of this system make it suitable as a "cell-free" system for studies on 
focal adhesion organisation: the maintenance of the adhesive receptors within their natural 
lipidic environment (i.e. the adherent portion of the plasma membrane of cells spread on 
ECM), and the accessibility to the cytoplasmic side of the adhesive membrane, without 
need for detergents that may affect the environment of the adhesive receptors.
The first part of my work will deal with the morphological and biochemical 
characterisation of VPMs. Together with giving the basis for the functional studies of the 
second part of the thesis, this work will allow to obtain new important information 
concerning the molecular composition of focal adhesion sites. In order to obtain new 
important tools for functional studies about focal adhesion regulation, I will describe the 
production and characterisation of some mAbs raised against VPMs preparations.
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In the second part of my work, I will describe the use of VPMs as a "cell-free" 
system to obtain new insights in the mechanism of organisation and regulation of the 
adhesive sites and of the connected actin cytoskeleton. It is known that the strength of 
adhesion should be finely regulated in order to allow a cell to move and to perform 
several important functions, and this regulation could act at the level of integrin affinity 
modulation for the extracellular ligands; how the cell can sense extracellular signals, and 
the molecular mechanism underneath these events are not clear yet. By using VPMs as a 
"cell-free" system, I will set up the conditions for the modulation of the function and 
redistribution on the membrane of integrin receptors. The requirements of various focal 
adhesion components and of the connected actin cytoskeleton will also be investigated.
The described "cell-free" system will be used also for the reconstitution of some 
of the interactions occurring at the adhesive sites, in particular between p i integrin 
receptors and a-actinin. Reconstitution of adhesive complexes from purified components 
is made difficult by the fact that focal adhesion assembly occurs at the plasma membrane 
where clusters of receptors may be necessary, and both extracellular ligand and 
intracellular milieu may be required. Reconstitution of the binding of focal adhesion 
proteins to permeabilised or partially disrupted cells has been previously reported (Avnur 
et a l, 1983; Ball et a l, 1986). One important advantage of our "cell-free" system is that 
we can test the binding of purified components to VPMs where integrin function can be 
modulated.
Focal adhesions are postulated to act as sites of signalling for the regulation of the 
connected actin cytoskeleton, and this event has a great biological importance in several 
aspects of cell behaviour. In order to start investigating the relationship between focal 
adhesions and the actin cytoskeleton, I will describe the reconstitution of the recruitment 
of exogenous actin on VPMs, and study the way it can be regulated by the presence of 
the focal adhesion complex.
Chapter 2
MATERIALS AND METHODS
2.1 CELL CULTURE
Chicken Embryo fibroblasts (CEFs) were isolated from 10-day-old embryos. 
The head, legs, wings and internal organs were removed and the embryo was squirted 
through a 10 ml syringe without a needle and trypsinized with 5 ml 0.1 trypsin in PBS 
for 15 min at room temperature. The suspension above the debris was taken and 10 ml 
of complete medium (DMEM containing 5% fetal calf serum (FCS), 1% chicken serum, 
100 U/ml penicillin and streptomicin, 20 mM glutamine) was added. After a 5 min spin 
at 500 g, the pellet containing cells was resuspended in 10 ml complete medium, filtered 
through a nylon membrane and the cells were counted. 0.5-2.0 x 10^ cells were plated 
on each 100 mm diameter petri dish at 37°C, 5% CO2 . Each dish reached confluence in 
2-3 days. A confluent dish of CEFs was washed twice with 10 ml of phosphate-buffered 
saline (PBS) and trypsinized by approximately 2 min shaking with 1 ml 0.02 % trypsin 
in PBS at room temperature. The trypsin was bloked by addition of 9 ml of complete 
medium, cells were resuspended and plated at a dilution of 1:5-1:10. After the second 
passage, CEFs were frozen and conserved in liquid nitrogen in 1 ml aliquots containing 
0.5-2.0 x 106 cells in 50% FCS, 40% complete medium and 10% DMSO. When used, 
each aliquot was thawed and added to 10 ml of complete medium, and plated in a 100- 
mm diameter culture dish which reached confluence in 2-3 days. CEFs up to the fifth 
passage were used for experiments.
2.2 ANTIBODIES
The production, purification and use of the pAb pl-cyto raised against a peptide 
corresponding to the last 23 amino acids from the C-terminal cytoplasmic domain of p i 
(Tomaselli et a l, 1988), and of the pAb a 6-EX against the amino-terminal portion of the 
chicken a 6 subunit (de Curtis and Reichardt, 1993), have been previously described. 
The mAb CSAT against the chick integrin p i subunit (Neff et a l, 1991) was a generous
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gift from Dr. A. F. Horwitz (University of Illinois, Urbana, Illinois). The production 
and characterisation of the mAb TASC against the chick integrin p i subunit has been 
previously described (Neugebauer and Reichard, 1991; Shih et al., 1993). The TS2/16 
anti-human p i integrin mAb was a generous gift of Dr. G.Tarone (University of Torino, 
Italy). The mAbs against actin, vinculin, tubulin, tensin and talin were purchased from 
Sigma Chemical Co (St. Luis, MO). The mAb against paxillin was from Zymed 
Laboratories, Inc. (San Francisco, CA). The pAb recognising FAK was a kind gift of 
Dr. G. Tarone, University of Torino, Italy, while the mAb 2A7 against FAK was from 
Upstate Biotechnology Inc. (Lake Placid, NY). The pAb AAL20 against actin was a 
generous gift from Dr. C. Chaponnier (University of Geneva, Switzerland), while the 
rabbit pAb anti-ezrin was raised against the entire ezrin produced in bacteria, as 
previuosly described (Algain et al., 1993), and was a gift from Dr. T. Crepaldi 
(University of Torino, Italy). MAbs PY20 (Glenney et al., 1988) and PT66 recognising 
tyrosine-phosphorilated polypeptides were purchased from ICN (Costa Mesa, CA) and 
Sigma Chemical Co (St Luis, MO). The pAb against Rac 1 was raised against 
recombinant Rac 1 and was a generous gift from Dr. A. Hall (Medical Research Concil 
Laboratory of Molecular Cell Biology, University College London, UK). The mAbs 
M2D5 (IgG) and X1E8 (IgM) were obtained by injecting VPM preparations into mice 
and by subsequent screening of the hybridoma clones by immunofluorescence, as 
described in the corresponding pharagraph.
2.3 PREPARATION OF VENTRAL PLASMA  
MEMBRANES (VPMs)
A confluent dish of CEFs was washed twice with PBS and trypsinized as 
described in 2.1. The cells were pelleted by 5 min centrifugation at 500 g and washed 
twice with 10 ml of serum-free medium. 1/60 to 1/20 of the resuspended cells were 
added to 15 mm or 13 mm diameter coverslips, or to a 100-mm culture dish. Glass 
coverslips were cleaned by boiling in 0.1 M HC1, washing with 70% ethanol, rinsing 
with double distilled water, and drying in air. When indicated, coverslips were 
previously coated with 20 pig/ml fibronectin. For experiments with VPMs on laminin, 
coverslips were treaated with dimetylclorosilane in trichloroethane (BDH Laboratories 
supplies, England) before incubation with 100 pig/ml laminin for 18 h at room 
temperature, and blocking of non specific binding by incubation with 1% Bovine Serum
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■ Integrin clusters
Actin stress fibers
Figure 2.1. P reparation  of Ventral Plasma M em branes (VPMs).
Panel A: CEFs were cultured and allowed to adhere for 18h on the extracellular matrix. 
Panel B: Adherent cells were transferred on ice, washed with an hypotonic buffer and 
squirted over under a jet of the same buffer. Panel C: Ventral membrane of cells remained 
attached to the substrate, together with clusters of integrin receptors in connection with 
the actin cytoskeleton.
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Albumin (BSA) in PBS for 2 h at 37°C. In this case, CEFs were cultured overnight in 
the absence of serum, and allowed to adhere on laminin-coated coverslips for 3 h in 
serum-free medium, in the presence of 25 pig/ml cycloheximide, to avoid extra cellular 
matrix (ECM) production. The volume of the medium was adjusted to 2 ml for the 15 
mm, 1 ml for the 13 mm, and to 10 ml for the 100-mm diameter culture dishes. VPMs 
from cells on coverslips cultured overnight (or for 3 h, when indicated) in serum-free 
medium were prepared utilising a modification of the lysis-squirting technique (Nermut et 
al., 1991). Cells were washed twice with ice-cold 20mM Hepes-KOH buffer, pH7. 
After 1 minute, cells were squirted over by using a jet of the same ice-cold buffer from a 
water bottle, and immediately fixed with 3% paraformaldehyde or processed for the "cell- 
free" assay, as described below (see figure 1). For biochemical analysis, VPMs were 
prepared by the same procedure, but in this case the jet of buffer (20 mM Hepes-KOH 
pH 7, 0.3 mM PMSF) was produced by forcing it under air pressure through a pipette.
2.4 "CELL-FREE" ASSAY
VPMs prepared from cells grown on 13 mm diameter glass coverslips or on 100- 
mm diameter culture dishes were incubated for the indicated time at 37°C in a humid 
chamber in 25 pi or 10 ml respectively, of low calcium buffer (LCB, containing 125 mM 
K-acetate, 2.5 mM MgCl2 , 12 mM glucose, 25 mM Hepes-KOH, pH 7 and 50 nM free 
Ca2+), or high calcium buffer (HCB, containing 125 mM K-acetate, 2.5 mM MgCl2, 12 
mM glucose, 25 mM Hepes-KOH, pH 7 and 1 mM free Ca2+). EGTA-CaCl2 buffer 
were used to obtain defined [Ca^+j, according to published procedures (Bers et ai,
1994). Buffering conditions different from those specified here have been described, 
when used, in Chapter 3. For stress fiber disassembly, VPMs were incubated for 3 min 
at 0°C in HCB containing 4 pM fusion protein corresponding to the full length gelsolin 
(Way et al., 1989), a generous gift from M.Way (European Molecular Biology 
Laboratory, Heidelberg, Germany). After incubation at 37°C, VPMs on coverslips were 
lifted with 200 p-1 of incubation buffer, and immediately transferred in 3% 
paraformaldehyde to be processed for immunofluorescence. VPMs in petri dishes were 
transferred on ice, washed twice with 10 ml incubation buffer and lysed for biochemical 
analysis. Untreated VPMs kept at 0°C were used as controls for immunofluorescence 
and for biochemical analysis. In some experiments, CEFs were treated iu extracellular
40
buffer (20 mM Hepes, 2.7 mM KC1, 137 mM NaCl, 5.6 mM glucose, 1 mM CaCl2 , 1 
mM MgCl2, pH7) before VPMs preparation.
2.5 BIOCHEMICAL METHODS
2.5.1 Preparation of lysates from CEFs and VPMs
VPMs were prepared from CEFs cultured overnight in serum-free medium on a 
100 mm diameter culture dish and treated for the "cell-free" assay, as described in 2.4. 
For each experimemt, two dishes of VPMs or one of confluent CEFs were transferred on 
ice, washed twice with 10 ml of ice-cold TBS (20 mM Tris-HCl, pH7.5,150 mM NaCl, 
ImM CaCl2 , 1 mM MgCl2), solubilised with 0.25 ml of either SDS-PAGE loading 
buffer (Laemmli, 1970), or lysis buffer (TBS containing 1% Triton X-100, ImM 
sodium orthovanadate, lOmM sodium fluoride, and 10 pig/ml each of antipain, 
chymostatin, leupeptin and pepstatin), and scraped with a bent syringe needle. For the 
preparation of lysates from embryonic chick brain, an E l3 brain was dissected, 
transferred on ice, washed with ice-cold TBS, and solubilised with 9 volumes of lysis 
buffer by 6 times douncing in a potter tube. Lysates obtained from VPMs, CEFs or 
chick brain were then transferred to tubes, and rotated for 15 min by end-over-end 
mixing at 0°C. The insoluble material was removed by centrifugation at 0°C for 15 min at 
12,000 g in a refrigerated centrifuge. Protein concentration was determined by using a 
kit from Biorad (Hercules, CA) (Bradford, 1976).
2.5.2 Immunoprécipitation
For immunoprécipitation, rabbit anti-mouse Ig and specific mAbs were 
preadsorbed for 2h to 20 \i\ Protein-A Sepharose beads (Pharmacia, Piscataway, NJ) 
The beads were washed 3x with 1 ml of washing buffer (lysate buffer containing only 
0.2% Triton X-100), added to 100-300 p.g of protein from cell or VPM lysates, and 
incubated for Ih at 4°C by end-over-end mixing. The beads were washed 2x with 1.5 ml 
of washing buffer and resuspended in SDS-PAGE loading buffer for SDS-PAGE 
analysis.
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2.5.3 SDS-PAGE and immunoblotting
Immunoprecipitates, lysates and purified proteins were analysed by SDS-PAGE 
on the indicated % acrylamide gels, according to Laemmli (1970). Gels were 
electrophoretically transferred to 0.2 mm nitrocellulose filters and stained with Ponceau S 
(0.2% in 3% TCA, destain with dd-water) to visualise molecular weight standards and 
proteins. After blocking the nitrocellulose with 50 mM Tris-Cl, 150 mM NaCl, 5% non­
fat dry m ilk, pH 7.5, for Ih at room temperature, filters were incubated overnight at 4°C 
in the same buffer containing the primary antibodies at the following dilutions: anti- 
phosphotyrosine antibodies, 2 pg/ml PY20 plus PT66 ascites 1:1000; anti-paxillin 
antibody, 1 pg/ml purified IgG; anti-actin, 1:2000 ascites; anti-talin, 1:100 ascites; anti- 
vinculin, 1:200 ascites; anti-tensin 1 pg/ml purified IgG; anti-pi integrin subunit, 6 
p,g/ml purified IgG; anti-ct6 integrin subunit, 9 p.g/ml purified IgG; anti-tubulin, 1:1400. 
MAbs and pAbs were detected by Ih incubation at room temperature with 0.2 piCi/ml of 
IZ^I-sheep anti-mouse IgG or ^^I-Protein A, respectively (Amersham, Aarlington 
Height, IL). Filters were exposed to Amersham Hyperfilm-MP. Quantification was 
done from autoradiograms by using a computing densitometer from Molecular Dynamics 
(Sunnyvale, CA).
When necessary, filters were stripped according to Cooke et al., 1991: filters 
were incubated by shaking for 1 h at room temperature in dénaturation buffer (7 M 
Guanidinium-HCl, 50 mM Tris-HCl, 2 mM EDTA, 50 mM DTP, 10 mM 
Phenylphosphate, pH 7.5); proteins on filters were than renaturated by 12-18 h 
incubation at 4°C with shaking in renaturing buffer (50 mM Tris-HCl, 100 mM NaCl, 2 
mM EDTA, 2 mM DTT, 0.1% NP-40, pH 7.5), and washed 4 times with 50 mM Tris- 
HCl, 150 mM NaCl, pH 7.5. Filters were dried and exposed to check the success of the 
stripping procedure, before being re-probed with different primary antibodies.
Based on the densitometric values obtained from the blots, the percentage of 
recovery of polypeptides in the VPM fraction was calculated as the percentage of 
polypeptides recovered in VPM lysate from one 100 mm culture dish, compared to the 
amount of the same polypeptides obtained in the lysate of one 100 mm culture dish of 
intact CEFs. The amount of polypeptide per milligram of protein in the fraction was 
defined as relative concentration^ Enrichments were calculated as the ratio between the 
relative concentration of the polypeptide in the VPM fraction, and the relative 
concentration in total CEF lysate, which was normalized to 1.
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2.5.4 Silver staining
For silver staining, gels were fixed in 30% MetOH, 10% TCA, 10% Acetic acid 
for at least 2 h. They were then incubated 15 min in 50% MetOH, 12% TCA, 1% 
CuCl2 , and washed 2x10 min in 10% EtOH, 5% Acetic. After 15 min incubation in 
0.01% KMnÛ4, 2x15 min washes in 10% EtOH, 5% Acetic acid, and an extensive wash 
with water, 0.1% AgNOg was added for 10 min. Gels were then briefly washed with 
water and incubated for 1 min with 10% K2C03. Protein bands were revealed untill 
necessary with 0.0075% HCOH, 2% K2C03, and the reaction was stopped by adding a 
solution containing 10% ethanol and 5% acetic acid. Stained gels were dried at 50-60°C.
2.6 TRANSFECTIONS
The plasmid coding for the piTR construct corresponding to the human integrin 
p i subunit missing the cytoplasmic domain (Retta, et al., 1998) was kindly provided by 
Dr. G. Tarone (University of Torino, Italy). CEFs were plated on glass coverslips in 1.5 
cm diameter wells and cultured 18 h before transfection. Subconfluent cells were 
transfected with liposomal transfection reagent Dosper (Boehringer, Mannheim, 
Germany), using 3 pig of plasmid and 6 pig of Dosper/well. The Dosper and the DNA 
were diluted separately to a final volume of 25 pil each with 20 mM Hepes, 150 mM 
NaCl, pH 7.4. The Dosper was added to the DNA drop by drop, and incubated 15 min 
at room temperature before being added to the well containing 1 ml of fresh medium with 
5% FCS. After 6 h, cells were washed and cultured in fresh medium for an additional 14 
h.
2.7 RECONSITUTION EXPERIMENTS
2.7.1 Reconstitution of a-actinin binding to VPMs
Purified a-actinin was a generous gift of Dr. D.R. Critchley (University of 
Leicester, Leicester, United Kingdom), and was obtained from smooth muscle (chicken 
gizzard) as previously described (Feramisco and Burridge, 1980). For reconstitution 
experiments, VPMs were incubated for 10 min at 37°C in a buffer with low ionic strength 
(2,5 mM MgCl2 , 12 mM glucose, 25 mM Hepes-KOH, 5% bovine serum albumin,
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pH7) with either high (1 mM) or low (50 nM) free Ca^+. This was done to induce 
integrin redistribution. When indicated, the buffer also contained 4 pM gelsolin to 
remove endogenous actin. VPMs were then washed once for 2 min at room temperature 
with 1 ml of the same buffer (without gelsolin), and further incubated for 10 min at 37°C 
in 20 pi/13 mm coverslip of the same buffer. When indicated, 100 |xg/ml of purified ct- 
actinin were present during this incubation. Samples were washed for 2 min at room 
temperature in 1 ml of the same buffer without a-actin in , and fixed for
immunofluorescence.
2.7.2 Reconstitution of actin binding and polymerisation on VPMs
Actin purified from rabbit muscle (Paardee and Spudich, 1982) was a kind gift 
from Dr. Tony Hyman (European Molecular Biology Laboratory, Heidelberg, 
Germany), and it was labelled with 5-and 6-carboxytetramethyl-rhodamine succinimidyl 
ester (Molecular Probes, Junction City, OR) as previously described. (Kellogg et al., 
1988). Two cycles of assembly-disassembly were performed. The labelled globular 
actin (G-actin) was stored in aliquots at -80°C in 10 mM Tris-HCl, 0.2 mM ATP, 0.2 
mM CaCl2, 1 mM DTT, pH 8, at a concentration of 26 pM. For reconstitution 
experiments, control or treated VPMs were incubated for 2 min at 37°C in LCB 
containing 1% BSA and 1 mM rhodamine-G-actin (Rh-actin). When indicated, the 
buffer also contained 100 nM cytochalasin D and 100 pg/ml DNase I.
2 .8  PRODUCTION OF MONOCLONAL ANTIBODIES 
AGAINST VPMs PREPARATION
2.8.1 Mice immunisation
For a single injection of two mice, VPMs were prepared from 20-30 subconfluent 
100-mm diameter culture dishes of CEFs plated for 18h on 20 jxl/ml purified human 
fibronectin (Collaborative Research, Bedford, MA), in the absence of serum. Before 
solubilisation, the complete rupture of the cells was controlled under a phase contrast 
microscope. VPMs were solubilised as described above, by using 300 pi lysis 
buffer/dish which was transferred from one dish to the next to keep protein concentrated 
in the lysate. Approximately 1.5 ml lysate was collected, precipitated for 18h at -20°C 
using 9 volumes of ice cold acetone, and centrifuged 30 min at 9500 rpm at 4°C. The
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pellet was resuspended in 300 pi of either 100 mM Tris-HCl, pH 8.8 (for the first three 
injections), or Phosphate-Buffered Saline (PBS) (for the following injections), and 
protein concentration was determined. Approximately 200pg of protein were obtained 
from 20-30 dishes, and the quality of the preparation was controlled by loading 10-20 pg 
protein on a 7 .5% acrylammide gel and by comparing the preparation with a protein 
lysate obtained from intact cells, after silver staining, as described above. 200 pg protein 
were used for a single injection of two 7 weeks old Balb/c mice, with the following 
scheme:
-l$t injection: the protein solution was emulsionated in 1:1 volume of Complete Freund 
Adiuvant (CFA). Approximately 1/3 of the emulsion was injected into the foot pad and 
2/3 subcutaneously;
-2M  injection: 1:1 volume CFA emulsion subcutaneously injected;
-31^ injection:: 1:1 volume CFA emulsion subcutaneously injected;
-4th-qth injections: intraperitoneal injections of proteins in PBS.
The last injection was performed 5 days before fusion.
2.8.2 Cell fusion
X63 Ag8 myeloma cells were cultured in Iscove's medium (Gibco, Life 
Technologies) with 10% fetal calf serum (Fetal Clonelll, Hyclone), 100 U/ml penicillin 
and streptomycin, 20 mM glutamine, 50 pM P-mercapto-ethanol, collected, and washed 
3x20 ml with Hanks' balanced salt solution (Gibco). Lymphocytes were obtained by 
disgregation of the spleen from the immunised mouse through a syringe without needle, 
filtration through a nylon membrane, and 3x20 ml washes with Hank's solution. 
Lymphocytes and myeloma cells were spun together at 500 g for 5 min at a ratio of 5 
lymphocytes/1 myeloma cell. 1 ml of Iscove's containing 10% dymethylsulfoxide 
(DMSO) and 1 gr of polyethylenglicole (PEG) were added drop by drop to the pellet at 
37°C under constant agitation. 19 ml Iscove's medium were added in 5 minutes under 
constant agitation at 37°C, and cells were centrifuged 10 min at 250 g . The pellet was 
resuspended in Iscove's medium with 10% fetal calf serum (Fetal Clonelll, Hyclone), 
100 U/ml penicillin and streptomycin, 20 mM glutamine, 50 pM p-mercapto ethanol, and
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5% Macrophage Conditioned Medium (obtained after 48-72h stimulation of P 388 D1 
cells with 10 pg/ml Lypopolysaccaride from E.Coli, Difco). Cells were plated at a 
concentration of 10^-10^ cells/ml in 96 wells dishes. After 24h culture the hybridomas 
were selected in the same medium containing Hypoxanthine, Aminopterin, Thymidine 
(HAT, Gibco).
2.8.3 Screening
The screening of the hybridoma supernatants started 8-10 days after fusion and 
was performed by immunofluorescence on VPMs preparations. Immunofluorescence 
was carried out as described below, but in this case VPMs were prepared from CEFs 
grown on 24x50 mm coverslips and 6-20 supematants/coverslip were tested each time: 
10 pi drops of hybridoma supernatant were disposed on a wet chamber and the coverslip 
was leaned on the drops, 1 mm in suspension, to avoid mixture of supernatants. As 
control, VPMs were co-stained with pl-cyto polyclonal antibody. In each experiment a 
positive control, consisting of anti-vinculin monoclonal antibody, and a negative control 
consisting of hybridoma medium alone, were included.
2.8.4 Subcloning and expansion
The positives hybridomas were transferred to larger wells (with a first passage in 
medium containing HT) and frozen in culture medium containing 20-30%  fetal calf 
serum, and 10% DMSO. In parallel, the hybridomas were subcloned by dilution to 10 
cells/ml and replated in a 96 wells dish. The supematans from wells with growing clones 
were screened again, and the clones from positive cells were subcloned again until all 
hybridomas in the plate were positive. The clones obtained were expanded in larger 
wells to be frozen in culture medium containing 20-30%  fetal calf serum, and 10% 
DM SO, and conserved in liquid nitrogen in 1 ml aliquots containing 0.5-2.0 x 10^ cells.
2.8.5 Monoclonal antibodies class determination
The Ig class of the monoclonal antibodies was determined by ELISA. Wells from 
a 96-well plates were preadsorbed with 20 pg/ml of anti-p, (x IgM) or anti-y (x IgG) IgG 
in PBS, the free sites on plastic were blocked with 3% Bovine Serum Albumin (BSA), 
and 50-150 pl/well of the hybridoma supernatants to be tested were added and incubated 
for 2h in the wells. The unbound material was removed by 3x250 ml washes with PBS.
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Wells were incubated with 1 [xg/ml Alkaline Phosphatase-conjugated Goat anti-Mouse Ig, 
in 3% BSA. The reaction was developed with 100 ml/well of 1 mg/ml 
paranitrophenylphosphate in diethanolammine buffer for 5-10 min at room temperature. 
The reactions were blocked by the addition of 50 ml of 3N NaOH, and the O.D. at 405 
nm was measured.
2.9 IMMUNOFLUORESCENCE AND MICROSCOPY
2.9.1 Immunofluorescence
After treatment of cells or VPMs under the different experimental conditions, 
samples were fixed for 20 min with 3% paraformaldehyde in PBS, at room temperature. 
After two washes with PBS, paraformaldehyde was blocked by 10 min incubation with 
2.5 mg/ml NH4CI. After two washes with PBS, cells and VPMs were permeabilised
with 0.2% Triton X-100 in PBS for 4 min (when indicated, no permeabilisation was 
performed), washed again with 2xPBS, and incubated 2x3 min with 0.2% gelatine in 
PBS. Coverslips were then incubated for 60 min at room temperature with the following 
primary antibodies diluted in 0.2% gelatine in PBS: anti-paxillin antibody, 40 pg/ml; anti- 
vinculin, ascites 1:200; anti-a-actinin mAb, ascites 1:300; pi-cyto, 10 pg/ml IgG; anti- 
ezrin, affinity purified IgG, 1:50; anti-Rac 1, serum 1:100; monoclonal antibody M2D5, 
hybridoma supernatant 1:25. In the case of TASC and CSAT, samples were incubated 
for 20 min with 20 pg/ml and 30 pg/ml of the antibody respectively, before fixation; 
incubation was at room temperature for intact cells, and at 0°C for VPMs, unless 
otherwise indicated. After two washes with 0.2% gelatine in PBS, the samples were 
incubated for 30 min with FTTC-conjugated sheep anti-rabbit IgG and TRITC-conjugated 
sheep anti-mouse IgG (Boehringer, Mannheim, Germany), or with FITC-conjugated 
donkey anti-mouse IgG and TRITC-conjugated donkey anti-rabbit IgG (Jackson 
Immunoresearch Laboratories, Inc., West Groove, PA). Filamentous actin (F-actin) was 
revealed by incubation with FTTC or TRITC-conjugated phalloidin (Sigma Chemical Co, 
St. Luis, MO). All the secondary antibodies were diluted in 0.2% gelatine in PBS. For 
staining with anti-FAK and anti-phosphotyrosine antibodies, a biulin-avidin amplification 
method was used: fixed cells and VPMs were permeabilised with 0.3% Triton X-100, 
and incubated 30 min at room temperature with avidin (Avidin/Biotin blocking kit, Vector 
Laboratories, Burlingame, CA). The samples were incubated overnight at 4°C with 10
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Hg/ml of the anti-FAK monoclonal antibody 2A7, or with PY20 and PT66, 20 ng/ml 
each. After 90 min at room temperature with Biotin-conjugated goat anti-mouse IgG, the 
coverslips were incubated for 1 h with Texas red-conjugated streptoavidin. For VPMs 
staining with the lipophilic carbocyanine dye DiICi6 (Molecular Probes, OR), VPMs 
were incubated at 0°C for 5 min with 4p,g/ml DiICi6 before fixation. All coverslips were 
mounted with 1 drop of Gelvatol solution (20% polyvinyl alchool, 2% propylgallate, in 
PBS) and observed after a few hours using a Zeiss-Axiophot microscope. When 
observed with the objective for Interferemce Reflection Microscopy, coverslips were 
mounted with 50% PBS, 50% glycerol and immobilised with few drops of nail polish.
2.9.2 Immunoelectron microscopy
After treatment of VPMs for 10 min at 37°C in LCB, they were fixed, 
permeabilised, and incubated with first antibodies as described in the preceding 
paragraph. First antibodies were: pi-cyto, 10 |ig/ml IgG; mAb X1E8, hybridoma 
supernatant 1:2; mAb M2D5, hybridoma supernatant 1:25; anti-actin polyclonal antibody 
AAL20, IgG fraction 1:100. For staining with the TASC mAb, intact cells were 
incubated 20 min at room temperature with 20 fxg/ml of purified IgG before preparation 
of VPMs. The secondary antibodies used were anti-rabbit IgG conjugated to 18 nm 
colloidal gold particles, anti-mouse IgG conjugated to 6 nm colloidal gold particles, and 
anti-mouse IgM conjugated to 6 nm colloidal gold particles (Jackson Immunoresearch 
Laboratories, Inc., West Groove, PA). The samples were post-fixed in 1% 
glutaraldehyde, incubated in 1% osmium, and stained with 10% uranile acetate. Samples 
were then dehydrated and coated with a carbon thread evaporator unit (Balzer Union, 
Liechtenstein). They were then floated off the coverslip with 4.8% hydrofluoric acid 
(Miller et al.9 1991), collected on copper grids, and viewed with a Hitachi H7000 
transmission electron microscope (Hitachi, Tokio, Japan).
2.9.3 Scanning force microscopy
VPM preparations from CEFs grown on 15 mm diameter coverslips were viewed 
in phase contrast at 4Û0X through an Axiophot microscope (Zeiss, Oberkochen, 
Germany) and approx. 200 pm diameter circles were scribed around selected VPMs, 
using an eccentric diamond scribe inserted in the microscope nosepiece. Marked 
coverslips were mounted for examination in a NanoScope HI MultiMode Scanning Force
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Miscroscope (Digital Instruments, Santa Barbara, CA) resting in a vibration-damped,
optical microscope (Nikon, Japan). 80-200X magnification permitted positioning of a
force-sensing, cantilever stylus within a scribed circle. Pyramidal, silicon nitride styli
integrated in cantilevers with spring constants of approx. 0.06 N/m (Digital Instruments
specifications) were used to trace in continuous contact mode the topography of the VPM
m PBS. The repulsive, contact force was typically 0.3 nN. The feedback gains ranged
from 0.3 to 5 at scan speeds of approx. 500 fxm/s at low magnification or 15-40 pm/s at
high magnification. Relative separation of the surface and the stylus, constant force or
height mode, was recorded along with the cantilever deflection error, at higher 
magnification.
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Chapter 3 -
RESULTS
3.1 T H E  M ORPHOLOGY O F VPMs
Focal adhesions are sites for integrin-mediated attachment of cultured cells to the 
extracellular matrix. They are formed by large clusters of integrins and by a large number 
of intracellular proteins which accumulate at these sites.- Although a large number of 
polypeptides have been identified at focal adhesions, the exact architecture of these sites 
of tight adhesion is not known. With the aim of investigating the structure of focal 
adhesions and the molecular mechanism of their regulation, we have used a modification 
of the lysis-squirting technique (Nermut et al., 1991; Cattelino et al., 1995) for the 
preparation of detergent-free VPMs obtained from adherent chicken embryo fibroblasts 
(CEFs), by means of hypotonic treatment and mechanical cell disruption. In this study, 
the structure of this subcellular fraction has been extensively characterised by using 
immunofluorescence analysis with antibodies against integrins and focal adhesion 
proteins^ together with interference reflection microscopy and scanning force analysis. 
By using these techniques, we are able to demonstrate that VPM preparations maintain 
well-structured focal adhesions and stress fibers. Moreover the analysis on VPMs with 
antibodies specific for polypeptides postulated to act as crosslinkers between the 
membrane and the actin cytoskeleton, or as actin regulators, such as ezrin and R ad  
GTPase, has allowed the analysis of their distribution on the ventral side of the cell.
3.1.1 VPM preparations preserve focal adhesion sites
VPMs were prepared from adherent fibroblasts by a combination of hypotonic 
treatment and mechanical cell disruption, as described in chapter 2. These structures 
were visible by phase microscopy thanks to the presence of dense fibrils which largely 
overlapped with the distribution of actin filaments, as shown after staining with FITC- 
phalloidin (Fig.S.lA and 3.IB). Focal adhesions are visible along stress fibers and often 
at the end of them, when stained with anti-vinculin antibody (Fig. 3.1C). In Fig. 3.2,
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Figure  3.1.  Phase contras t ,  actin and v inculin  s ta in ing  on VPM  
preparat ions.
VPMs were prepared, fixed and processed for immunofluorescence as described in 
chapter 2. The anti-vinculin monoclonal antibody was used to stain focal adhesions 
(Panel C). FITC-phalloidin was used to visualise actin stress fibers (Panel A), while a 
phase contrast view of the same VPM is visible in panel B. Arrowheads show 
colocalisation of structures on VPM. Bar = 10 pm.
Figure 3.2. Phospholipid staining of  VPMs.
After VPM preparations, membranes were stained with the lipophilic carbocyanine dye 
DilC16 as described in chapter 2. The asterisk shows an area at the periphery of VPM 
were a portion of the dorsal plasma membrane is still present. Bar = 20 pm.
52
VPM preparations were stained with the fluorescent lipophilic dye DiIC16, in order to 
control that the phospholipid bilayer was not significantly damaged after the hypotonic 
and mechanical cell disruption.
By using an Interference Reflection Microscope (IRM), focal adhesions are visualised in 
intact cells as dark dots on a light surface, thanks to the fact that the part of the membrane 
engaged in focal adhesions is closer to the substrate (Block and Geiger, 1980). In order 
to investigate whether this property of the membrane was mantained in our preparations, 
we looked at VPMs with an IRM. As shown in two examples in Fig.3.3, dark areas 
corresponding to clusters of (31 integrins were still clearly visible on VPM preparations.
3.1.2 VPM preparations allow a clearer look at antigens on the 
ventral side of the cell
The distribution of the integrin (31 subunit and of vinculin appeared much clearer 
in VPM preparations as compared to intact cells (Fig. 3.4), due to the elimination of the 
fluorescent signal from the dorsal cell membrane, and from the cytoplasm. For the same 
reason, this system has revealed itself to be very useful for the study of the distribution 
on the membrane of other antigens that have a complex staining in intact cells. The small 
GTP-binding protein R a d  showed a typical late endosomal, lysosomal pattern in intact 
cells, while it distributes along actin fibers and in focal adhesions in VPM preparations, 
as the costaining with vinculin indicates (Fig. 3.5).
Ezrin, radixin, and moesin (the ERM proteins) are closely related proteins known to 
function as membrane/cytoskeleton linkers (Tsukita and Yonemura, 1997; Tsukita et a i ,  
1997). The ERM proteins are found in dynamic plasma membranes/actin interfaces such 
as membrane ruffles, cleavage furrows, and microvilli; ezrin is a component of microvilli 
in a number of polarized epithelia (Bretscher, 1983; Hanzel et al., 1991; Berryman et al., 
1993;, Franck et al., 1993;, Winckler et al., 1994; Amieva and Furthmayr, 1995). By 
using VPM preparations from adherent CEFs, we were able to demonstrate the presence 
of ezrin together with vinculin in focal adhesion sites, as shown in Fig.3. 6.
3.1.3 Scanning force topography of VPMs
In order to obtain additional information about the structure of VPMs and of focal 
contacts, scanning force microscopy was performed on VPM preparations in parallel with 
immunofluorescence microscopy. A typical scanning force micrograph is a colour-coded
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Figure 3.3. IRM and (31 integrins staining on VPMs.
VPMs were prepared and processed for immunofluorescence with (31-cyto polyclonal 
antibody against (31 integrins, as described in chapter 2. Panels B and D show b l  
integrins staining in focal adhesions and diffused on the membrane, while in panels A 
and G  the corresponding VPMs were observed with an Interference Reflection 
Microscope (IRM). Bar = 20 pm.
Figure 3.4. Distribution of  the (31 integrin subunit and vinculin in intact 
cells and VPMs.
CEFs (panels A and B) and VPMs (panels C and D) were processed for 
immunofluorescence with the (31-cyto polyclonal antibody (panels A and C) and with the 
anti-vinculin monoclonal antibody (panels B and D). The same cell is shown in panels A 
and B, and the same VPM in panels C and D. Bar = 10 pm.
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Figure 3.5. Rac 1 distribution on VPMs.
CEFs (panel A) and VPMs (panels B and C) were stained with the anti-Rac 1 polyclonal 
antibody (panels A and B) and with the anti-vinculin monoclonal antibody (panel C). The 
same membrane is shown in panel B and C. Arrowheads in panels B and C indicate areas 
of colocalisation of Rac 1 and vinculin. Bar = 10 pm.
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Figure 3.6. Ezrin colocalises with vinculin in focal adhesions on VPMs.
VPMs were processed for immunofluorescence using the anti-ezrin polyclonal antibody 
(panel A) and the anti-vinculin monoclonal antibody (panel B). The same membrane is 
shown in the two panels and arrowheads indicate sites of colocalisation between the two 
proteins. Bar = 10 pm.
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topograph obtained by a digital recording of the separation necessary to maintain a 
constant force between a spring-mounted stylus and a sample surface throughout a serial, 
two-dimensional scan of the surface.
One of the most striking aspects of the topographs of VPMs was the complete 
view of the complex weave of components that resulted. Fig. 3.7 is an example of the 
thorough view of VPM structure provided by scanning force microscopy. In Fig. 3.7A, 
a VPM lay beside an unsheared cell (arrow). The height of the intact cell exceeded the 
vertical scan range of the microscope and thus saturated the colour-coded height scale. 
Fine details of the surface of the intact cell were not visible, while the nearby VPM had 
clearly distinguished stress fibers that radiated from the centre. The terminations of the 
stress fibers were clearly depicted in a higher magnification image, Fig. 3.7B. In 
addition to high contrast detection of focal adhesion sites and stress fibers, small holes in 
the membrane (Fig. 3.7A, arrowheads) and small particles of approximately 100 nm- 
diameter (Fig. 3.7B, arrowheads) were observed. These features were not detected in 
immunofluorescence or phase contrast micrographs of the membrane (see Fig. 3.1).
In another example, a VPM exhibited a pair of prominent actin bundles (Figs 
3.8C and 3.8D, arrows) which appeared to connect directly to focal contacts (Figs 3.8B 
and 3.8D, arrowheads). Actin in the fibers and vinculin in the focal contacts was 
identified using immunofluorescence microscopy, but the precise alignment at these 
junctions was succinctly displayed in the topograph (Fig. 3.8D). A damaged area of this 
ventral plasma membrane was visible in scanning force micrographs (Fig. 3.8A, dark 
outline).
Unidentified filaments were also detectable under and around the ventral plasma 
membranes. In both Fig. 3.9A (15 hours culture) and Fig. 3.9C (3 hours culture) the 
perimeters of the membranes were obvious and many fibers were found crossing the 
membranes. Fluorescent, actin labelling was delimited by the membrane perimeters and 
numerous parallel stress fibers were visible on the membrane of a cell cultured overnight 
(Fig. 3.9B) or for 3 hours (Fig. 3.9D). On both membranes there were also filaments 
that lay transverse to the predominant orientation (arrows in Figs 3.9A, 3.9C, 3.9E, and 
3.9F). In the fluorescence image (Fig. 3.9B), actin labelling did not reveal the transverse 
filaments crossing the membrane of Fig. 3.9A (also Fig. 3.9F), while the transverse 
fibers in Fig. 3.9C (also Fig. 3.9E) were clearly labelled in Fig. 3.9D. The unlabelled, 
transverse filaments were continuous with filaments that extended beyond the perimeter 
of the membrane (Fig. 3.9A), but they did not colocalise with anti-vinculin labelling (data
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Figure 3.7. Scanning force micrograph of  a VPM.
Panel A: a scanning force micrograph of a VPM from a cell cultured 3 hours on 
fibronectin-coated glass. Small holes in the membrane (arrowheads) were visible as well 
as an intact cell (arrow). Panel B: a higher magnification, scanning force micrograph of 
the left-hand edge of the same ventral plasma membrane revealed numerous small 
particles (arrowheads). Bar = 10 pm in panel A and 4 pm in panel B. Colour-coded 
height range = 800 nm in panel A and 200 nm in panel B.
59
Figure 3.8. Scanning force, vinculin and actin staining of a VPM.
Panel A: a scanning force micrograph of a ventral plasma membrane from a cell cultured 
15 hours on glass. Some damage to the membrane (dark outline) was evident. The same 
membrane was labelled by immunofluorescence with the anti-vinculin monoclonal 
antibody (panel B), or with phalloidin for F-actin staining. Vinculin-labelled focal 
adhesions (arrowheads) and actin-labelled stress fibers (arrows) are indicated. Panel D: a 
higher magnification scanning force micrograph of the boxed area in panel A, showing 
the focal adhesions (arrowheads) and stress fibers (arrows) indicated in panels B and C. 
Scale bars: panels A, B and C = 10 pm, panel D = 2 pm. Colour-coded height ranges: 
panel A = 450 nm, panel D = 350 nm.
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Figure 3.9.  Scanning force micrograph and actin stain ing o f  VPMs  
prepared from CEFs cultured for different times.
Panel A: a scanning force micrograph of a ventral plasma membrane from a cell cultured 
15 hours on glass and (panel B) immunofluorescent, F-actin labelling of the same ventral 
plasma membrane. Arrows indicate filaments oriented transversely with respect to the 
majority of filaments. Panel C: a scanning force micrograph of a ventral plasma 
membrane from a cell cultured 3 hours on fibronectin-coated glass and (panel D) 
immunofluorescent, F-actin labelling of the same ventral plasma membrane. Panels E and 
F: higher magnification scanning force micrographs of the transverse filaments indicated 
in panel C and A (respectively). Scale bars: panels A, B, C and D = 20 pm, panel E 5 = 
pm, panel F = 10 pm. Color-coded height ranges: panel A = 500 nm, panels C and E = 
250 nm, panel F = 400 nm.
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Figure 3.10. Scanning force micrograph and immunofluorescent labelling  
of a VPM from short term culture.
Panel A: a scanning force micrograph of a ventral plasma membrane from a cell cultured 
3 hours on fibronectin-coated glass. Immunofluorescent labelling of vinculin (panel B) 
and actin (panel C) on the same ventral plasma membrane. Panel D: a higher 
magnification scanning force micrograph of the focal contact in the boxed area in panel A. 
Arrows indicate 60 nm actin-containing fibrils. Scale bars: panels A, B and C = 20 pm, 
panel D = 2 pm. Color-coded height ranges: panels A and D = 200 nm.
62
not shown), as reported previously for cable-like extracellular matrix structures lying 
under ventral plasma membranes (Chen and Singer, 1982).
The areas surrounding VPMs differed greatly according to the duration of the cell 
culture. After an overnight culture (Fig. 3.9A) the substrate was strewn with filaments 
that were not labelled by fluorescent phalloidin (Fig. 3.9B) and therefore did not appear 
to be actin. Instead for ventral plasma membranes prepared after brief cultures (Fig. 
3.9C) the surrounding substrate was free of such filaments.
When fibroblasts were cultured for 1.5-3 hours, they formed large focal 
adhesions on their peripheries, as we have previously published (Cattelino et al., 1995). 
VPMs prepared from these brief cultures were often free of overlying stress fibers. The 
VPM shown in Fig. 3.10A had broad focal contacts revealed by fluorescent labelling of 
vinculin in Fig. 3.10B. In a high magnification scanning force micrograph of the focal 
contact (Fig. 3.10D), fine parallel fibers as small as 60 nm in width were revealed 
(arrowheads). These fibers were probably very thin bundles of actin lilaments associated 
with vinculin and other focal contact proteins, since this focal contact was also lightly 
stained for actin (Fig. 3.10D). Such fine fibers were not resolved in the fluorescence 
micrograph at 1000 X.
3 . 2  P R E F E R E N T IA L  LO C A L ISA TIO N  OF T YR O SIN E-  
P H O SP H O R Y L A T E D  PAXILLIN IN FO C AL  
A D H E S IO N S
Focal adhesions are formed by large clusters of integrins and by a large number of 
intracellular proteins which accumulate at these sites, and that seem to be important both 
for signalling and cytoskeletal reorganisation. The mechanism of assembly of focal 
adhesions and the role of the numerous proteins colocalising with these adhesive 
structures is still poorly understood. Tyrosine phosphorylation is known to be an early 
event in integrin-mediated signalling (Schaller and Parsons, 1993), and integrin 
clustering is an important event for the recruitment of several cytoplasmic proteins at the 
adhesive sites (Miyamoto et ah, 1995). Paxillin and focal adhesion kinase (FAK), a non­
receptor tyrosine kinase, are among the best characterised proteins colocalising with 
integrins in focal adhesions (Turner et al., 1990; Schaller et al., 1992; Schaller and 
Parsons, 1993; Turner, 1994). FAK and paxillin are highly phosphorylated on tyrosine 
residues during early embryonic development (Turner, 1991; Turner et a l ,  1993), upon
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integrin-mediated cell adhesion or antibody-induced integrin clustering (Kornberg et a l,  
1991; Burridge et a l ,  1992), and in response to a variety of mitogens (Zachary et a l ,  
1992; Zachary et a l ,  1993; Rankin and Rozengurt, 1994). The finding that paxillin 
tyrosine-phosphorylation is accompanied by a similar increase in the tyrosine 
phosphorylation of FAK (Burridge et a l ,  1992) suggests that the activity ol FAK and 
paxillin tyrosine phosphorylation may be closely related, although their exact role in focal 
adhesion assembly and cytoskeleton reorganisation is not known yet. Furthermore, 
tyrosine-phosphorylated FAK and paxillin polypeptides usually represent a minor 
fraction of the total polypeptide in non-transformed cells, and the role of tyrosine 
phosphorylation of these proteins in vivo remains to be established.
The utilisation of VPM preparations for biochemical and morphological 
characterisation is described in this part, by using antibodies raised against different 
components of the focal adhesions. The results from this study show the accumulation 
of several tyrosine-phosphorylated proteins in VPMs, including tyrosine-phosphorylated 
FAK and paxillin. In particular, our findings identify a pool of highly tyrosine- 
phosphorylated paxillin accumulating in focal adhesions, suggesting an important role of 
the phosphorylated polypeptide in the mechanisms of integrin-mediated adhesion.
3.2.1 VPMs enriched in p i  integrins contain focal adhesion
components and are enriched in tyrosine-phosphorylated 
polypeptides
We have used a preparation of VPMs to biochemically characterise the adhesion 
sites formed by fibroblasts on extracellular matrix. Intact cells and VPM preparations 
were extracted with 1% Triton X-100 lysis buffer, and equal amounts of protein from the 
solubilised fractions were analysed by immunoblotting with different primary antibodies. 
VPM  extracts were highly enriched in the integrin p i  polypeptide, a major 
transmembrane component of focal adhesions (Fig. 11 A). VPMs showed a less dramatic 
enrichment for non-membraneous, cytosolic components of the focal adhesions, such as 
talin and vinculin, although immunofluorescence showed a clear colocalisation of these 
proteins with p i  integrins at the adhesion sites found in VPMs prepared from CEFs (see 
Fig.3.4 for vinculin). These results suggest that only a fraction of these polypeptides 
could be recovered in a membrane-associated form in these cells. Moreover the results 
show that most of these proteins were solubilised by Triton X-100 from VPMs, while a 
fraction of actin was recovered in the Triton-insoluble pellet (Fig. 3.11 A, lane 3).
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Figure 3.11.  Accumulation of  focal adhesion components  and tyrosine-  
phosphorylated polypeptides in VPMs.
CEFs were cultured for 18 h, and VPMs were prepared as described in chapter 2. Equal 
amounts of protein from Triton X-100 extracts of intact CEFs (lanes 1) and of VPMs 
(lanes 2), and from the Triton X-100-insoluble fraction of VPMs (lanes 3) were analysed 
by immunoblotting with antibodies against the indicated proteins (panel A), or against 
phosphotyrosine (panel B). In panel B, molecular mass markers are indicated to the left 
of the blot; the arrows point to two major tyrosine-phosphorylated polypeptides of 120 
kDa and 68 kDa.
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The analysis of tyrosine-phosphorylated polypeptides showed a clear increase in 
the signal of a number of bands in VPM preparations when equal amounts of whole cell 
extracts and of extracts from VPMs were compared (Fig. 3.1 IB). Immunofluorescence 
analysis of intact, fixed and permeabilised CEFs with anti-phosphotyrosine antibodies 
showed a clear localisation of phosphotyrosine at focal adhesion sites, together with a 
more diffuse, dotted intracellular staining (Fig. 3.12A). On the other hand, anti- 
phosphotyrosine antibodies stained only focal adhesions in VPMs, indicating that the 
observed enrichment of tyrosine-phosphorylated proteins in the VPM preparations is due 
to accumulation in focal adhesions (Fig. 3.12B).
3.2.2 Accumulation of Tyrosine-Phosphorylated FAK in VPMs
A major tyrosine-phosphorylated band of approximately 120 kDa was visible by 
immunoblotting with anti-phosphotyrosine antibodies both in whole cell and VPM lysates 
(Fig. 3.13). Interestingly, a small, but reproducible difference could be observed in the 
mobility of the major tyrosine-phosphorylated band of about 120 kDa between CEFs and 
VPM s (Fig. 3.13, lanes 1 and 2, respectively). To check whether this band 
corresponded to tyrosine phosphorylated FAK, we immunoprecipitated FAK from equal 
amounts of protein from CEF and VPM lysates, and analysed the immunoprecipitates by 
immunoblotting with anti-phosphotyrosine antibodies (Fig. 3.13, lanes 3 and 4). Anti- 
FAK antibodies specifically immunoprecipitated the 120 kDa tyrosine-phosphorylated 
band, which was enriched in VPMs compared to CEFs. Although tyrosine- 
phosphorylated FAK was enriched in VPM compared to whole cell lysates, the VPM 
lysate could not be completely depleted of the 120 kDa tyrosine-phosphorylated band by 
immunoprécipitation with anti-FAK antibodies (Fig. 3.13, lane 6). Longer exposures of 
the autoradiogram show that depletion of the 120 kDa polypeptide was incomplete also in 
the whole cell lysate (not shown). Since we were able to deplete the lysates obtained 
from other chick cell types of tyrosine-phosphorylated FAK by using the same antibody 
(not shown), we think that the presence of a tyrosine-phosphorylated 120 kDa protein in 
the unbound fraction of CEFs and VPMs was not due to inefficient immunoprécipitation 
of the antigen, but was probably due to the presence of a different protein comigrating 
with FAK.
Analysis of the distribution of FAK by immunofluorescence showed that FAK 
could only be detected in focal adhesions in VPM preparations (Fig. 3.14B). In intact,
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Figure  3.12.  Dis tribution  o f  tyros ine-phosphorylated  po lypept ides  in 
focal adhesions.
Intact CEFs (panel A) and VPMs (panel B) were fixed and permeabilised as described in 
chapter 2. Incubation with anti-phosphotyrosine antibodies was followed by incubation 
with biotin-conjugated anti-mouse immunoglobulin and Texas red-conjugated 
streptavidin. Bar = 10 pm.
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Figure 3.13. Enrichment of  tyrosine-phosphorylated FAK in VPMs.
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FAK was immunoprecipitated from equal amounts of protein from CEF (lane 3) and 
VPM (lane 4) lysates. Immunoprecipitates, equal amounts (40 pg) of lysates (lanes 1, 
CEFs; lane 2, VPMs), and about half of each of the non-bound fractions from the 
immunoprecipitates (lanes 5 and 6, respectively) were blotted and incubated with anti- 
phosphotyrosine antibodies. The two arrows to the left of the blot point to the two 
tyrosine-phosphorylated bands of about 120kDa visible in the CEF and VPM lysates, 
respectively. The 116 kDa molecular mass marker is indicated to the right.
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Figure 3.14. Distribution of  FAK to focal adhesions in VPMs.
Intact CEFs (panel A) and VPMs (panel B) were fixed and permeabilised as described in 
chapter 2. Incubation with anti-FAK antibodies was followed by incubation with biotin- 
conjugated anti-mouse immunoglobulin and Texas red-conjugated streptavidin. Bar = 10 
pm.
permeabilised CEFs, FAK distribution was characterised by localisation to focal 
adhesions, and by a diffuse, cytoplasmic punctate staining (Fig. 3.14A).
3.2.3 Enrichment of Tyrosine-Phosphorylated Paxillin in VPMs
We analysed preparations of VPMs for the presence of paxillin. Analysis of equal 
amounts of protein from lysates from whole cells and from VPMs (Fig. 3 .ISA) showed 
that the relative concentration for paxillin was similar in the two preparations, with a U.S- 
fold enrichment in VPMs compared to whole cell lysate. Interestingly, a reproducible 
shift was observed for the paxillin detected in VPMs, which migrated on the gels with a 
slightly slower mobility compared to paxillin from whole cell extracts (Fig. 3 .ISA, lanes 
2 and 1, respectively). Analysis of equal amounts of protein from the same preparations 
by immunoblotting with anti-phosphotyrosine antibodies revealed a band of about 68 kDa 
comigrating with the VPM form of paxillin, which was strongly enriched in VPMs 
compared to whole cell extract (Fig. 3 .ISA, compare lanes 4 and 3, respectively). As 
shown in Figure 3.15B, immunoprécipitation with anti-paxillin antibodies was able to 
immunodeplete the tyrosine-phosphorylated 68 kDa polypeptide from VPM lysates, 
showing that this phosphorylated band corresponded to the tyrosine-phosphorylated 
paxillin. Stripping and re-blotting of the same filters with anti-paxillin antibodies 
confirmed that similar amounts of the paxillin polypeptide could be immunoprecipitated 
from equal amounts of protein from whole cell and VPM lysates (Fig. 3.ISC).
The recovery of several focal adhesion components in VPMs was quantified from
A-
blots by densitometry as described in the Methods. Quantitation showed that only 2.6% 
(±1.4, s.eg n=2) of the total Triton-X-100 extractable protein was recovered in VPM 
lysates, and that more than 33% (±13.6, s.eg n=2) of the transmembrane integrin (31 
subunit present in the cells was recovered in VPM lysates. Only a minor fraction of 
cytosolic focal adhesion components, such as talin, vinculin and paxillin, were recovered 
in VPM preparations (not shown). On the contrary, 36% (±12.7, s.eg n=2) of tyrosine- 
phosphorylated paxillin was recovered in VPM lysates, indicating a specific accumulation 
of this phosphorylated polypeptide in VPMs. In Figure 3.16, the enrichment of focal 
adhesion components in VPM lysates compared to total CEF lysates is shown. 
Enrichments were calculated as described in chapter 2. No enrichment was detectable for 
paxillin in VPMs (0.7-fold), while a strong enrichment (14.2-fold) in the tyrosine- 
phosphorylated form of paxillin could be observed in the same preparations. A similar 
enrichment (12.6-fold) was calculated for the integrin (31 subunit.
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Figure 3.15. A tyrosine-phosphorylated 68 kDa band highly enriched in 
V P M s .
Panel A: CEFs (lanes 1 and 3) and VPMs (lanes 2 and 4) prepared from CEFs cultured 
on fibronectin-coated dishes were lysed as described in chapter 2. Lysates were 
fractionated by SDS-PAGE, transferred to nitro-cellulose, and incubated with anti- 
paxillin (lanes 1 and 2), or with anti-phosphotyrosine (lanes 3 and 4) antibodies. The 66 
kDa molecular mass marker is indicated to the left. The two arrows to the right indicate 
the difference in migration of paxillin in lanes 1 and 2. Panel B: paxillin was 
immunoprecipitated from 130 pg of protein from CEF or VPM lysates (lanes 1 and 2, 
respectively). Immunoprecipitates, and same amounts of non-bound fractions (lanes 3 
and 4, respectively) and of lysates (lanes 5 and 6, respectively) were blotted and 
incubated with anti-phosphotyrosine antibodies. Panel C: the same blot shown in panel B 
was stripped as described in chapter 2, and reblotted with the anti-paxillin antibody. 
Molecular mass markers are indicated to the left of the blots. Paxillin (panel C), and 
tyrosine-phosphorylated paxillin (panels A and B) are indicated by the arrows to the 
right. No evident differences in paxillin phosphorylation were observed when cells were 
plated on fibronectin (panel A) or directly on plastic (panel B).
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Figure 3.16. Enrichment of  focal adhesion components in VPMs.
Lysates from CEFs and VPMs were analysed for protein content, and by immunoblotting 
for the presence of focal adhesion components, as shown in Figures 11, 13 and 15. 
Enrichments of polypeptides in VPMs were calculated as the ratio between the relative 
concentrations in VPM and in CEF lysates, as detailed in chapter 2. The values are 
expressed as the average from two experiments. Bars = standard deviation.
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Localisation by immunofluorescence in CEFs showed that anti-paxillin antibodies 
gave both a diffuse, cytoplasmic staining, and a focal adhesion pattern (Fig. 3.17A). 
Staining of VPMs was more defined, and concentrated uniquely in focal adhesions, 
showing loss of the diffuse staining upon cell disruption (Fig. 3.17C).
3.2.4 Comparison of the level of Tyrosine-Phosphorylation of 
paxillin in CEFs and in VPMs
The different percentages of total paxillin and of tyrosine-phosphorylated paxillin 
recovered in VPM preparations indicated that the levels of tyrosine phosphorylation of 
paxillin in CEF and VPM lysates were different. To quantitatively analyse the differences 
in the level of tyrosine phosphorylation between the populations of paxillin recovered 
from whole cell lysates versus VPM lysates, we immunoprecipitated total paxillin and 
tyrosine-phosphorylated paxillin from equal amounts of protein from CEF lysates, by 
using  an t i-p ax il l in ,  and an t i-p h o sp h o ty ro s in e  an t ib o d ies ,  re sp ec t iv e ly .  
Immunoprecipitates and non-bound fractions after immunoprécipitation were analysed by 
immunoblotting with anti-phosphotyrosine (Fig. 3 .ISA), and anti-paxillin antibodies 
(Fig. 3.18B). Both antibodies were able to immunodeplete the lysates from tyrosine- 
phosphorylated paxillin (Fig. 3 .ISA, lanes 3 and 4). On the other hand, only the anti- 
paxillin antibody was able to immunodeplete the lysate of paxillin (Fig. 3.18B, lane 4). 
The anti-phosphotyrosine antibody was able to immunoprecipitate only the tyrosine- 
phosphorylated, 68 kDa form of paxillin (Fig. 3.18B, lane 1, upper arrow), while most 
of paxillin, corresponding to the non-tyrosine-phosphorylated polypeptide, was 
recovered in the non-bound fraction (Fig. 3.18B, lane 3).
The bands from the blot shown in Figure 3.18 were quantitated by densitometry, 
and the ratio between the values from lanes 1A and IB was considered equivalent to a 
level of 100% tyrosine phosphorylation of paxillin (Fig. 3.19, PY-CEF). By using this 
as a reference, we found that only about 5% of total paxillin was tyrosine-phosphorylated 
in whole cell lysates (Fig. 3.19, PAX-CEF), while the level of paxillin tyrosine 
phosphorylation in VPMs was 90% (Fig. 3.19, PAX-VPM).
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Figure 3.17. Localisation of  paxillin in focal adhesions o f  VPMs.
Double immunolocalisation in CEFs (panels A and B) and in VPMs (panels C and D) of 
paxillin (panels A and C) and of the integrin (31 subunit (panels B and D). Samples were 
fixed and permeabilised as described in chapter 2. First antibodies were revealed with 
FITC anti-mouse Ig (panels A and C) and TRITC anti-rabbit Ig (panels B and D). Bar = 
10 pm.
A B
6 6  -
1 2  3 4
Figure 3.18. Tyrosine-phosphorylation of  paxillin in CEFs.
200 pg of protein from CEF lysates were immunoprecipitated with anti-phosphotyrosine 
(lanes 1A and IB) or with anti-paxillin (lanes 2A and 2B) antibodies. Equal amounts of 
the non-bound fractions from the anti-phosphotyrosine (lanes 3A and 3B) and anti- 
paxillin (lanes 4A and 4B) immunoprécipitations were loaded on the same gel. After 
blotting, part (A) of the blot was incubated with anti-phosphotyrosine antibodies, and 
part (B) was incubated with anti-paxillin antibodies. The 66 kDa molecular mass marker 
is indicated to the left of the blot. The two arrows to the right indicate the position of 
migration of the tyrosine-phosphorylated (upper arrow) and total (lower arrow) paxillin.
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Figure 3.19. C ompar ison  of  the level o f  tyros ine-phosphorylat ion  of  
paxillin in CEFs and in VPMs.
Bands from blots of experiments like the one described in Figure 18 were quantitated by 
densitometry, and the ratio between the values obtained from bands like those shown in 
lanes 1A and IB of Figure 18 was used as 100% of tyrosine phosphorylation of paxillin 
(PY-CEF). From this value, the percentage of tyrosine-phosphorylated paxillin was 
calculated in CEF lysates (PAX-CEF), and in VPM lysates (PAX-VPM). The value for 
PAX-VPM was calculated from blots like those shown in Fig. 15 (lanes 2B and 2C). 
Each value represents the average from two different experiments. Bars = standard 
deviation.
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3.3 PRODUCTION AND CHARACTERISATION OF mAbs 
RAISED AGAINST VPM PREPARATIONS
Although there is much known about the structure of focal adhesions, the exact 
architecture and the role of single polypeptides at these adhesive sites is still far from 
being clarified. Moreover, it is generally believed that some players and regulators of 
focal adhesions are still waiting to be discovered.
By using a combination of morphological and biochemical approach, in 3.1 and 
3.2 we have demonstrated that VPM preparations preserve intact the focal adhesion 
complex and the connected actin cytoskeleton, and that they are enriched in some focal 
adhesion components and in tyrosine phosphorylated polypeptides. Therefore VPMs can 
be considered a subcellular fraction where focal adhesions are enriched when compared 
to the whole cell, and they represent an ideal starting material for a better characterisation 
of focal adhesion structure. With the aim of obtaining new important tools for functional 
studies about focal adhesions, and eventually identifying new components or regulators, 
we have injected VPM preparations into mice, for the production of mAbs. The clones 
obtained were screened by immunofluorescence for their localisation on VPMs, and some 
of them have been characterised. By using this approach we have obtained antibodies 
that were useful for studies of focal adhesion regulation and of the connected actin 
cytoskeleton, and were used for some of the experiments described in 3.4 and 3.5.
3.3.1 Preparation of material for immunisation
In order to prepare VPMs for mice injections, CEFs were cultured over night on 
fibronectin in the absence of serum to allow organisation of focal adhesions, and to 
minimise the production and secretion of other extracellular matrix, as well as the 
deposition of proteins from serum on the substrate. VPMs were prepared from CEFs, 
lysates were collected, and the material concentrated by acetone precipitation, as 
described in chapter 2. The quality of each preparation was controlled by analysing the 
pattern of polypeptides in lysates obtained from VPM preparations, in comparison with 
that obtained from intact CEFs. In Fig. 3.20 the same amount of protein from VPM 
preparations and from CEFs was loaded on a gel and processed for silver staining, as 
described in chapter 2. Arrows in lane 2 indicate some of the polypeptides enriched in 
VPM preparations. Arrowheads point to some examples of polypeptides that were lost or
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Figure 3.20. Analysis  by silver staining of  the patterns o f  polypeptides  
from CEF and VPM lysates
CEF (lane 1) and VPM lysates (lane 2) were prepared as described in chapter 2. 5 pg of 
each sample were loaded on a 6% acrylamide gel and processed for silver staining as 
described in chapter 2. Molecular mass markers are indicated on the left. Arrowheads in 
lane 1 indicate polypeptides enriched in CEFs compared to VPM preparations, while 
arrows in lane 2 indicate polypeptides enriched in VPM preparations.
decreased in amount in VPM preparations (lane 2), as compared to a total cell lysate (lane 
1).
3.3.2 Mice immunisation, cell fusion, and screening
Each mouse was injected with 100 pg of protein, and at least 5 injections were 
performed, as detailed in chapter 2. Before fusion, sera from immunised animals were 
tested by immunofluorescence on VPM preparations together with the corresponding pre- 
immune sera. The resulting staining was strong and complex for all animals, and the pre- 
immune sera gave only a weak, non specific staining (not shown). Ag8 myeloma cells 
and lymphocytes from an immunised mouse were fused, hybridomas were selected, and 
their supernatants were screened by immunofluorescence, as described in chapter 2. 
1882 wells out of 1920 contained growing cells, and were screened. Among these, 53 
hybridomas were initially selected as positive, and some of these have been subcloned as 
described in chapter 2, and characterised. Fig. 3.21 shows the staining of some positives 
clones: S1E2 showed a microtubular staining on CEFs (panel A), and a similar but 
weaker staining on VPMs (not shown); T4F12 and AGI showed nearly a diffused 
pattern on VPMs (panels B and C, respectively); H3A7 gave a punctate staining along 
stress fibers (panel D), and X1E8 stained homogeneously actin stress fibers (panel E), as 
confirmed by colocalisation with phalloidin (Fig. 3.22); M2D5 gave both a diffused and a 
fibrillar staining on the substrate, escluding VPMs, when permeabilisation with detergent 
was not performed (panel F). AF3 stained actin stress fibers and focal adhesions, and 
colocalised with (31 integrins in focal adhesions in several points (Fig. 3.23, 
arrowheads).
3.3.3 Ig class determination and biochemical characterisation
The Ig class of the selected clones was determined by ELISA, by using antibodies 
specific for u or y chains, as detailed in chapter 2. Fig. 3.24 shows the results obtained 
for the same clones shown in Fig. 3.20: S1E2, T4F12, AGI, H3A7, and M2D5 bound 
selectively to anti-y chain antibodies, and were therefore IgG, while X1E8 and AF3 were 
IgM.
The same supernatants were characterised by western blotting on lysates from 
CEFs (Fig. 25): S1E2 gave a predominant band of 57 KD, compatible with the molecular 
weight of tubulins; T4F12 stained a single band of 40 KD; AGI gave only some
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Figure 3.21.  Localisation of  the antigens recognised by some o f  the 
identified mAbs.
CEFs (panel A) or VPMs (panels B-F) were fixed, permeabilised (except for panel F), 
and immunostained as described in chapter 2, with the following hybridoma 
supernatants: S1E2 (panel A), T4F12 (panel B), A GI (panel C), H3A7 (panel D), X1E8 
(panel E), and M2D5 (panel F). Primary antibodies were revealed with FITC-conjugated 
donkey anti-mouse Ig. Bar = 10 pm.
80
Figure 3.22. Colocalisation o f  the X1E8 antigen with actin on VPMs.
VPMs were prepared, fixed, and stained with X1E8 supernatant (panel A). The primary 
antibody was revealed with FITC-conjugated donkey anti-mouse Ig. RITC-phalloidin 
was used to stain actin stress fibers (panel B). Bar = 10 pm.
Figure 3.23. The AF3 antigen localises along actin stress fibers and focal 
adhesions on VPMs.
VPMs were prepared, fixed, and costained with (31 integrins (panel A), and AF3 
supernatant (panel B), as described in chapter 2. Arrowheads indicate sites of 
colocalisation of the two antigens. Bar = 10 pm.
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Figure 3.24. Ig class determination of  some positives clones.
Wells from a 96-well plate were precoated with anti-y (for IgG determination,O), or anti- 
p (for IgM determination, # )  IgG. Ig from hybridoma supernatants were allowed to 
bind. Binding was quantified as described in chapter 2, and expressed as O .D .405 X 
1000. MAb CSAT was used as positive control for IgG. Each sample was done in 
triplicate, and bars indicate the standard deviations.
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Figure 3.25. Western blotting o f  positive clones on CEF lysates.
100 pg protein from CEF lysates were loaded on each lane of a 5-13% gradient 
polyacrylamide gel. Each lane was analysed by western blotting with the indicated 
hybridoma supernatants (panel A). In panel B, the AF3 supernatant was diluted 1:50. 
Primary antibodies were revealed with l-^ I-sheep  anti-mouse Ig. Molecular mass 
markers are indicated on the left of each panel.
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background and did not recognise any specific band on CEF lysate; H3A7 recognised a 
predominant band of 200 KD; X1E8 gave a faint band of the 45 KD. This result, 
together with the colocalisation of X1E8 antigen with phalloidin (Fig. 3.23), strongly 
indicated the correspondence of X1E8 antigen with actin. M2D5 gave a predominant 
band of 250 KD, a molecular weight compatible with that of extracellular matrix proteins, 
such as fibronectin; while AF3 stained a series of bands between 31 and 14 KD, and the 
pattern did not become simpler by incubation of the filters with higher dilutions of the 
hybridoma supernatant (Fig. 3.25 B).
To look at the expression of the antigens in neural tissue, the hybridoma 
supernatants were tested by western blotting on CEF lysates, together with lysates
â
obtained from E13 chick embryonic brain. The results shown in Fig. 3.26 indicated thgt 
only S1E2 and X1E8 recognised antigens present both in brain and fibroblasts, as 
expected from broadly expressed and conserved proteins such as tubulin and actin, while 
all the other clones recognised antigens present only in fibroblasts.
S1E2 antigen was further characterised by comparing its exact molecular weight 
with that of chicken a  and 6-tubulin. In Fig. 3.27 A, CEF lysates were analysed by 
western blotting with S1E2 supernatant (lanes 2 and 4), and with anti-a-tubulin (lane 1) 
or anti-6-tubulin (lane 3) antibodies: S1E2 antigen comigrated exactly with chicken cc- 
tubulin, while it migrated slightly slower than |3-tubulin. These results, together with the 
tubular staining of S1E2 in CEFs (see Fig. 3.21 A), suggest the correspondence of S1E2 
antigen with a-tubulin.
In order to characterise M2D5 antigen, various extracellular matrix proteins were 
loaded on a gel and analysed by western blotting with M2D5 mAb (Fig. 3.27 B). M2D5 
recognised the purified fibronectin (lane 1), while it did not recognise collagen I (lane 2) 
or tenascin C (lane 3). As shown in Fig. 3.25, M2D5 recognised a 250 KD polypeptide 
in CEFs, and it recognised a band of the same molecular weight in the supernatant from 
CEFs cultures (lane 5). This result indicates that the antigen recognised by the M2D5 
mAb corresponds to a secreted protein.
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Figure 3.26.  Analys is  o f  the express ion o f  the ant igens  in ch ick  
embryonic brain
100 pg protein from E13 embryonic chick brain lysate (odd lanes) and from CEF lysate 
(even lanes) were analysed by western blotting on a 5-13% gradient gel, by using the 
indicated hybridoma supernatants as primary antibodies, as described in chapter 2. 
Molecular mass markers are indicated on the left.
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Figure 3.27. The S1E8 antigen comigrates with a - tu b u l in ,  and M2D5  
specif ically recognises f ibronectin.
Panel A: 100 jig CEF lysate were loaded on each lane of a 5-13% acrylamide gel, and 
western blotting was performed as described in chapter 2, by using S1E8 hybridoma 
supernatant (lanes 2 and 4), and anti-a-tubulin (lane 1) or anti-p-tubulin (lane 3) mAbs. 
Panel B: 2 pg purified fibronectin (lane 1), collagen I (lane 2), or tenascin C (lane 3), 
and 50 pg CEF lysate (lane 4), or supernatant from CEF cultures (lane 5) were loaded on 
a 5% acrylamide gel, and analysed by western blotting as described in chapter 2, by 
using M2D5 supernatant as primary antibody. Molecular mass markers are indicated on 
the left.
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3 .4  [Ca2+]-REGULATED [31 INTEGRINS FUNCTION AND 
DISTRIBUTION ON VPMs
Assembly and modulation of focal adhesions during dynamic adhesive processes 
are poorly understood, and the precise role of numerous proteins colocalising with these 
structures is not estabilished yet. The set up of a "cell-free" system would be of great 
advantage for a better understanding of the sequence of molecular events leading to focal 
adhesion organisation, and to the exploration of focal adhesion regulation and dynamics. 
In the previous paragraphs, I have described the characterisation of detergent-free VPMs 
obtained from adherent CEFs. I have shown that VPMs contain well-structured focal 
adhesions and stress fibers, as detected both by morphological and biochemical criteria. 
Two important advantages make this system useful for functional studies about focal 
adhesion dynamics: the preservation of the adhesive receptors within the natural lipidic 
enviroment (i.e., the adherent portion of the plasma membrane of cells spread on ECM), 
and the accessibility to the cytoplasmic side of the adhesive membrane, without need for 
detergents, that may affect the enviroment of the adhesive receptors. By using this 
system, I show that it is possible to reversibly modulate integrin function and distribution 
within VPMs. The requirements for such a modulation will be investigated, with a 
particular attention to the connection with focal adhesions components and the actin 
cytoskeleton.
3.4.1 Regulation of (31 integrin distribution by calcium under cell- 
free conditions
I have utilised VPMs prepared from adherent fibroblasts with the aim of setting up 
an in vitro system to study the regulation of focal adhesions and integrin function under 
cell-free conditions. For this purpose, I have treated VPMs under different experimental 
conditions to identify parameters that would affect integrin distribution and/or function in 
v i tr o .  At the end of each experiment, cells were fixed for analysis by 
immunofluorescence, as described in chapter 2.
Among the experimental parameters examined were ionic composition, ionic 
strength, divalent cations, pH, and temperature. Surprisingly, preliminary analysis 
showed that VPMs prepared from CEFs in the presence of divalent cations appeared well 
preserved also after several hours of incubation at 37°C, as detected by staining with the 
lipophilic dye D iIC i6  (not shown). I then utilised immunofluorescence to look for
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conditions that would affect integrin distribution upon incubation of VPMs at 37°C. 
Control, untreated samples were obtained by fixing the VPMs immediately after 
preparation on ice. Staining of control VPMs with the polyclonal antibody (31-cyto 
showed that the receptors were localised both into focal adhesions, and diffuse 
throughout the ventral surface of the adherent fibroblasts (Fig. 3.28A). We then tested 
the effect of the incubation of the VPMs at 37°C for 15 minutes in different buffers. 
Among the parameters analysed, variations in [Oa-+] in the presence of 2.5 mM M gC b 
showed interesting effects on the distribution of the (31 receptors in vitro. When VPMs 
were incubated for 15 min at 37°C in a buffer containing [Ca^+Js equal or above 10 pM, 
(31 integrins appeared predominantly diffuse on the membrane, and their distribution 
became more homogeneous after incubation at 37°C with 1 mM free C a -+ (Fig. 3.28C). 
The diffusion of the integrin (31 subunits at high [C a-+] was not caused by disassembly 
of the a/(3 heterodimers, since biochemical analysis showed coprecipitation of the a 6  
subunits with (31 under these conditions (Fig. 3.29). The [31 receptors showed a 
dramatically different distribution when VPMs were incubated at low [Ca~+]. In fact, 
after incubation at 37°C for 15 min in LOB (containing 50 nM free Oa-+), (31 integrins 
were found concentrated along fibrillar structures (Fig. 3.28E), which were generally 
thinner and longer compared to focal adhesions (compare Fig. 3.28E with Fig. 3.28A). 
In this situation, the diffuse integrin staining observed in control VPMs disappeared, 
suggesting that all (31 integrins had redistributed into the fibrillar structures. It should be 
emphasised though that the fibrillar distribution of integrins observed at low [Ca^+J is 
different from that of typical focal adhesions observed in whole cells, or in untreated 
VPMs (compare Fig. 3.28E with 3.28A). The same results were observed when control 
VPMs or samples treated with high or low [Ca^+J were analysed by immunofluorescence 
with the CSAT monoclonal antibody, directed against a distinct epitope of the (31 subunit 
(Fig. 3.28B, D, and F). These findings strongly indicate that the distinct patterns 
observed are due to actual changes in receptor distribution, rather than to the inability of a 
specific antibody to fully recognise the (31 antigen under different experimental 
conditions. Although 15 min incubation was utilised as standard experimental condition, 
both high and low [Ca^+J-induced effects were observed already after 3 min at 37°C, 
while incubation at 0°C under different [C a-+]s did not affect integrin distribution (not 
shown).
To investigate the reversibility of the [Ca“ +]-mediated effects on (31 distribution, 
VPMs treated for 15 min at 37°C in HCB, were incubated for an additional 15 min in 
LCB. Under these conditions, (31 integrins that were diffused on the membrane after
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Figure 3.28. Calcium-dependent redistribution of  (31 integrins in VPMs.
Adherent CEFs were incubated 20 min at room temperature with 30 pg/ml CSAT mAb 
(panels B, D and F), before preparation of VPMs. VPMs were fixed after preparation on 
ice (panels A, B), or after incubation for 15 min at 37°C in HCB (panels C, D), or in 
LCB (panels E, F). VPMs were then processed for immunofluorescence with the [31- 
cyto polyclonal antibody (panels A, C and E). Primary antibodies were revealed by 
FITC-conjugated anti-rabbit IgG and TRITC-conjugated anti-mouse IgG, respectively. 
The same fields are shown in panels A and B, C and D, and E and F. Bar = 10 pm.
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Figure 3.29. The association between (31 and a 6  subunits is mantained 
after treatment of VPMs with high [Ca^*].
VPMs from adherent CEFs were incubated in HCB for 15 min at 37°C, and lysates were 
obtained as described in chapter 2. Immunoprécipitation was performed by using an anti- 
131 integrin serum. The immunoprecipitate (lane 1), and half of the unbound fraction 
(lane 2), were loaded on a 5% acrylamide gel and analysed by western blotting with the 
a6-EX  pAb, recognising the a 6  integrin subunit. Molecular mass markers are indicated 
on the left.
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treatment in HCB (Fig. 3.30A), were now found concentrated into fibrillar structures 
(Fig. 3.30B). In contrast, [31 receptors concentrated into fibrillar structures by 15 min 
incubation at 37°C in LCB were not able to diffuse when VPMs were incubated for 
further 15 min in HCB (Fig. 3.30C). These results show that high [Ca^+J-induced (31 
integrins diffusion is quasi-reversible, since it can be affected by low [C a-+]. On the 
other hand, low [Ca^+J treatment somehow irreversibly locks (31 integrins into the
fibrillar pattern.
To control whether the inability of the receptor concentrated into librillar 
structures in LCB to diffuse again after high [Ca^+J treatment was due to disruption of 
the membranes, we used the lipophilic fluorescent dye DilCift to stain VPMs treated at 
37°C for 15 min in LCB followed by 15 min incubation in HCB (Fig. 3.30D). 
Membrane integrity was not affected by this treatments. These findings strongly indicate 
that the distinct patterns observed at different [C a-+]s, together with the inability of the 
receptor to reverse its distribution from low to high [Ca-+], are due to actual changes in 
receptor distribution within the lipid bilayer, rather than to a modification of the structure 
of the plasma membrane.
3.4.2 [Ca2+] regulates the distribution of (31 integrins on VPMs 
by affecting the affinity for the extracellular ligand
Integrin receptors may be expressed in different activation states on the surface of 
the cell. We tested the hypothesis that the different [Ca^+Js were affecting (31 integrin 
distribution by modulating the affinity of the receptors for their ECM ligands. For this 
purpose we compared the distribution of the total population of (31 receptors, using the 
antibody (31-cyto, with the distribution obtained by staining with the mAb TASC, which 
recognises activated, high affinity (31 receptors (Neugebauer and Reichardt, 1991). In 
control VPMs, the (31-cyto antibody recognised the receptors concentrated into focal 
adhesions, as well as those diffused throughout the membrane (Fig. 3.31A), while the 
mAb TASC only recognised the receptors localised in focal adhesions (Fig. 3 .3 IB). 
Furthermore, TASC did not recognise the diffuse (31 receptors in VPMs treated with 
HCB (compare Fig. 3.3ID with 3.31C), while it was able to recognise the LCB-induced 
fibrillar pattern (compare Fig. 3.31F with 3.31E). These results show that under cell- 
free conditions, the [Ca2+ ] is able to affect (31 integrins distribution, possibly by 
regulating the ability of the receptors to recognise their extracellular ligands.
CEFs in culture are known to produce their own ECM, which they deposit and organise
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Figure  3 .30 .  Revers ib i l i ty  o f  high [ C a ^ + ] - in d u ced  p i  in t e g r in s  
redistribution on VPMs.
VPMs from adherent CEFs were incubated in HCB for 15 min at 37°C (panel A), in 
HCB followed by 15 min at 37°C in LCB (panel B), or in LCB followed by 15 min at 
37°C in HCB (panels C and D). In panel D, VPMs were stained with the lipophilic 
carbocyanine dye DilCiô- After fixation, VPMs in panels A, B and C were processed for
immunofluorescence with the p l-cyto polyclonal antibody, revealed by a following 
incubation with FITC-conjugated anti-rabbit IgG. Bar = 10 pm.
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Figure 3.31. The mAb TASC only recognises p i  integrins localised in 
focal adhesions and along ECM fibrils.
VPMs were incubated with 20 jag/ml of the anti-integrin pi TASC mAb for 20 min at 0°C 
(panels B, D and F), and immediately fixed (panels A and B), or incubated for 15 min at 
37°C in HCB (panels C, D), or in LCB (panels E, F), before fixation. VPMs were then 
processed for immunofluorescence with the pl-cyto polyclonal antibody (panels A, C 
and E). Primary antibodies were revealed by FITC-conjugated anti-rabbit IgG and 
TRITC-conjugated anti-mouse IgG, respectively. The same fields are shown in panels A 
and B, in panels C and D, and in panels E and F. Arrowheads in panels A and B point to 
focal adhesions, where colocalisation of pi-cyto and TASC staining is visible. Bar = 10 
pm.
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on the substrate. The low [Ca2+]-induced redistribution of (31 integrins into fibrillar 
structures suggested a possible relocalisation of the receptors along ECM fibrils 
underlying the VPMs. We therefore analysed the distribution of the receptors and of 
ECM in control and experimentally treated VPMs. In control VPMs fixed after 
preparation at 0°C, ECM fibrils, stained by the mAb M2D5 recognising chicken 
fibronectin (see pharagraph 3.3 for M2D5 characterisation), colocalised only partially 
with (31-positive focal adhesions (Fig. 3.32A and B, arrowheads). After incubation for 
15 min at 37°C in HCB, (31 integrins were predominantly diffuse on the membrane 
(Figure 3.32C), while ECM fibrils could still be observed (Figure 3 .3ID). Incubation 
for 15 min at 37°C in LCB induced a redistribution of (31 integrins to sites which 
strikingly corresponded to the ECM fibrils (Figure 3.3IE, F, arrowheads).
We utilised immunoelectron microscopy to obtain more detailed information on 
the nature of the fibrillar structures where (31 integrins localise at low [Ca~+]. Figure 
3.33 shows different "en face" views of VPMs treated with LCB. Bundles of actin 
filaments were visible as electron dense structures that were abundantly decorated both by 
the mAb X1E8, characterised in pharagraph 3.3 (Fig. 3.33A, small gold particles), and 
by a polyclonal anti-actin antibody (Fig. 3.33B, large gold particles). (31 integrins were 
concentrated along fibrils, which sometimes ran parallel to the actin bundles (Fig. 3.33A, 
large gold particles), but most of the times the receptors were clearly separated from them 
(Fig. 3.33B, small gold particles). These structures correspond to ECM fibrils, since 
they could be stained with the mAb M2D5 recognising fibronectin (Figure 3.33C, small 
gold particles), and were often heavily decorated by anti-integrin (31 antibodies (Figure 
3.33C, large gold particles). Ultrastructural analysis of VPMs incubated in HCB showed 
a diffuse distribution of the (31 receptors (Fig. 3.34, large gold particles), which had no 
obvious colocalisation with ECM fibrils (Fig. 3.34, small gold particles), confirming the 
data obtained by immunofluorescence. As expected from the diffuse ECM staining 
observed around fibrils by immunofluorescence (see Fig. 3.32B, D, and F), diffuse 
ECM staining could be observed also at the ultrastructural level in VPMs treated with 
both LCB and HCB (small gold particles in Fig. 3.33C, and 3.34, respectively).
These results show that the fibrillar structures decorated by integrins upon 
incubation at low [Ca^+J correspond to sites of fibrillar accumulation of ECM, which are 
distinct from actin stress fibers.
Interestingly, when CEFs were cultured on a non fibrillar substrate such as 
laminin, under conditions that inhibit production of ECM (see MATERIALS AND
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Figure 3.32. Localisation of (31 integrins and ECM fibrils after treatment
o f  VPMs at different calcium concentrations.
VPMs from CEFs were fixed immediately after preparation on ice (panels A and B), after 
incubation for 15 min at 37°C in HCB (panels C and D), or after incubation for 15 min at 
37°C in LCB (panels E and F). Fixed VPMs were processed for immunofluorescence 
using the (31-cyto antibody (panels A, C, and E), and the M2D5 mAb recognising 
fibronectin (panels B, D, and F). Primary antibodies were revealed by FITC-conjugated 
anti-rabbit IgG, and TRITC-conjugated anti-mouse IgG. The same fields are shown in 
panels A and B, C and D, E and F. Arrowheads in panels A and B, and in panels E and 
F point to sites where colocalisation of integrins with ECM fibrils is visible. Bar = 10 
pm.
95
Figure 3.33. Ultrastructural localisation o f  |31 integrins along ECM fibrils
at low [Ca^ + ].
VPMs were incubated for 15 min at 37°C in LCB. and processed for immunoelectron 
microscopy as described in chapter 2. Panel A: double labelling with the (31-cyto 
antibody (large, 15 nm gold, arrows), and the X1E8 mAb decorating actin stress fibers 
(small, 6 nm gold, arrowheads); Panel B: double labelling with the anti-(31 TASC mAb 
(small, 6 nm gold), and the AAL20 polyclonal antibody against actin, decorating actin 
stress fibers (large, 15 nm gold); Panel C: fibrillar structures are labelled both by the (31- 
cyto antibody (large gold particles) and by the mAb M2D5 recognising ECM (small gold 
particles). In panel C, a few examples are shown of colocalisation of (31 integrins 
(arrows), with ECM (arrowheads) along fibrils. Bar = 200 nm.
Figure 3.34. U ltrastructural localisation of (31 integrins and ECM fibrils 
at high [Ca2+].
VPMs were incubated for 15 min at 37°C in HCB, and processed for immunoelectron 
microscopy as described in chapter 2. Diffused (31 integrins are labelled with the (31-cyto 
antibody (large, 15 nm gold, arrows), while ECM is labelled with the mAb M2D5 
recognising fibronectin (small gold particles). Bar = 200 nm.
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METHODS for details), (31 integrins which were concentrated in focal adhesions and 
diffused in control VPMs (Fig. 3.35A), gave a diffuse pattern after treatment with both 
high (Fig. 3.35C), and low [Ca2+]s (Fig. 3.35E). Under these condotions, the mAb 
TASC was still able to recognise only the receptors concentrated in focal adhesions in the 
control situation (Fig.3.35B); it was unable to recognise the receptors diffused in HCB 
(Fig. 3.35D), while it was able to recognise the receptor diffused in LCB (Fig. 3.34F).
All together these results suggest that the pattern of distribution of the high- 
affinity (TASC-positive) integrins is a consequence of the activation of the receptors 
induced by low [Ca^+J, and depends on the organisation of the available ECM.
3.4.3 (31 integrins distribution can be altered by mAbs affecting 
receptor function
We investigated whether mAbs known to affect (31 integrin function were able to 
induce receptor redistribution in vitro. Incubation of VPMs for 15 min at 37°C in HCB in 
the presence of the stimumatory anti-(31 integrin mAb TASC was able to prevent high 
[Ca“ +]-induced (31 integrins diffusion, and to cause receptor clustering along ECM (Fig. 
3.36A and B). This effect was similar to that observed after incubation of VPMs in LCB 
(Fig. 3.28E). As already shown in Fig. 3.30C, the effect of low [C a-+] on receptor 
distribution could not be reversed by incubation in HCB (Fig. 3.36C). On the other 
hand, when VPMs which had been incubated at low [Ca^+J were further incubated at 
high [Ca^+J in the presence of the function-blocking mAb CSAT, receptor clustering 
induced by low [C a-+] could be partially reversed (Fig. 3.36D), since a clear diffuse 
staining for integrins could be observed together with the fibrillar pattern. This result 
indicates that the presence of the function-blocking antibody can disrupt low [C a-+ ]- 
mediated integrin distribution, probably by interfering with receptor-ligand binding. 
Furthermore, the low [C a-+]-induced aggregation of receptors in VPMs previously 
treated with HCB (Fig. 3.36E), was largely prevented by incubating HCB-treated VPMs 
with LCB in the presence of the CSAT mAb (Fig. 3.36F).
These results confirm the idea that high [Ca^+J-induced receptor diffusion within 
ventral surface of the cell may be explained by inhibition of integrin function, while low 
[C a-+]-induced receptor concentration along ECM fibrils may be explained by receptor 
activation. These data also point out that the effects of function-affecting antibodies on 
receptor distribution/activity are dominant over the [Ca-+]-induced effects under our
98
Figure 3.35. (31 integrins distribution after treatment at different calcium 
concentrations of  VPMs from CEFs adherent to laminin.
VPMs were prepared from CEFs cultured for 3 h on laminin, under the conditions 
described in chapter 2, incubated with 20 pg/ml of the anti-integrin (31 TASC mAb for 
20 min at 0°C (panels B, D and F), and immediately fixed (panels A and B), or 
.incubated for 15 min at 37°C in HCB (panels C, D), or in LCB (panels E, F), before 
fixation. VPMs were then processed for immunofluorescence with the (31-cyto 
polyclonal antibody (panels A, C and E). Primary antibodies were revealed by FITC- 
conjugated anti-rabbit IgG and TRITC-conjugated anti-mouse IgG, respectively. The 
same fields are shown in panels A and B, in panels C and D, and in panels E and F. 
Arrowheads in panels A and B point to focal adhesions, where colocalisation of (31-cyto 
and TASC staining is visible. Bar = 10 pm.
Figure 3.36. Function-regulating mAbs interfere with calcium-induced (31 
redistribution
VPMs were incubated 15 min at 37°C in HCB in the absence (panel A), or presence 
(panel B) of the mAb TASC (20 pg/ml); in panels C and D, VPMs were incubated 15 
min at 37°C in LCB, followed by 15 min at 37°C in HCB; in panels E and F, VPMs were 
treated at 37°C in HCB, followed by 15 min at 37°C in LCB. During all treatments, 
samples were incubated in the absence (panel C and E) or presence (panels D and F) of 
200 pg/ml of the function-blocking mAb CSAT. In panels G and H, intact CEFs were 
incubated for 1 h at 37°C in extracellular buffer (see MATERIALS AND METHODS) in 
the presence of the activating mAb TASC (ascite, 1:30), or with 200 mg/ml of the 
function-blocking mAb CSAT, respectively. At the end of the incubation, cells were 
cooled on ice for preparation of VPMs. The samples were fixed and processed for 
immunofluorescence using the (31-cyto antibody, revealed by FITC-conjugated anti­
rabbit IgG. bar = 10 pm.
experimental conditions.
TASC-dependent relocation of the receptors along ECM fibrils was also observed 
in intact CEFs (Fig. 3.36G). Moreover, incubation of CEFs with the function-blocking 
mAb CSAT induced diffusion of integrins from focal adhesions (Fig. 3.36H). These 
results point out that antibody-induced alteration of integrin distribution can occur both in 
vivo and in vitro.
3.4.4 (31 integrin redistribution on VPMs does not require the 
presence of stress fibers and the accumulation of focal 
adhesion components.
Integrin receptors colocalised with vinculin into focal adhesions of control, 
untreated VPMs (Fig. 3.37A and D, respectively). Interestingly, incubation for 15 min at 
37°C either in HCB (Fig. 3.37B and E) or in LCB (Fig. 3.37C and F) led to loss of 
vinculin staining from VPMs (Fig. 3.37E and F). All the effects observed on integrin 
and vinculin distribution were negligible when VPMs were incubated at 0°C under the 
same experimental conditions (not shown).
To confirm this result, and to extend the analysis to other focal adhesion 
components, we performed immuno-blot analysis on lysates from control and 
experimentally-treated VPM preparations. Control samples solubilised immediately after 
preparation at 0°C (Fig. 3.38A, lanes 1 and 3), were compared to VPMs incubated 15 
min at 37°C in LCB (Fig. 3.38A, lane 2), or HCB (Fig. 3.38A, lane 4), respectively. 
The results show that incubation at 37°C with either LCB or HCB did not affect the 
recovery of the integrin (31 subunit compared to the respective controls, as expected for a 
transmembrane protein. Actin was also largely retained on VPMs under all conditions 
analysed. In contrast, the recovery of several cytosolic components of the focal 
adhesions, such as tensin, talin, vinculin, and paxillin, was dramatically decreased after 
incubation at 37°C at either high or low [C a-+] (Fig. 3.38A, compare lanes 2 and 4 with 
lanes 1 and 3, respectively). These biochemical data were confirm ed by 
immunofluorescence with antibodies specific for the different focal adhesion proteins (not 
shown).
Our data imply that low [C a-+]-induced relocation of diffuse receptors along 
ECM fibrils in VPMs pretreated with high [Ca^+] (see Fig. 3.28E) did not require the 
accumulation of the analysed focal adhesion components on the cytoplasmic side of the 
membrane. Loss of vinculin and other focal adhesion components from VPMs was not
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Figure 3.37. Loss o f  vinculin from focal adhes ions  during [Ca2 + ] - 
induced integrin redistribution.
VPMs from adherent CEFs were fixed after preparation on ice (panels A and D), or after 
incubation for 15 min at 37°C in HCB (panels B and E) or in LCB (panels C and F). 
VPMs were then processed for immunofluorescence using the (31-cyto polyclonal 
antibody (panels A, B, and C), and the anti-vinculin mAb (panels D, E, and F). The 
same fields are shown in panels A and D, B and E, C and F. Arrowheads in panels A 
and C point to focal adhesions and fibrillary structures, respectively. Bar = 10 pm.
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Talin
Vinculin
Paxillin
A c t i n
F igure  3.38.  Loss o f  focal adhes ion com pon ents  from V PMs af ter  
incubation at 37°C, and actin depletion by gelsolin treatment.
Panel A: VPMs were extracted in SDS-PAGE buffer immediately after preparation on ice 
(lanes 1 and 3), or after incubation for 15 min at 37°C in LCB (lane 2), or in HCB (lane 
4). Equal volumes of the lysates were run on a 5-13% polyacrylamide gradient gel, and 
processed for immuno-blotting using the following primary antibodies: (31-cyto ((31), 
anti-tensin, anti-talin, anti-vinculin, anti-paxillin, and anti-actin. Primary polyclonal and 
monoclonal antibodies were revealed by l-^I-protein A or l-^I-sheep anti-mouse IgG, 
respectively. Loss of focal adhesion components was evident after incubation of VPMs 
at 37°C in the presence of either low (lane 2) or high (lane 4) [C a-+]; (31 integrins and 
actin were not significantly affected by either treatment.
Panel B: VPMs from adherent fibroblasts were incubated for 3 min at 0°C in HCB (lane 
1), or HCB containing 4 pM gelsolin, before extraction in SDS-PAGE buffer. Equal 
volumes of lysates were loaded on a 7% polyacrylamide gel and processed for 
immunoblotting with anti-actin mAb. The primary antibody was revealed by ^ 1 - s h e e p  
anti-mouse IgG.
simply due to warming of the samples at 37°C. In fact, under similar experimental 
conditions, loss of focal adhesion proteins could be prevented by incubation of VPMs at 
37°C in buffers of lower ionic strength, or with more acidic pH (below pH 6, not 
shown).
To investigate the role of actin on [Ca^+J-mediated [31 integrins redistribution in vitro, 
we selectively disassembled the stress fibers by using the actin capping and severing 
protein gelsolinK Incubation of VPMs for 3 min at U°C in the presence of 4 pM 
recombinant gelsolin was sufficient to induce loss of more than 90% of actin present on 
VPMs, as revealed by immuno-blotting (Fig. 3.38B). As confirmed by F-actin staining 
with fluorescent phalloidin (Fig. 3.39D), treatment with gelsolin was able to disassemble 
most, if not all stress fibers. Some F-actin could still be detected only in areas at the 
border of VPMs, where residues of the dorsal plasma membrane were probably 
preventing efficient access of gelsolin (Fig. 3.39E and F, asterisks). This residual actin 
could justify the presence of approximately 10% actin in gelsolin-treated VPMs, as 
detected by immuno-blotting (Fig. 3.38B). In VPMs maintained at 0°C, (31 integrins 
could be detected in focal adhesions even in the absence of detectable stress fibers 
(compare Fig. 3.39C and D, with 3.39A and B, respectively). Furthermore, high 
[Ca^+j-induced diffusion of the receptors (Fig. 3.39E), and subsequent low [C a-+ ]- 
induced concentration along ECM fibrils (Fig. 3.39G) were not affected by lack of stress 
fibers (Fig. 3.39F and H, respectively). These results show that stress fibers are not 
required for the redistribution of [31 integrins under cell-free conditions. Moreover, 
removal of stress fibers from VPMs does not affect maintenance of (31 integrins into focal 
adhesions at 0°C.
3.4.5 The distribution of (31 integrins lacking the cytoplasmic 
domain is affected by a mAb modulating integrin function, 
but not by [Ca2+]
To study whether interactions between integrins and intracellular factors may play 
a role in receptor redistribution, we transfected CEFs with the (31TR construct 
corresponding to the human (31 integrin lacking the entire cytoplasmic domain. The 
distribution of (31TR on VPMs was analysed by immunofluorescence using the mAb 
TS2/16, specific for the human (31 subunit. As expected, we found that in contrast to the 
endogenous (31 receptor (Fig. 3.40A), (31TR was not clustered in focal adhesions, but
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HFigure 3.39.  Maintenance of  (31 integrins in focal adhesions,  and their  
ca lc ium -dependent  redistribution are not affected by ge lsol in-induced  
stress fibers disassembly under cell-free conditions.
VPMs from adherent fibroblasts were fixed immediately after preparation on ice (panels 
A and B), or were incubated 3 min at 0°C with 4 pM gelsolin to disrupt F-actin (panels 
C-H). After the treatment with gelsolin, VPMs were either fixed (panels C and D), or 
incubated 15 min at 37°C in HCB (panels E-H). VPMs were then fixed (panels E and F), 
or incubated for further 15 min at 37°C in LCB (panels G and H). After fixation, all 
samples were processed for immunofluorescence with the (31-cyto antibody, and TRITC- 
conjugated anti-rabbit IgG (panels A, C, E and G). FITC-phalloidin (panels B, D, F, 
and H) was used to stain F-actin. The same fields are shown in panels A and B, C and 
D, E and F, G and H. Arrowheads in panels A and B show colocalisation of integrins in 
focal adhesions A, with the tip of actin stress fibers (panel B). Asterisks in panels E 
and F show areas at the periphery of the VPM where a portion of the dorsal plasma 
membrane is present, and some F-actin is still visible. Bar = 10 pm.
105
Figure 3.40.  Low [Ca^+ ] does not affect the localisation of  integrin (3 1 
receptors lacking the cytoplasmic domain.
CEFs were transiently transfected to express the truncated (31TR construct corresponding 
to the human integrin (31 subunit lacking the cytoplasmic domain. After 20 h culture, 
VPMs were prepared at 0°C and immediately fixed (panels A and B), or incubated for 15 
min at 37°C in LCB (panels C and D), or in HCB containing 40 pg/ml of the activating 
mAb TS2/16 specific for the human (31 subunit (panels E and F). In panels G and H, 
intact transfected CEFs were incubated for 1 h at 37°C with 40 pg/ml of the activating 
mAb TS2/16 specific for the human (31 subunit, in a buffer containing 20 mM Hepes, 
2.7 mM KC1, 137 mM NaCl, 5.6 mM glucose, 0.2 mMEGTA, 1 mM MgCl2, pH7. 
After fixation, the samples were incubated with the (31-cyto antibody and FITC- 
conjugated anti-rabbit IgG to detect the endogenous chicken (31 subunit (panels A, C, E, 
and G), while the truncated human (31 subunit was detected with the anti-human (31 mAb 
TS2/16, revealed by TRITC-conjugated anti-mouse IgG (panels B, D, F, and H). The 
same fields are shown in panels A and B, C and D, E and F, G and H. Bars = 10 pm.
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showed a diffuse staining on VPMs fixed immediately after preparation at 0°C (Fig. 
3.40B). After incubation in LCB, |31TR was found predominantly diffuse, without a 
clear colocalisation with the endogenous receptor (Fig. 3.40C and D). As expected, 
(31TR had a diffuse localisation after incubation of VPMs in HCB (not shown).
In contrast, (31TR did clearly concentrate along ECM fibrils if VPMs were 
incubated 15 min at 37°C in the presence of the human-specific stimulatory mAb TS2/16. 
This effect was observed either at high [Ca^+j (Fig. 3.40F), with the endogenous 
receptor diffuse on the membrane (Fig. 3.40E), or at low [C a-+], with the endogenous 
(31 receptors colocalising with (31TR in ECM fibrils (not shown). As observed for the 
endogenous wild type receptors in CEFs treated with the chicken-specific activating mAb 
TASC (Fig. 3.36G), incubation of intact CEFs with the human-specific activating 
antibody TS2/16 induced localisation of part of |31TR along ECM fibrils (Fig. 3.40H). 
Under these conditions, transfected (31TR colocalised with the endogenous receptor,
concentrated into focal adhesions (Fig. 3.40G).
These results show that the mechanism of low [Ca^+J-mediated [31 integrin
redistribution along fibrils in vitro requires the cytoplasmic domain of the receptor, while 
receptors lacking the cytoplasmic domain retain the ability to redistribute in vivo and in 
vitro, upon activation by stimulatory antibodies.
3 .5  RECONSTITUTION OF A RECEPTOR COMPLEX AND 
RECRUITMENT OF EXOGENOUS ACTIN AT FOCAL 
ADHESION SITES ON VPMs
By using VPMs as a "cell-free" system, we have demonstrated that it is possible 
to modulate integrin function and distribution on the membrane, by changing cations 
concentration in the buffer. Moreover, this "cell-free" system, has allowed the dissection 
of focal adhesion architecture, demonstrating an uncoupling of the receptor from the 
connected cytoskeleton. These results indicated that this may be a suitable model for the 
reconstitution of some of the molecular interactions required for the assembly of focal 
adhesions. In our system we can test the binding of purified components to VPMs in 
which (31 receptors affinity for the ligand can be modulated. For this purpose, we have 
used purified oc-actinin, an actin-binding protein known to interact in vitro with the 
cytoplasmic tail of integrins (Otey et al., 1990). The results obtained showed that 
purified a-actinin colocalises and redistributes with (31 receptors, implicating binding ol 
a-actinin to the receptors.
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The relationships between focal adhesions and actin assembly is not well 
characterised. To start investigating this problem, we have used our "cell-free" system 
and found a special property of focal adhesion complexes in recruiting exogenous actin 
under conditions in which new actin polymerisation is inhibited.
3.5.1 Reconstitution of a-actinin binding to F-actin-depleted 
VPMs: [Ca2+]-mediated redistribution under cell-free
conditions
We have utilised purified a-actinin in binding experiments to VPMs, with the aim 
of reconstituting some of the molecular interactions which are believed to be important for 
focal adhesion assembly. This protein is known to bind both integrin and F-actin. In 
contrast to most of the focal adhesion proteins examined (see Fig. 3.38), some a-actinin 
remained along stress fibers after 15 min incubation at 37°C in either high or low [C a-+] 
buffers (Fig. 3.41B and D, respectively). Incubation of VPMs for 10 min at 37°C with 
purified a-actinin in high [Ca^+j buffer led to the accumulation of the exogenous protein 
(Fig. 3.41H) predominantly along stress fibers (Fig. 3.41 G). Binding of exogenous a -  
actinin was evident (Fig. 3.41F and H), when compared with the endogenous a-actinin 
remaining after incubation at 37°C in the absence of the exogenous protein (Fig. 3.41B 
and D). In both cases, the pattern of distribution of a-actinin was largely different from 
that of integrins (compare Fig. 3.41 B with A, and F with E).
To test whether binding of a-actinin to (31 integrins could be reconstituted in this 
system, we repeated the experiments on VPMs depleted of F-actin (Fig. 3.39D). After 
incubation with gelsolin at 37°C at high [C a-+], no endogenous a-actin in  could be 
detected on the membranes (Fig. 3.42E). Incubation of these membranes for 10 min at 
37°C in the presence of purified a-actinin at high [C a-+] resulted in a strong, diffuse 
signal on the membranes (Fig. 3.42F), which was similar to that observed for (3 1 
integrins (Fig. 3.42C).
Treatment of VPMs at 37°C with gelsolin at low [Ca^+j resulted also in complete 
removal of the endogenous a-actinin (Fig. 3.423), and further incubation with purified 
a-actinin at low [C a-+] resulted in a fibrillar staining (Fig. 3.42K), which overlapped 
with the staining for the (31 receptors (Fig. 3.42H). Moreover, binding of exogenous a -  
actinin to gelsolin-treated VPMs at high [Ca--+], followed by incubation at 37°C at low 
[Ca^+J in absence of the exogenous protein, resulted in the redistribution of both pre­
bound a-actinin and integrins along ECM fibrils (Fig. 3.421 and L).
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Figure 3.41. Reconstitution o f  the binding o f  a -act in in  to VPMs in the 
presence of  actin stress fibers.
After a first incubation for 10 min in low ionic strength, high [Ca~+]-containing buffer, 
VPMs were incubated for further 10 min in the same buffer in the absence (panels A-D), 
or presence (panels E-H) of purified a-actinin, as described in chapter 2. After fixation, 
F-actin was detected with FITC-phalloidin (panels C and G), (31 integrins were detected 
with the (31-cyto antibody (panels A and E), and a-actinin was detected with a specific 
mAb (panels B, D, F, and H). Same fields are shown in panels A and B, C and D, E 
and F, G and H. Bar = 10 pm.
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Figure 3.42. Reconstitution o f  the binding o f  a-actin in  to VPMs in the 
absence of  F-actin.
VPMs were incubated for 10 min in low ionic strength buffer containing 4 \xM gelsolin, 
at high [Ca2+ ] (panels A-F, I, L), or low [Ca2+ ] (panels G, H, J, K). The samples 
were further incubated at 37°C in a buffer with high [Ca2+] (panels A-F, I, L), or low 
[Ca2+] (panels G, H, J, K). In panels C, F, H, I, K, and L, the second incubation was 
in the presence of purified a-actinin, as detailed in the Methods. Membranes were then 
washed and fixed for immunofluorescence. For low [Ca2 + ]-induced a -a c t in in  
redistribution (panels I and L), after the second incubation at 37°C for 10 min with a -  
actinin in high [Ca2+]-containing buffer, the samples were immediately transferred to 
low [Ca2+ ]-containing buffer and incubated for 10 min at 37°C, to induce integrin 
redistribution along ECM fibrils before fixation. Panels A-C and G-I, integrin 
distribution, by using the pl-cyto polyclonal antibody; panels E, F, and J-L, localisation 
of a-actinin with the specific mAb; Panel D, F-actin localisation with TRITC-phalloidin. 
Same fields are shown in panels A and D, B and E, C and F, G and J, H and K, I and L. 
Bar = 10pm.
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These data provide evidence for the reconstitution of the binding of a focal 
adhesion component to (31 receptors in VPMs. Moreover, the [Ca- + ] - induced  
redistribution of partially reconstituted adhesive complexes under cell-free conditions, 
illustrates the possibility to use this system for further reconstitution studies.
3.5.2 Recruitment of exogenous actin to focal adhesion sites on 
VPMs
To start investigating the relationships between focal adhesions and actin 
assembly in our cell-free system, we performed a number of experiments utilising Rh- 
actin. We found that incubation of freshly prepared VPMs with 1 pM Rh-actin for 2 min 
at 37°C, a condition which preserved the localisation of vinculin into focal adhesions 
(Fig. 3.43A), resulted in the accumulation of the exogenous actin in fibrillar structures on 
the membranes (Fig. 3.43D). Under these conditions, exogenous actin colocalised with 
stress fibers (compare Fig. 3.43B and E). When Rh-actin was added to VPMs in the 
presence of cytochalasin D and DNase I (which inhibit polymerisation from the barbed 
and pointed end of actin, respectively), exogenous actin accumulated specifically to focal 
adhesion sites (Fig. 3.43C and F), while binding along stress fibers was not detected. 
The same result was obtained by incubation with cytochalasin D only (not shown). Since 
the short incubation with cytochalasin D and DNase I did not evidently affect endogenous 
stress fibers (not shown), this result indicates that accumulation along stress fibers 
requires new actin polymerisation, and is somehow different from binding of exogenous 
actin to focal contacts.
Exogenous actin accumulated along stress fibers on VPMs pre-incubated for 15 
min at 37°C at low [C a-+] (Fig. 3.43J), and had a distribution distinguishable from the 
fibrillar pattern observed for (31 (Fig. 3.43(3). Cytochalasin D and DNase I completely 
prevented actin recruitment on VPMs under these conditions (Fig. 3.43K). Since 
incubation for 15 min at 37°C in low [Ca^+] resulted in the absence of detectable levels of 
several focal adhesion proteins on VPMs (e.g., vinculin: see Fig. 3.37F), these data 
indicate that focal adhesion complexes are required to specifically recruit actin under 
conditions in which new actin polymerisation is inhibited.
With the aim of starting to analyse the minimal requirements for the recruitment of 
actin at adhesive sites, we tried to reconstitute Rh-actin binding to partially reconstituted 
adhesive complexes in the presence of actin polymerisation inhibitors. VPMs containing 
exogenous a-actinin were prepared as described in the previous paragraph (see Fig.
I l l
Figure  3.43. Accumulation of  exogenous actin at focal adhesion sites is 
not affected by inhibitors of  actin polymerisation.
VPMs were incubated for 2 min at 37°C in LCB with 1 pM Rh-actin either immediately 
after preparation (panels A-F), or after 15 min incubation at 37°C in LCB (panels G, H, 
J, and K). In panels I and L, VPMs were incubated with exogenous a-ac tin in  (as 
described in the legend of Fig. 3.41L), before incubation for 2 min at 37°C with Rh-actin 
in LCB. In panels C, F, H, I, K, and L, 100 nM cytochalasin D and 100 pg/ml DNase I 
were present during the incubation with Rh-actin. After fixation, the samples were 
processed for immunofluorescence with the anti-vinculin mAb (panels A and C), the (31- 
cyto polyclonal antibody (panels G and H), or the anti-a-actinin polyclonal antibody 
(panel I). In panel B, F-actin was detected with FITC-phalloidin, while in panels D, E, 
F, J, K, and L, bound Rh-actin is shown. Arrows in panels A and D, C and F, point to 
sites where Rh-actin colocalises with vinculin in focal adhesions, while arrows in panels 
B and E indicate colocalisation of Rh-actin with stress fibers. The same field is shown in 
panels A and D, B and E, C and F, G and J, H and K, I and L. Bar = 10 pm
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3.42L), and incubated for 2 min at 37°C with 1 \iM Rh-actin in the presence of 
cytochalasin D and DNase I. Under these conditions, detectable levels of Rh-actin could 
not be observed on the membranes. This result suggests that complexes between active 
(31 integrins and a-actinin are not sufficient to recruit exogenous actin to sites of 
interaction between the cell and the ECM.
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-  Chapter 4  -
DISCUSSION
4.1 MORPHOLOGICAL CHARACTERISATION OF VPMs: 
VPMs retain well preserved focal adhesions and stress fibers
In this study, I have used a modification of the lysis-squirting technique (Avnur 
and Geiger, 1981; Nermut et a i ,  1991), for the preparation of detergent-free ventral 
plasma membranes (VPMs) obtained from adherent chicken embryo fibroblasts (CEFs). 
By a combination ol different morphological (indirect immunofluorescence, phase 
contrast, interference reflection and scanning force microscopy) and biochemical 
techniques, I have shown that known focal adhesion components and the connected actin 
cytoskeleton are retained on the membrane after the hypotonic treatment and the 
mechanical cell disruption for VPMs preparation, suggesting that relatively strong 
interactions are involved in the maintenance of these structures.
An advantage of using VPM preparations is the possibility of studying the 
distribution of antigens on the ventral surface of the cell and on the connected 
cytoskeleton, without interference coming from the signal inside the cell or from the 
dorsal portion of the membrane. We have already successfully utilised VPMs for the 
study of the differential subcellular distribution of two cytoplasmic variants of the a6|31 
integrin laminin receptor (Cattelino et al., 1995). Here I reported the distribution of the 
small GTP-binding protein Rac 1 along actin stress fibers and in focal adhesions in VPM 
preparations (Fig. 3.5), while the same protein showed a typical late endosomal, 
lysosomal pattern in intact cells, according to pervious reports in other cell types (Ridley 
et a i ,  1992; Robertson et a i ,  1995). Although it is well known that Rho family GTP- 
binding proteins, including Rac, are implicated in the dynamic organisation of the actin 
cytoskeleton (Nobes and Hall, 1995), to my knowledge, this is the first indication of the 
localisation of a Rho GTPase at the actin cytoskeleton. In line with this result, we have 
recently demonstrated that the overexpressed wild type Rac 1 has the same localisation of 
the endogenous protein in VPMs prepared from CEFs, and that the overexpression of 
this GTPase induces disassembly of stress fibers, and production of long, highly
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branched actin-rich protrusions, with consequent dramatic changes in cell morphology 
(Albertinazzi et a i ,  in press).
Ezrin is a component of the ERM (Ezrin/Radixin/Moesin) family ot proteins, 
specifically localised to microvilli in a number of polarised epithelia (Bretscher, 1983; 
Hanzel et a i ,  1991; Berryman et a i,  1993;, Franck et a i,  1993;, Winckler et a l ,  1994; 
Amieva and Furthmayr, 1995). The use of VPMs has allowed us to visualise the 
localisation of this protein at focal adhesion sites (Fig. 3.6). Interestingly, radixin, 
another member of the family, has been also localised to focal adhesions using a similar 
approach (Sato et a i ,  1992). This finding, together with the finding that ERM family 
proteins can reconstitute actin polymerisation and focal contact formation in response to 
activation of Rho and Rac in serum-starved 3T3 fibroblasts permeabilised with digitonin 
(McKay et al. 1997), strongly indicates a role of these proteins in the regulation of focal 
adhesion sites, and of the connected actin cytoskeleton.
Scanning force microscopy was useful for a general, high resoluting view of the 
topography of VPMs. While indirect immunofluorescence enhances the contrast of 
selectively revealed antigenic structures, their organisation with respect to adjacent, 
unlabeled components cannot be determined. In scanning force microscopy, the height 
of any membrane component that is significantly different from its surroundings is 
contrasted and quantitated. In topographs of VPMs different structures could be 
revealed: 100 nm-diameter particles, probably corresponding to early endosomes (Fig. 
3.7); holes in the lipid bilayer (Figs 3.7 and 3.8); unlabeled filaments extending beyond 
the perimeter of the membrane, probably corresponding to extracellular matrix libers 
(Fig. 3.9); stress fibers and focal contacts. Focal contacts were always visible in 
scanning force micrographs unless overlaid by bulky stress fibers. On ventral plasma 
membranes prepared from cells cultured for 1.5-3 hours, large focal contacts were 
common at the periphery. These focal adhesions exhibited fine librillar structures 
probably related to actin networks associated with stress fiber terminals (Fig. 3.10). 
Such fine fibrillar structures could not be revealed in fluorescence images of the same 
membranes labelled for actin and vinculin.
All together these results evaluate the system for further studies on focal adhesion 
composition. With the aim of obtaining new informations about focal adhesion 
composition and regulation, we have injected VPMs preparations into mice for the 
production of monoclonal antibodies. The injection of a miscellaneous material has been 
a successful approach in a number of other systems for the production of monoclonal 
antibodies, and for the identification of new polypeptides. In our case, the approach used
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was successful for the production of antibodies against components of the extracellular 
matrix and of the actin cytoskeleton, including some actin-binding proteins, which need 
to be further characterised. Unfortunately, despite the presence of well-preserved focal 
adhesions in VPM preparations, we were unable to obtain antibodies against either 
known or new focal adhesion components. This could be due to the relatively scarce 
amount, exposure, or antigenity of single focal adhesion components as compared to 
other structures present in VPM preparations.
4.2 BIOCHEMICAL CHARACTERISATION OF VPMs: 
tyrosine-phosphorylated paxillin is preferentially localised at 
focal adhesion sites
The results presented in 3.2 show the specific accumulation of several tyrosine- 
phosphorylated polypeptides at focal adhesions in VPMs, and the preferential localisation 
of the tyrosine-phosphorylated form of focal adhesion components, such as paxillin, at 
focal adhesion sites. These results indicate that tyrosine-phosphorylated proteins are 
constitutive components of the adhesion sites of CEFs, where they may play an important 
role in focal adhesion formation and maintenance.
Ligand-dependent integrin clustering has been shown to be sufficient to induce the 
aggregation and colocalisation of several focal adhesion molecules at the adhesion sites 
(Miyamoto et a i ,  1995), although the mechanisms involved are poorly understood. 
Tyrosine phosphorylation is thought to play an important role in integrin signalling and 
integrin-mediated cytoskeletal reorganisation, but no direct functional evidence on the role 
of tyrosine phosphorylation in cell adhesion to the extracellular matrix is available yet. 
Elevated phosphotyrosine has been detected in focal adhesions of transformed (Comoglio 
et al., 1984) and non-transformed cells (Maher et a i ,  1985). Since the levels of tyrosine 
phosphorylation of focal adhesion components are generally low, it has been recently 
proposed that the pools of proteins in focal adhesions may contain much higher levels of 
phosphate compared to the total cellular pools (Pavalko and Otey, 1994), but direct 
evidence for this hypothesis has been missing until now. To be able to investigate this 
issue, we have used the VPM preparation. The results obtained from the biochemical 
analysis show that VPMs are highly enriched in tyrosine-phosphorylated proteins when 
compared to whole cell lysates. The fact that hypotonic treatment and mechanical
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disruption, while releasing most of the cytosolic proteins, did not disassemble focal 
adhesions, suggests that relatively strong interactions are involved in the maintenance of 
these structures, which could be disrupted by detergent extraction. In fact, although a 
detergent-insoluble pellet remained after extraction of VPMs with Triton X-100, we 
found that most of the tyrosine-phosphorylated proteins and of other focal adhesion 
components were recovered in the detergent-soluble fraction, while part of the actin 
cytoskeleton remained insoluble (Fig. 3.11). Tyrosine-phosphorylated components were 
analysed in CEFs that had spread on the substrate for 18 h before preparation of VPMs, 
suggesting that high levels of phosphorylation are preserved after the initial formation of 
focal adhesions, and may be required for maintenance and/or continuous reorganisation 
of the adhesive sites in these cells. Furthermore, the localisation studies presented here 
indicate that tyrosine-phosphorylated proteins recovered in VPM preparations are 
concentrated in the focal adhesions.
Well-characterised focal adhesion components, such as vinculin, talin and 
paxillin, can be clearly localised to focal adhesion in VPMs by immunofluorescence, but 
they show only a weak or no enrichment in VPMs compared to whole cell lysates. This 
finding is an indication of the existence of large cytosolic pools, which are not associated 
to the adhesion sites. This is evident for paxillin, where the diffuse intracellular staining 
observed in fixed, permeabilised cells disappears in VPMs, where only focal adhesion 
staining for paxillin can be observed.
One explanation for these findings comes from the analysis of the distribution of 
tyrosine-phosphorylated paxillin. As previously reported (Turner et al., 1990; Turner, 
1991; Turner et a i ,  1993; Glenney and Zokas, 1989), we found that tyrosine- 
phosphorylated paxillin represents only a minor fraction of the polypeptide found in 
whole cell lysates. On the other hand, our results indicate that the level of tyrosine- 
phosphorylated paxillin detected in VPM lysates is close to 100%. Therefore, although 
the total paxillin polypeptide is not enriched in VPMs, tyrosine-phosphorylated paxillin is 
highly enriched in these preparations (see scheme of Fig. 4.1). This finding, together 
with the specific localisation of paxillin in focal adhesions of V PM s by 
immunofluorescence, indicates the preferential localisation of a minor pool of paxillin 
with a high level of tyrosine-phosphorylation at focal adhesion sites.
We were not able to determine the level of tyrosine phosphorylation of FAK in the 
VPM s, since we could not detect a band above background levels in FAK 
immunoprecipitates blotted with anti-FAK antibodies under our experimental conditions 
(data not shown). On the other hand, quantitation of the specific 120KD tyrosine-
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FAK and paxillin are two of the best characterised focal adhesion components, 
and they are tyrosine-phosphorylated during cell adhesion to the extracellular matrix 
(Burridge et ah, 1992; Kornberg et a l,  1992). While FAK may regulate the function of 
focal adhesion components by phosphorylation, paxillin is believed to play a role in the 
assembly of the focal adhesions, by forming complexes with several components of the 
adhesive sites, as shown by in vitro and in vivo studies (Birge et a l ,  1993; Hildebrand 
et al., 1995; Sabe et a l ,  1994; Turner and Miller, 1994; Weng et a l ,  1993). Although 
in vitro studies have shown that the SH2 domains of Crk, Csk, Src, and Fyn can 
recognise tyrosine-phosphorylated paxillin (Schaller and Parsons, 1995), the role of 
paxillin tyrosine-phosphorylation in vivo remains to be established. The use of mutants 
of a major paxillin phosphorylation site (tyrosine 118) in vivo (Schaller and Parsons, 
1995) indicates that phosphorylation of this site is not required for recruitment to focal 
adhesions (Beilis et a l ,  1995), although a number of other phosphorylation sites exist on 
paxillin that may perform this function. Alternatively, paxillin may become 
phosphorylated once recruited to the adhesion site by a different mechanism. Further 
work will be required to distinguish between these two possibilities.
To our knowledge, this represents the first biochemical evidence for the 
preferential localisation of a phosphorylated pool of focal adhesion components at the 
adhesive sites. The selective accumulation of tyrosine-phosphorylated proteins to focal 
adhesions suggests an important role of the phosphorylated form of these proteins in the 
formation and maintenance of focal adhesions.
4.3 [Ca2+] REGULATES (31 INTEGRINS FUNCTION AND 
DISTRIBUTION ON VPMs
The analysis of the mechanisms involved in focal adhesion formation and 
regulation is complicated by the fact that several events may concomitantly occur during 
assembly and disassembly of a focal adhesion in the living cell. The possibility to 
uncouple some of these events would facilitate the analysis of the mechanisms involved. 
The presence of accessible integrin receptors in an intact lipid bilayer in VPMs makes this 
an ideal system for the experimental manipulation of integrin function and distribution.
By using VPMs as a "cell-free" system, we found that endogenous (31 integrins 
rapidly redistribute within VPMs incubated at different [C a-+]s. In particular, high
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Tyrosine-phosphorylated paxillin represents only the 10% of the pool of paxillin present 
in the cell, and it is selectively accumulated at sites of focal adhesions. At these sites, 
integrin receptors are clustered and bound to the extracellular ligand from one side, and to 
intracellular focal adhesion components from the other side.
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phosphorylated band immunoprecipitated with FAK antibodies showed an enrichment of 
the tyrosine-phosphorylated form of FAK in VPM lysates.
FAK and paxillin are two of the best characterised focal adhesion components, and they 
are tyrosine-phosphorylated during cell adhesion to the extracellular matrix (Burridge et 
a i ,  1992; Kornberg et a i ,  1992). While FAK may regulate the function of focal 
adhesion components by phosphorylation, paxillin is believed to play a role in the 
assembly of the focal adhesions, by forming complexes with several components of the 
adhesive sites, as shown by in vitro and in vivo studies (Birge et a i ,  1993; Hildebrand 
et a i ,  1995; Sabe er rz/., 1994; Turner and Miller, 1994; Weng ef a/., 1993). Although 
in vitro studies have shown that the SH2 domains of Crk, Csk, Src, and Fyn can 
recognise tyrosine-phosphorylated paxillin (Schaller and Parsons, 1995), the role of 
paxillin tyrosine-phosphorylation in vivo remains to be established. The use of mutants 
of a major paxillin phosphorylation site (tyrosine 118) in vivo (Schaller and Parsons, 
1995) indicates that phosphorylation of this site is not required for recruitment to focal 
adhesions (Beilis et a i ,  1995), although a number of other phosphorylation sites exist on 
paxillin that may perform this function. Alternatively, paxillin may become 
phosphorylated once recruited to the adhesion site by a different mechanism. Further 
work will be required to distinguish between these two possibilities.
To our knowledge, this represents the first biochemical evidence for the 
preferential localisation of a phosphorylated pool of focal adhesion components at the 
adhesive sites. The selective accumulation of tyrosine-phosphorylated proteins to focal 
adhesions suggests an important role of the phosphorylated form of these proteins in the 
formation and maintenance of focal adhesions.
4.3 [Ca2+] REGULATES pi INTEGRINS FUNCTION AND 
DISTRIBUTION ON V P M s
The analysis of the mechanisms involved in focal adhesion formation and 
regulation is complicated by the fact that several events may concomitantly occur during 
assembly and disassembly of a focal adhesion in the living cell. The possibility to 
uncouple some of these events would facilitate the analysis of the mechanisms involved. 
The presence of accessible integrin receptors in an intact lipid bilayer in VPMs makes this 
an ideal system for the experimental manipulation of integrin function and distribution.
By using VPMs as a "cell-free" system, we found that endogenous p i  integrins 
rapidly redistribute within VPMs incubated at different [Ca2+]s. In particular, high
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[Ca^+j causes dispersion of integrins out of focal adhesions, while (31 integrins rapidly 
concentrate along ECM fibrils at low [Ca^+J (see scheme of Fig. 4.2A and B).
To correlate [C a -+]-induced integrin redistribution with changes in receptor 
activity we have utilised function-modulating mAbs. It has been recently shown that at 
least two distinct populations of (31 receptors are present on the surface of CEFs, which 
may correspond to two different functional states of the receptors (Cruz et a i ,  1997). 
By using the function-blocking mAb CSAT (Neff et a i ,  1982), and the (31-stimulating 
mAb TASC (Neugebauer and Reichardt, 1991), we have been able to confirm these data 
on untreated VPMs from CEFs. In addition, the inability of TASC to recognise the 
receptors on VPMs treated at high [Ca^+J is an indication of the low affinity state of the 
diffuse (31 receptors, while TASC-positive receptors concentrated along ECM fibrils at 
low [Ca^+j correspond to high affinity receptors. Interestingly, the stimulatory mAb 
TASC is able to induce clustering of diffuse receptors along ECM fibrils even in the 
presence of high [Ca^+J. Since morphological analysis did not reveal any evident 
[Ca2 + ]-mediated reorganisation of the ECM, our data suggest that the pattern of 
distribution of integrins is a consequence of the activation of the receptors induced by low 
[Ca2+], and depends on the organisation of the available ECM. According to this 
hypothesis, at low [Ca^+J high affinity (TASC-positive) (31 receptors were diffuse on 
substrates uniformly coated with purified laminin, where extracellular matrix fibers were 
not formed.
Intriguingly, VPMs remain spread on the substrate even after incubation for 
several hours at high [Ca-+], suggesting that adhesion may be mediated by low affinity 
binding of (31 integrins to the ECM, or by other receptors. Similarly, serum starved 
Swiss 3T3 cells remain spread and adherent even when no detectable focal contacts are 
present (Nobes and Hall, 1994), and it has been recently shown that adhesion of serum- 
starved cells is still RGD-dependent (Barry et a i ,  1997). The finding that integrin (33 
and (35 subunits are present in much lower amounts in CEFs compared to the (31 subunit 
(Bossy and Reichardt, 1990), suggests that (31 receptors are the major integrin players in 
VPM adhesion to endogenous ECM. Moreover, analysis of the distribution of the (33 
subunit in untreated VPMs showed a diffuse, weak signal, which was not affected by 
incubation at 37°C at different [Ca-+]s (data not shown). These observations exclude (33 
integrins as likely major players in the adhesion of VPMs. On the other hand, given the 
inability of the function-blocking CSAT mAb to detach VPMs from the substrate (data
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shown), the role of other, non-integrin receptors in the adhesion of VPMs to ECM can 
not be excluded.
An interesting finding of this study is the uncoupling of integrin redistribution 
from actin stress fibers and focal adhesions under cell-free conditions. Contractility is 
important for actin stress fibers and focal adhesion formation (Chrzanowska-Wodnicka 
and Burridge, 1996), and stress fibers are essential for the maintenance of focal 
adhesions in intact cells (Domnina et a i ,  1982; Cooper et a i ,  1987). These and other 
findings have suggested that the clustering of integrins, while requiring an ECM, is 
driven from the acto-myosin force generated within the cell (reviewed by Burridge et a i,  
1997). We find that incubation of VPMs at 37°C leads to a drastic loss of components 
from the focal contacts of a major fraction of VPMs, indicating that a detectable presence 
of these proteins at the membrane is not required for integrin redistribution under cell-free 
conditions. Uncoupling of [Ca“ + ]-induced integrin localisation from the actin 
cytoskeleton was shown by the fact that disassembly of stress fibers with gelsolin did not 
affect [C a- + ]-mediated receptor redistribution at 37°C, and by the finding that 
disassembly of stress fibers by gelsolin at 0°C did not perturb receptor localisation into 
focal contact areas. Our results suggest that mechanisms increasing integrin binding to 
the ligand are also able to cluster integrins along ECM fibrils, without need of actin- 
myosin tension. In this direction, Pavalko and Burridge (1991) have shown that 
disassembly of stress fibers by microinjection of a-actinin fragments into cells only 
partially affected focal adhesions. On the other hand, we find that reversion of high 
[Ca2+]-induced diffusion of integrins by low [Ca2+] leads to recruitment of the receptors 
in elongated ECM fibrillar structures which are clearly distinguishable from the focal 
adhesions found in control VPMs (compare, for example, Figure 3.37A with 3.37C). As 
depicted in Fig. 3.32, in intact CEFs and in untreated VPMs, (31 integrins clustered into
focal adhesions colocalise with the tip of stress fibers on one face of the membrane, and 
often with part of an ECM fibril on the other face of the membrane (see for example Fig. 
3.32A and B). In contrast, low [Ca2+]-induced, elongated integrin clusters evidently 
colocalise with ECM fibrils (see Fig. 3.32E and F), while ultrastructural analysis shows 
that colocalisation of (31 receptors with stress fibers is not evident under these conditions. 
These findings suggest that coupling between actin stress fibers and ligand-driven 
localization of high affinity receptors is required for the recruitment of (31 integrins into
focal adhesions of intact cells.
The mechanisms by which divalent cations modulate integrin activity in our 
system requires further investigations. In particular, from our analysis we can not
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conclude whether the effects induced by C a -+ are due to the action of this ion extra- 
and/or intracellularly. The finding that redistribution in the presence of low [C a -+] 
requires the presence of the cytoplasmic domain of the (31 subunit, together with the 
finding that integrin distribution can not be altered by changing the [Ca-+] in the medium 
of intact CEFs (not shown), suggests that [Ca-+] could act on the intracellular portion of 
the membrane, but still an action of [Ca^+J extracellularly could not be excluded. Both 
possibilities will be discussed below.
1) Extracellular action of Oa-+ on (31 integrins function and distribution.
(31 integrins are known to be regulated by extracellular divalent cations, as 
indicated by studies by using either solubilised receptors or cell binding assays with intact 
cells (Humphries, 1996). Both integrin a  and (3 subunits contain binding sites for 
divalent cations in their extracellular portions, which can positively (M g-+ or M n-+) or 
negatively (Ca2+) affect integrin-ligand affinity (Tuckwell et a l ,  1992). Modulation of 
integrin-mediated cell adhesion to ligands by these cations suggests that the ratio between 
Mg2+ and Ca2+ is involved in the regulation of integrin function, which may in turn 
influence cell behaviour (Grzesiak et a l ,  1992). According to this model, we found that 
(31 receptors redistribute on the VPM at different [Ca-+]s, in the presence of 2.5 mM 
[M g2 + ], Hypothesising an extracellular action of Ca^ + , the requirement of the 
cytoplasmic tail of (31 for the low [Ca^+J-mediated effect on receptor redistribution could 
be interpreted by an alteration of the conformational state of the deleted receptors, which 
makes them inactivable by decreasing the [C a-+]. The fact that the mutated receptor 
could still redistribute upon mAbs stimulation suggests that low [Ca^+] and mAbs 
mediate receptor redistribution through different mechanisms.
While the diffuse, low affinity (31 integrins could be concentrated along ECM fibrils by 
lowering the [Ca^+J in the buffer, low [Ca^+j somehow locks the receptors in the high 
affinity state (see scheme of Fig. 4.2A and B). Diffusion of the receptors could only be 
achieved by incubation of VPMs with the function-blocking mAb CSAT. One possible 
explanation for this observation comes from studies pointing at the interplay between 
distinct cation binding sites in the regulation of ligand binding (Smith et a l ,  1994; Hu et 
a l ,  1996). Mould et a l  (1995) found that while high [C a-+] can displace M g-+ from 
the integrin, low [C a-+] greatly increased the apparent affinity of M g -+ for its binding 
site, suggesting the existence of a distinct high affinity C a -+-binding site. This may lead 
to more efficient ligand binding by the receptor, that may not be reversed by subsequently 
increasing the [Ca^+J.
122
Xlow [C a2+]
4 1  i l  i l  I I  11 II I I I I  II
/ ft
high [Caa
HA A a A
low [Caa+]
A A A-
A
B
low a ffin ity  receptor
1 trunca ted  receptor
J^ high a ffin ity  receptor
AA4AAWA extrace llu la r m atrix fibril
l \ \ V focal adhesion com plex
0 actin
Figure 4.2. Schematic  summary o f  the effects o f  [Ca^ + ] on receptor  
distribution and function.
On the ventral surface of intact cells and in untreated VPMs, p i  integrins are found both 
concentrated in focal adhesions (high affinity receptors), and diffuse (low affinity 
receptors). In focal adhesions, integrins colocalise with focal adhesion components, and 
with the tip of actin stress fibers, while they only partially colocalise with ECM fibrils.
(A) Low [C a-+] induces p i  integrin clustering along ECM fibrils, which may be caused 
by an increase in receptor affinity for the ligands. (B) High [Ca-+] causes diffusion of pi 
integrins out of focal adhesions, and this may be due to a decrease in the affinity of the 
receptors for the ligands. [Ca-+]-induced redistribution of pi receptors does not require 
actin stress fibers, nor detectable amounts of focal adhesion proteins. Moreover, high 
[Ca“ +]-induced receptor diffusion can be quasi-reversed by incubation at low [Ca^+j 
(full arrow), while low [Ca^+J-induced receptor clustering along ECM fibrils can only be 
affected by incubation in the presence of receptor function-blocking antibodies (dotted 
arrow). (C) Low [C a-+] is unable to induce clustering along ECM of integrins with 
deleted pi cytoplasmic domain. In this respect, the finding that activating pi antibodies 
are able to induce redistribution of the truncated receptors suggests that low [C a-+] is not 
sufficient to activate the truncated integrins, and that low [Ca-+]-mediated activation of 
the wildtype receptor acts via mechanisms requiring the cytoplasmic domain of the pi 
subunit.
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The observation that integrin distribution can not be altered by changing the 
[Ca2+] in the medium of intact CEFs (not shown), can be explained by thinking that 
other factors present in intact cells, and probably lost during VPMs preparation, are 
responsible for the control of integrin distribution and function in vivo. On the other 
hand, Stuiver et a l  (1996) have shown that (33 integrin distribution in intact MO-63 
osteosarcoma cells can be regulated by extracellular divalent cation, implicating different 
mechanisms for different receptors and/or cell types.
In favour of a physiological role of extracellular Ca2+ on integrin function, it has 
been found that free [Ca2+] in the extracellular space is not invariable as previously 
thought, but can be modified during different biological activities that involve integrin 
function, such as platelet aggregation, kératinocytes differentiation in the skin, and even 
during embryonic development, in blood, cerebrospinal fluid and lung (see Maurer et a l, 
1996, for a review).
2) Intracellular action of Ca2+.
Integrin activation is often mediated by intracellular signals ("inside-out" 
signalling) that change the affinity of integrins for their ligands (Faull, et al., 1993; 
Crowe et a l ,  1994; O'Toole, et al., 1994). In particular, limiting quantities of 
intracellular factors may bind to (3 integrin cytoplasmic domains to modulate ligand 
binding affinity (Chen et a l,  1994; Shattil et a l,  1995; Colanus, et a l ,  1996; Chang et 
a l,  1996). Integrin affinity for the ligand is regulated during important biological events, 
such as cell migration and mitosis, concomitantly with the intracellular [Ca2+] (Alteraifi 
and Zhelev, 1997; Anilkumar et ah, 1996). Moreover, integrins are known to increase 
the intracellular [Ca2"1"] in many cell types (Ingber et a i,  1990; Hendey and Maxfield, 
1993;, Shankar et a l,  1993; Zimolo et a l,  1994; Sjaadtad et a l ,  1996), and integrin- 
mediated C a2+-signalling has been postulated to participate in a feedback loop that 
regulates integrin-mediated cell adhesion (Sjaastad et ah, 1994). The molecular 
mechanism of intracellular Ca2+ action on integrin function is not known. Although in 
our experiments 1 mM [Ca2+] gave a more dramatic redistribution of (31 integrins, the 
effect was evident already at 10 pM (not shown). It could be argued that 10 pM 
intracellular [Ca2+] is still too high to be considered a physiological condition. In this 
regard, it is noteworthy that local [Ca2+]s nearby the plasma membrane could be higher 
than the one measured with the usual soluble calcium dyes. Moreover, it has been 
described that during fibroblasts contraction, transient plasma membrane passages for 
Ca2+ uptake are formed (Lin et a l,  1997). Interestingly, Haas and Plow (1996) have 
demonstrated the formation of a ternary complex between the cytoplasmic domains of
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a l lb  and (33 and a cation. This finding raises the possibility that Ca2+ may act by 
directly binding to integrins, although an analogous complex with (31 integrins has not 
been demonstrated yet. More likely, Ca2"*" could bind to an intracellular factor preserved 
after VPMs preparation, which in turn would directly or indirectly control integrin 
function. The irreversibility of the low Ca2"*"-mediated effect could be explained by a loss 
of a Ca2"*"-sensing factor from the membrane after incubation at low Ca2"*". A possible 
candidate for a Ca2"*"-sensing integrin regulator is calreticulin, a Ca2"*"-binding protein 
known to interact with the a  chain of integrins in an inducible manner, and proposed to 
stabilise the high affinity state of integrins (Rojjani et a i,  1991; Coppolino et a i ,  1995; 
Coppolino et a i, 1997). Unfortunately, by using an anti-calreticulin antibody, we were 
unable to obtain a specific staining for this protein on VPMs (not shown). Another 
candidate for a Ca2+-binding integrin regulator is suggested by studies on migrating 
neurophils, where intracellular Ca2 "*" transients control integrin-mediated adhesion, 
through the action of Ca2+-calmodulin-activated protein phosphatase 2B (calcineurin) 
(Lawson and Maxfield, 1995). Interestingly, a Ca2+- and integrin-binding protein with 
homology to calcineurin B has been identified which interacts with the cytoplasmic tail of 
the integrin a l lb  (Naik, et a i,  1997). Protein kinase C is known to be activated by Ca2"*" 
and to participate in focal adhesion regulation in different cell types (Tang et a i,  1993; 
Woods and Couchman, 1992). Moreover, the receptor for activated protein kinase C 
(Rack 1) has recently been shown to interact with (31, (32 and (35 cytoplasmic tails 
(Liliental et a i, 1998).
Further work will be necessary for a better understanding of the molecular 
mechanisms of Ca2+-mediated integrin redistribution and regulation, and the described 
"cell-free" system would be useful to facilitate the identification of the molecules involved 
in this process.
4.4 RECONSTITUTION STUDIES ON VPMs
Ex novo reconstitution of adhesive complexes from purified components is made 
difficult by the fact that focal adhesion assembly occurs at the plasma membrane where 
clusters of receptors are necessary, and both extracellular ligands and the intracellular 
milieu may be required. Another major achievement of my work is the reconstitution and 
modulation of the distribution of a receptor complex in actin-depleted VPMs. 
Reconstitution of the binding of focal adhesion proteins to permeabilised or partially
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for the ligand can be modulated. The use of purified a-actinin, an actin binding protein 
known to interact in vitro with the cytoplasmic tail of integrins (Otey et a i,  1990) resulted 
in decoration of actin stress fibers, confirming published observations (Geiger, 1981). 
Interactions of integrins with the cytoskeleton via talin (Horwitz et al ; 1986) and a -  
actinin (Otey et a i ,  1990) are thought to occur as a consequence of integrin-ligand 
engagement, thus contributing to the formation of focal-adhesion complexes. The novel 
finding from this study is that after disruption of stress fibers by gelsolin, we can still 
observe binding of exogenous a-actinin to VPMs in conditions of both high or low 
affinity of the receptors for the ligands, although a different affinity for the two forms of 
the receptor can not be excluded. The pattern of distribution of exogenous a-actinin 
overlaps with that of p i  integrins, and is equally dependent on the [Ca^+J (Fig.4.3 A). 
The low [Ca-+]-induced codistribution of pre-bound, exogenous a-actinin with 
endogenous p i  receptors strongly indicates that they are part of the same complex (Fig. 
4.3A). These results suggest that molecular interactions which are believed to be 
important for focal adhesion assembly can be reconstituted in a "cell-free" system, and 
that modulation of the partially reconstituted receptor complex is feasible in this 
experimental setup. Moreover, the observation that a-actinin can bind to both the active 
and the inactive form of the receptor suggests a revision of the simple model indicating 
integrins binding to the cytoskeleton as an event subsequent to receptor activation by the 
ligand.
Reconstitution experiments with VPMs have also evidenced a special property of 
focal adhesion complexes in recruiting exogenous actin under conditions in which actin 
polymerisation is inhibited (diagram of Fig. 4.3B-1 and 4.3B-2). The concentration of 
cytochalasin D used should indeed block the barbed ends of the actin filaments present 
(Cooper, 1987). On the other hand, the amount of DNase I used should block all pointed 
ends and may also bind to the exogenous G-actin. If this is true, exogenous G-actin 
recruitment to preformed actin filaments should be prevented. Our finding indicates that 
the actin filament ends are still available at focal adhesions, suggesting that these sites 
must protect the actin filaments from cytochalasin D and DNase I. One alternative 
explanation could be that focal adhesions contain proteins which may specifically recruit 
available G-actin monomers or dimers, by interacting to available sites on the actin 
molecule. Such a complex may regulate filament growth and may have the ability to 
nucleate actin polymerisation under appropriate conditions. The finding that the
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Figure 4.3.  Schematic summary of the reconstitution experiments on  
V P M s .
(A) Exogenous a-actinin bound to actin-depleted VPMs colocalises with p i  integrins at 
high [Ca^+J (1), and redistributes with integrins along ECM fibrils at low [Ca~+] (2).
(B) Exogenous actin added to VPMs polymerises along stress fibers (1). Under 
conditions which prevent actin polymerisation (in the presence of cytochalasin D and 
DNase I), recruitment along stress fibers is prevented, but exogenous actin is still 
specifically recruited to focal adhesions (2). In reconstitution studies, a complex between 
activated integrins and a-actinin is not sufficient to recruit exogenous actin on VPMs 
when actin polymerisation is prevented (3).
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reconstituted integrin-a-actinin complex fails to support recruitment of exogenous G- 
actin to the cell membrane (diagram Fig. 4.3B-3) is not surprising, considering that a -  
actinin is a bundling protein, able to interact with F-actin. On the other hand, this results 
would support the hypothesis that exogenous actin is recruited as monomers in the focal 
adhesions of VPMs, and that focal adhesions represent preferential actin nucléation sites
on the membrane.
4.5 FINAL CONCLUSIONS AND PERSPECTIVES
Several conclusions can be drawn from the characterisation and use of VPMs as a 
"cell-free" system to study integrin function and focal adhesions regulation:
1) In VPMs, Rac 1 and ezrin localise on the actin cytoskeleton and in focal adhesions,
respectively.
2) Focal adhesions represent sites for specific accumulation of the tyrosine- 
phosphorylated form of focal adhesion components, such as paxillin.
3) [Ca2+] affects (31 integrin localisation in a cytoskeleton-independent manner, and a
correlation exists between the pattern of distribution of the receptors and their activation 
state.
4) The relocalisation of the receptors in the presence of low [Ca2+] requires the 
cytoplasmic portion of the integrin (31 subunit.
5) The use of the "cell-free" system has allowed the partial reconstitution of a [Ca-+]- 
modulated receptor complex in F-actin-depleted membranes.
6) Focal adhesions represent a site for specific recruitment of exogenous actin under
conditions that prevent actin polymerisation along stress fibers.
Altogether, these results show that modulation of integrin affinity in the presence 
of the extracellular ligands is not sufficient to organise focal contacts, although it is 
sufficient to induce integrin clustering along ECM fibrils. On the other hand, the 
possibility to reconstitute receptor complexes in a "cell-free" system where integrins are 
maintained in an intact lidip bilayer, and their function can be modulated, will open the 
possibility for further reconstitution studies on the functional interactions occurring at 
focal adhesion sites. Furthermore, the identification of experimental conditions allowing 
specific recruitment of actin into focal adhesions, together with the localisation on the 
actin cytoskeleton of proteins known to play a central role in the regulation of the 
cytoskeleton, can be utilised to further explore the molecular machinery connecting 
adhesive receptors to actin organisation by utilising the described cell-free system.
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